Verzeichnis der lebensrettenden Transplantationen

Wir lagern Stammzellen sicher für die jeweilige Familie ein. Diese bleiben jederzeit Eigentum der Familie und werden ausschliesslich für ihre eigenen medizinischen Behandlungen freigegeben.

Darüber hinaus engagiert sich die FamiCord Gruppe auch im Bereich von Spenden: Über unser internationales Netzwerk von Transplantationszentren konnten bereits mehr als 7’000 Patientinnen und Patienten erfolgreich mit Stammzellen aus den Laboren der Gruppe therapiert werden – sowohl mit für die eigene Familie freigegebenen Stammzellen („related“) als auch mit freiwillig gespendeten Stammzellen („unrelated“).

In der Liste sehen Sie, aus welcher Quelle die Stammzellen stammen, bei welchen Diagnosen sie eingesetzt wurden und vieles mehr.

 

Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

Lp.QuelleQuellentypDiagnoseMedizinbereichAnwendungsjahrTherapieLandAlter des Empfängers
1Cord TissueAllogeneic - Related Chronic renal disease Endocrinology2025Experimental TherapyRomania50
2Cord TissueAllogeneic - RelatedAutismNeurology2025Experimental TherapyRomania6
3Cord TissueAutologousAutismNeurology2025Experimental TherapyRomania6
4Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland57,2
5Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland3,1
6Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland3,4
7Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland2,8
8Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland5,9
9Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland11,9
10Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland54,2
11Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland78,4
12Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland6,8
13Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland58,2
14Cord TissueAutologousAutismNeurology2025Experimental TherapyRomania5
15Cord TissueAllogeneic - RelatedAutismNeurology2025Experimental TherapyRomania5
16Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland4,1
17Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland7,9
18Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland7,8
19Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland25,8
20Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland6,8
21Cord TissueAllogeneic - UnrelatedProgressive bulbar palsyNeurology2025Experimental TherapyPoland62,3
22Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2025Experimental TherapyPoland67,2
23Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland7,8
24Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2025Experimental TherapyPoland61,9
25Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland5,11
26Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland6,8
27Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland1,5
28Cord TissueAllogeneic - UnrelatedMyelitisNeurology2025Experimental TherapyPoland38,8
29Cord TissueAllogeneic - UnrelatedAnemiaNeurology2025Experimental TherapyPoland3,2
30Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland6,8
31Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland7,1
32Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2025Experimental TherapyPoland5,1
33Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland1,2
34Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2025Experimental TherapyPoland1,1
35Cord TissueAllogeneic - UnrelatedAutismNeurology2025Experimental TherapyPoland5,11
36Cord BloodAllogeneic - RelatedThalassemia MajorHematology2025Standard TherapyTurkey5,9
37Cord BloodAutologousAplastic AnemiaHematology2025Standard TherapyPoland2
38Cord BloodAllogeneic - RelatedThalassemia MajorHematology2025Standard TherapyTurkey6,8
39Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2025Experimental TherapyPortugal1 year and 8 months
40Cord BloodAutologousAutismNeurology2025Experimental TherapyRomania5
41Cord BloodAllogeneicAcute lymphoblastic leukemiaHematology2025Standard TherapyPoland13
42Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland5 ,5
43Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland7,2
44Cord BloodAllogeneicThalassemia MajorHematology2025Standard TherapyTurkey10,9
45Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland4,1
46Cord BloodAutologousCerebral PalsyNeurology2025Experimental TherapyPoland3,1
47Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland5,2
48Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland2,11
49Cord BloodAutologousUnbalanced AVSDCardiovascular2025Experimental TherapyPoland5 months
50Cord BloodAllogeneic - RelatedRelapsed Lymphoblastic LeukemiaHematology2025Standard TherapyTurkey8,5
51Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland10,1
52Cord BloodAutologousAutismNeurology2025Experimental TherapyPoland5,7
53Bone Marrow FamilyAllogeneicMyelofibrosisHematology2025Standard TherapyPoland71
54Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom72
55Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance47
56Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUkraine43
57Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly49
58Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance51
59Bone Marrow FamilyAllogeneicPhiladelphia - positive Acute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany61
60Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance58
61Bone Marrow FamilyAllogeneicMyelofibrosisHematology2025Standard TherapyNETHERLANDS63
62Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland65
63Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyFrance63
64Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland68
65Bone Marrow FamilyAllogeneicMyelofibrosisHematology2025Standard TherapyFrance71
66Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyRussia51
67Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany62
68Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCzechia54
69Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom16
70Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA61
71Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPoland61
72Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly70
73Bone Marrow FamilyAllogeneicpostET myelofibrosisHematology2025Standard TherapyNetherlands21
74Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland68
75Bone Marrow FamilyAllogeneicAcute Myelogenous Leukemia/ Mielodysplastic SyndromeHematology2025Standard TherapyGermany65
76Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyNETHERLANDS60
77Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA33
78Bone Marrow FamilyAllogeneicMuscular Dystrophy AssociationHematology2025Standard TherapyUnited Kingdom75
79Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2025Standard TherapyGermany72
80Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA77
81Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance23
82Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany58
83Bone MarrowAllogeneicAplastic AnemiaHematology2025Standard TherapySpain15
84Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyNorway55
85Bone MarrowAllogeneicInherited Immune System DisorderHematology2025Standard TherapyFrance3
86Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA7
87Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUkraine36
88Bone MarrowAllogeneicInherited Immune System DisorderHematology2025Standard TherapyFrance10
89Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA76
90Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland39
91Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySouth Africa6
92Bone MarrowAllogeneicWiskott-Aldrich syndromeHematology2025Standard TherapyTurkey6
93Bone MarrowAllogeneicCombined immnunodeficiencyHematology2025Standard TherapyUkraine3 months
94Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2025Standard TherapyPoland3
95Bone MarrowAllogeneicMixed Phenotype Acute LeukemiaHematology2025Standard TherapyPoland13
96Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland7
97Bone MarrowAllogeneicB-cell precursor Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland56
98Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland43
99Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland19
100Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2025Standard TherapyPoland12
101Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland5
102Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland10 months
103Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland6
104Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland44
105Bone MarrowAllogeneicParoxysmal Nocturnal HemoglobinuriaHematology2025Standard TherapyPoland25
106Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2025Standard TherapyPoland4
107Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUSA21
108Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly12
109Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyHungary10
110Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCzechia68
111Bone MarrowAllogeneicAdrenoleukodystrophyHematology2025Standard TherapyPoland53
112Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany4
113Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyFrance4
114Bone MarrowAllogeneicParoxysmal Nocturnal HemoglobinuriaHematology2025Standard TherapyNorway18
115Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapySpain24
116Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyBelarus5
117Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyGermany53
118Bone MarrowAllogeneicdiamond-Balckfan anemiaHematology2025Standard TherapyGermany11
119Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland57
120Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland61
121Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyFrance3
122Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBelarus1
123Bone MarrowAllogeneicpB-Acute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany15
124Bone MarrowAllogeneicOHID XIAP - Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis ProteinHematology2025Standard TherapySwitzerland2
125Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA46
126Bone MarrowAllogeneicAcquired Idiopathic Sideroblastic AnemiaHematology2025Standard TherapyRussian Federation5
127Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA10
128Bone MarrowAllogeneicHodgkin LymphomaHematology2025Standard TherapyUSA47
129Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCROATIA11
130Bone MarrowAllogeneicJuvenile myelomonocytic leukemiaHematology2025Standard TherapyPoland5
131Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyBrazil12
132Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyAustralia8
133Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly3
134Bone MarrowAllogeneicMyelodysplatic SyndromeHematology2025Standard TherapyUSA60
135Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyRussia36
136Bone MarrowAllogeneicThalassemia majorHematology2025Standard TherapyTurkey10
137Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland58
138Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland2
139Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUSA18
140Bone MarrowAllogeneicOther Non-Malignant Disease, SpecifyHematology2025Standard TherapyUSA17
141Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA15
142Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly15
143Bone MarrowAllogeneicaplastic anemiaHematology2025Standard TherapyBelgium36
144Bone MarrowAllogeneicPrimary RefractoryHematology2025Standard TherapyIreland27
145Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA39
146Bone MarrowAllogeneicSickle Cell Disease (SCD)Hematology2025Standard TherapyItaly8
147Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA68
148ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany58
149ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA34
150ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly61
151ApheresisAllogeneicMyelodysplastic Syndrome/Myeloproliferative neoplasmHematology2025Standard TherapyNETHERLANDS62
152ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyAustria68
153ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany70
154ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany66
155ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA77
156ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUkraine12
157ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany58
158ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA67
159ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland4
160ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA73
161ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany56
162ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly50
163ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland39
164ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyLithuania43
165ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPoland66
166ApheresisAllogeneicMultiple MyelomaHematology2025Standard TherapyUSA61
167ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyAustria55
168ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly69
169ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyDenmark 67
170ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUnited Kingdom75
171ApheresisAllogeneicT - cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland24
172ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyBelgium68
173ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUkraine42
174ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA50
175ApheresisAllogeneicProlymphocytic LeukemiaHematology2025Standard TherapyUSA62
176ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUnited Kingdom62
177ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyUSA69
178ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany85
179ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA54
180ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyUSA39
181ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany45
182ApheresisAutologousAcute myeloid leukemiaHematology2025Standard TherapyGermany59
183ApheresisAllogeneicMultiple myelomaHematology2025Standard TherapyGermany68
184ApheresisAllogeneicMultiple myelomaHematology2025Standard TherapyGermany68
185ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany73
186ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany66
187ApheresisAutologousAcute myeloid leukemiaHematology2025Standard TherapyGermany69
188ApheresisAutologousHodgkin lymphomaHematology2025Standard TherapyGermany38
189ApheresisAllogeneicTcell acute leukemiaHematology2025Standard TherapyRomania31
190ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly37
191ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden69
192ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA55
193ApheresisAllogeneicFanconi's AnemiaHematology2025Standard TherapyRussia14
194ApheresisAllogeneicPeripheral T-cell Lymphoma not otherwise specifiedHematology2025Standard TherapyGermany54
195ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance63
196ApheresisAllogeneicMyeloid SarcomaHematology2025Standard TherapyPoland48
197ApheresisAllogeneicOther Myelofibrosis/MyelosclerosisHematology2025Standard TherapyUSA72
198ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyGermany11
199ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA37
200ApheresisAllogeneicMyelofibrosisHematology2025Standard TherapyAustralia59
201ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA35
202ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland51
203ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany59
204ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland70
205ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA70
206ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA66
207ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany63
208ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany66
209ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyItaly61
210ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA71
211ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2025Standard TherapyCzechia45
212ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBrazil61
213ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyHungary35
214ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyNETHERLANDS48
215ApheresisAllogeneicMantle Cell LymphomaHematology2025Standard TherapyIreland62
216ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland62
217ApheresisAllogeneicAcute Myeloid Leukemia, Myelodysplasia-RelatedHematology2025Standard TherapyRussia53
218ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany56
219ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA68
220ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany70
221ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany62
222ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany53
223ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany52
224ApheresisAutologousDiffuse large B-cell lymphomaHematology2025Standard TherapyGermany63
225ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany72
226ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany64
227ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany74
228ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany65
229ApheresisAllogeneicT-cell prolymphocytic leukemiaHematology2025Standard TherapyGermany53
230ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany70
231ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany61
232ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland54
233ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland41
234ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland32
235ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland72
236ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyPoland52
237ApheresisAllogeneicChronic Myeloid LeukemiaHematology2025Standard TherapyPoland50
238ApheresisAllogeneicT-cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland17
239ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland66
240ApheresisAllogeneicMultiple Myeloma Hematology2025Standard TherapyPoland49
241ApheresisAllogeneicChronic Granulomatous DiseaseHematology2025Standard TherapyPoland5
242ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland55
243ApheresisAllogeneicDiffuse Large B-cell LymphomaHematology2025Standard TherapyPoland68
244ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland64
245ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland51
246ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland58
247ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland65
248ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland61
249ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland65
250ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland19
251ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland65
252ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2025Standard TherapyPoland47
253ApheresisAllogeneicPolycythemia VeraHematology2025Standard TherapyPoland61
254ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland56
255ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland53
256ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland55
257ApheresisAllogeneicMyelodysplastic Syndrome, Myeloproliferative NeoplasmsHematology2025Standard TherapyPoland34
258ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland50
259ApheresisAllogeneicMyelodysplastic DisordersHematology2025Standard TherapyPoland71
260ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyPoland64
261ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland54
262ApheresisAutologousNon-Hodgkin lymphomaHematology2025Standard TherapyGermany50
263ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany50
264ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany35
265ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany54
266ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany52
267ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany61
268ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany55
269ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany64
270ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany68
271ApheresisAllogeneicPrimary myelofibrosisHematology2025Standard TherapyGermany71
272ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany47
273ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany58
274ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany68
275ApheresisAutologousMultiple myelomaHematology2025Standard TherapyPortugal44
276ApheresisAutologousMultiple myelomaHematology2025Standard TherapyPortugal59
277ApheresisAutologousLymphoma non-HodgkinHematology2025Standard TherapyPortugal58
278ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden59
279ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland2
280ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA41
281ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyFrance48
282ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden64
283ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUnited Kingdom63
284ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance64
285ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA58
286ApheresisAllogeneicMyelodysplastic Syndrome, Myeloproliferative NeoplasmsHematology2025Standard TherapyPoland68
287ApheresisAllogeneicMyelodysplastic Syndrome, Myeloproliferative NeoplasmsHematology2025Standard TherapyGermany59
288ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland56
289ApheresisAllogeneicDiffuse Large B-cell LymphomaHematology2025Standard TherapyBelarus53
290ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA60
291ApheresisAllogeneicImmunodeficiency – LRBAHematology2025Standard TherapyTurkey14
292ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyPoland20
293ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA65
294ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUkraine54
295ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA75
296ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA58
297ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland48
298ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland37
299ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyChile40
300ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany72
301ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySwitzerland65
302ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPortugal68
303ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyEstonia9
304ApheresisAllogeneicHodgkin LymphomaHematology2025Standard TherapyUSA63
305ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySweden67
306ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyLithuania45
307ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland59
308ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland69
309ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany64
310ApheresisAllogeneicAcute lymphoblastic leukemiaHematology2025Standard TherapyGermany42
311ApheresisAutologousPrimary central nervous system lymphomaHematology2025Standard TherapyGermany64
312ApheresisAllogeneicmyelodysplastic syndrome/ Acute myeloid leukemiaHematology2025Standard TherapyGermany62
313ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany42
314ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany55
315ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany72
316ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany58
317ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany65
318ApheresisAutologousFollicular lymphomaHematology2025Standard TherapyGermany67
319ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany70
320ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany60
321ApheresisAutologousMultiple myelomaHematology2025Standard TherapyPortugal64
322ApheresisAutologousMultiple myelomaHematology2025Standard TherapyPortugal63
323ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany67
324ApheresisAutologousAcute myeloid leukemiaHematology2025Standard TherapyGermany60
325ApheresisAutologousHodgkin lymphoma rezidivHematology2025Standard TherapyGermany65
326ApheresisAutologousNon-Hodgkin lymphomaHematology2025Standard TherapyGermany64
327ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany67
328ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany70
329ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany62
330ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany62
331ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany66
332ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA55
333ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland60
334ApheresisAllogeneicFanconi's AnemiaHematology2025Standard TherapyUkraine6
335ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA69
336ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyLithuania54
337ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyMacedonia56
338ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyCROATIA64
339ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA75
340ApheresisAllogeneicT-cell LymphomaHematology2025Standard TherapyNETHERLANDS65
341ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland65
342ApheresisAllogeneicMyeloid SarcomaHematology2025Standard TherapyBrazil48
343ApheresisAllogeneicT-cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland17
344ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyUnited Kingdom13
345ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA69
346ApheresisAllogeneicT-cell Acute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland13
347ApheresisAllogeneicB-cell precursor Acute Lymphoblastic LeukemiaHematology2025Standard TherapySlovakia67
348ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA72
349ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly52
350ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBelgium64
351ApheresisAllogeneicMyelofibrosisHematology2025Standard TherapyItaly68
352ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyCanada56
353ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA64
354ApheresisAllogeneicOther Myelofibrosis/MyelosclerosisHematology2025Standard TherapyUSA55
355ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA64
356ApheresisAllogeneicMyelodysplastic disorderHematology2025Standard TherapyFrance63
357ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany63
358ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA20
359ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance23
360ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA73
361ApheresisAllogeneicInherited Immune System DisorderHematology2025Standard TherapyFrance9
362ApheresisAllogeneicLymphoma - DLBCLHematology2025Standard TherapyUnited Kingdom55
363ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany61
364ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyLithuania58
365ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany73
366ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland35
367ApheresisAllogeneicChronic myelomonocytic leukemiaHematology2025Standard TherapyGermany65
368ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany70
369ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany66
370ApheresisAutologousDiffuse large B-cell lymphomaHematology2025Standard TherapyGermany42
371ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyNetherlands65
372ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA60
373ApheresisAllogeneicPost MielofibrosisHematology2025Standard TherapyPoland66
374ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA74
375ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland17
376ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyUSA72
377ApheresisAllogeneicT-cell prolymphocytic leukemiaHematology2025Standard TherapyNew Zealand64
378ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany62
379ApheresisAllogeneicmielofibrosisHematology2025Standard TherapyFinland68
380ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland35
381ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA34
382ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBelgium63
383ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapyPoland72
384ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapySwitzerland69
385ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland52
386ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom26
387ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany50
388ApheresisAllogeneicChronic Lymphocyte LeukemiaHematology2025Standard TherapyPoland71
389ApheresisAllogeneicanaplastic large cell lymphomaHematology2025Standard TherapyGermany3
390ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyUSA71
391ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA29
392ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUkraine38
393ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyPoland28
394ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland46
395ApheresisAllogeneicHodking lymphomaHematology2025Standard TherapySpain28
396ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapySlovakia52
397ApheresisAllogeneicT-NHL Angioimmunoblastic T-cell LymphomaHematology2025Standard TherapyGermany56
398ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA71
399ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly23
400ApheresisAllogeneicMielodysplastic syndromeHematology2025Standard TherapySpain69
401ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyBrazil71
402ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUnited Kingdom36
403ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany58
404ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapyGermany68
405ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA61
406ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA35
407ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA39
408ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySerbia58
409ApheresisAllogeneicHodgkin LymphomaHematology2025Standard TherapyUSA47
410ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapyNetherlands62
411ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA69
412ApheresisAllogeneicT-cell LymphomaHematology2025Standard TherapyUnited Kingdom35
413ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany71
414ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany70
415ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany61
416ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany71
417ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany39
418ApheresisAutologousPrimary central nervous system lymphomaHematology2025Standard TherapyGermany64
419ApheresisAllogeneicMyelodysplastic syndromeHematology2025Standard TherapyGermany56
420ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany65
421ApheresisAllogeneicMyelofibrosisHematology2025Standard TherapyGermany65
422ApheresisAllogeneicAcute myeloid leukemiaHematology2025Standard TherapyGermany60
423ApheresisAutologousHodgkin lymphomaHematology2025Standard TherapyGermany32
424ApheresisAllogeneicMyelodysplastic syndromeHematology2025Standard TherapyGermany67
425ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany56
426ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyColumbia62
427ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA46
428ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapyUSA66
429ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland46
430ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom33
431ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance31
432ApheresisAllogeneicB-Acute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany62
433ApheresisAllogeneicB-Acute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA62
434ApheresisAllogeneicHemophagocytic lymphohistiocytosisHematology2025Standard TherapyCzechia27
435ApheresisAllogeneicShwachman-Diamond SyndromeHematology2025Standard TherapySpain11
436ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland67
437ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCanada60
438ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCROATIA43
439ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyUSA69
440ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyAustria61
441ApheresisAllogeneicOther Immune SystemHematology2025Standard TherapyUSA62
442ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA74
443ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland63
444ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA66
445ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyDenmark 50
446ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany62
447ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyAustralia71
448ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany76
449ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyCanada66
450ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany74
451ApheresisAllogeneicMorbus HodgkinHematology2025Standard TherapyGermany21
452ApheresisAllogeneicMyelodysplastic DisordersHematology2025Standard TherapyFrance66
453ApheresisAllogeneicMielodysplastic SyndromeHematology2025Standard TherapyUSA65
454ApheresisAllogeneicT Lymphoblastic LymphomaHematology2025Standard TherapyPortugal25
455ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyRomania29
456ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance37
457ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany49
458ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland32
459ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany72
460ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA43
461ApheresisAllogeneicHodking lymphomaHematology2025Standard TherapySerbia32
462ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCanada66
463ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany71
464ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA66
465ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA68
466ApheresisAllogeneicOMDS/ Myeloproliferative NeoplasieHematology2025Standard TherapySwitzerland46
467ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA3
468ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2025Standard TherapyUSA75
469ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA58
470ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGreece63
471ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA64
472ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany65
473ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapySpain49
474ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland30
475ApheresisAllogeneicsAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany66
476ApheresisAllogeneicChronic Lymphocyte LeukemiaHematology2025Standard TherapyCanada55
477ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2025Standard TherapyUSA64
478ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyPoland16
479ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2025Standard TherapyUSA73
480ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUkraine47
481ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA64
482ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance67
483ApheresisAllogeneicOther Myelofibrosis/MyelosclerosisHematology2025Standard TherapyUSA65
484ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyGermany58
485ApheresisAllogeneicNon-Hodgkin LymphomaHematology2025Standard TherapyGermany57
486ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyRUSSIAN FEDERATION22
487ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUkraine33
488ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapySlovakia41
489ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyGreece54
490ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUkraine46
491ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyArgentina26
492ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA70
493ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany59
494ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland34
495ApheresisAllogeneicMyelofibrosisHematology2025Standard TherapyNorway53
496ApheresisAllogeneicOther Immune SystemHematology2025Standard TherapyUSA19
497ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyPoland6
498ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA68
499ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany72
500ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyGermany64
501ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUnited Kingdom33
502ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyItaly63
503ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyLithuania33
504ApheresisAutologousCentral nervous system lymphoma Hematology2025Standard TherapyGermany61
505ApheresisAllogeneicAcute lymphocytic leukemiaHematology2025Standard TherapyGermany51
506ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany64
507ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany54
508ApheresisAutologousTesticular tumorHematology2025Standard TherapyGermany42
509ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany52
510ApheresisAutologousT-cell lymphomaHematology2025Standard TherapyGermany49
511ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany73
512ApheresisAutologousMultiple myelomaHematology2025Standard TherapyGermany62
513ApheresisAutologousLymphoma HodgkinHematology2025Standard TherapyPortugal39
514ApheresisAutologousMultiple MyelomaHematology2025Standard TherapyGermany60
515ApheresisAutologousMultiple MyelomaHematology2025Standard TherapyGermany70
516ApheresisAutologousMultiple MyelomaHematology2025Standard TherapyGermany64
517ApheresisAutologousT-Cell LymphomaHematology2025Standard TherapyGermany60
518ApheresisAutologousMultiple MyelomaHematology2025Standard TherapyGermany62
519ApheresisAutologousMantle Cell LymphomaHematology2025Standard TherapyGermany60
520ApheresisAutologousMultiple MyelomaHematology2025Standard TherapyGermany43
521ApheresisAllogeneicMyeofibrosisHematology2025Standard TherapyPoland37
522ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyRussia22
523ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyNETHERLANDS66
524ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance57
525ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom56
526ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA78
527ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyUSA65
528ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany53
529ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPortugal41
530ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUnited Kingdom56
531ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA22
532ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland36
533ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyCanada65
534ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA71
535ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapySweden73
536ApheresisAllogeneicNK LGL LeukemiaHematology2025Standard TherapyUSA42
537ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyItaly29
538ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany71
539ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany68
540ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyCzechia64
541ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyUSA10
542ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyBrazil57
543ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyLithuania21
544ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapyLithuania54
545ApheresisAllogeneicRichter Transformation From CLLHematology2025Standard TherapyPoland55
546ApheresisAllogeneicRichter Transformation From CLLHematology2025Standard TherapyPoland63
547ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyGermany68
548ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyFrance55
549ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyItaly26
550ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyNETHERLANDS63
551ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyPoland33
552ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyKAZAKHSTAN10
553ApheresisAllogeneicSevere Aplastic AnemiaHematology2025Standard TherapyItaly53
554ApheresisAllogeneicHodking LymphomaHematology2025Standard TherapyBelgium62
555ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2025Standard TherapyUSA54
556ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2025Standard TherapyPoland66
557ApheresisAllogeneicMyelodysplastic SyndromeHematology2025Standard TherapySpain47
558ApheresisAllogeneicT-Cell LymphomaHematology2025Standard TherapyPoland25
559ApheresisAutologousMultiple MyelomaHematology2025Standard TherapyPortugal62
560ApheresisAutologousNo DataHematology2025Standard TherapyPortugal65
561Cord TissueAutologousAutismNeurology2024Experimental TherapyRomania6
562Cord TissueAllogeneic - RelatedAutismNeurology2024Experimental TherapyRomania6
563Cord TissueAutologousAutismNeurology2024Experimental TherapyRomania4
564Cord TissueAllogeneic - RelatedAutismNeurology2024Experimental TherapyRomania6
565Cord TissueAllogeneic - UnrelatedDegenerative and Traumatic CartilageOrthopedy2024Experimental TherapyPoland50,3
566Cord TissueAllogeneic - UnrelatedDegenerative and Traumatic CartilageOrthopedy2024Experimental TherapyPoland49,5
567Cord TissueAllogeneic - UnrelatedDegenerative and Traumatic CartilageOrthopedy2024Experimental TherapyPoland58,11
568Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2024Experimental TherapyPoland7,7
569Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2024Experimental TherapyPoland15,7
570Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2024Experimental TherapyPoland48,1
571Cord TissueAllogeneic - RelatedSevere Pulmonary Hypertension +Mitral RegurgitationCardiovascular/Pulmonary2024Experimental TherapyRomania2,6
572Cord TissueAllogeneic - UnrelatedAmyotrophic lateral sclerosisNeurology2024Experimental TherapyPoland57,6
573Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2024Experimental TherapyPoland68,2
574Cord TissueAllogeneic - RelatedAutismNeurology2024Experimental TherapyRomania17
575Cord TissueAutologousAutismNeurology2024Experimental TherapyRomania7
576Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2024Experimental TherapyPoland61,9
577Cord TissueAllogeneic - UnrelatedDegenerative and traumatic cartilage damageOrthopedy2024Experimental TherapyPoland45,4
578Cord TissueAllogeneic - UnrelatedAmyotrophic lateral sclerosisNeurology2024Experimental TherapyPoland56,9
579Cord TissueAllogeneic - UnrelatedGraft-versus-host diseaseHematology2024Experimental TherapyPoland0,10
580Cord TissueAllogeneic - UnrelatedAmyotrophic lateral sclerosisNeurology2024Experimental TherapyPoland39,0
581Cord TissueAllogeneic - UnrelatedGvHDNeurology2024Experimental TherapyPoland9,2
582Cord TissueAllogeneic - UnrelatedCerebral palsyNeurology2024Experimental TherapyPoland5,11
583Cord TissueAllogeneic - UnrelatedCerebral palsyNeurology2024Experimental TherapyPoland13,10
584Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2024Experimental TherapyPoland1,9
585Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2024Experimental TherapyPoland7,11
586Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2024Experimental TherapyPoland1
587Cord TissueAllogeneic - UnrelatedCerebellar-spinal ataxiaNeurology2024Experimental TherapyPoland35,5
588Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2024Experimental TherapyPoland1,9
589Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2024Experimental TherapyPoland4,5
590Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania11
591Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania10
592Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania6
593Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania4
594Cord BloodAutologousAutismNeurology2024Experimental TherapyRomania5
595Cord BloodAllogeneicCerebral PalsyNeurology2024Experimental TherapyPoland3,5
596Cord BloodAllogeneicCerebral PalsyNeurology2024Experimental TherapyPoland7,7
597Cord BloodAutologousCPNeurology2024Experimental TherapyHungary4
598Cord BloodAutologousPervasive Developmental DisorderNeurology2024Experimental TherapyPoland3,7
599Cord BloodAutologousPervasive Developmental DisorderNeurology2024Experimental TherapyPoland5,9
600Cord BloodAutologousPervasive developmental disorderNeurology2024Experimental TherapyPoland4,8
601Cord BloodAllogeneic - Relatedfanconi aplastic anemiaHematology2024Standard TherapyTurkey12
602Cord BloodAutologousNeuroblastomaNeurology2024Standard TherapyPoland4
603Cord BloodAutologousPervasive developmental disorderNeurology2024Experimental TherapyPoland9,9
604Cord BloodAutologousAutismNeurology2024no dataSlovakia4
605Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
606Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
607Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland75
608Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland56
609Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland23
610Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland54
611Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
612Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
613Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
614Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland48
615Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany72
616Bone Marrow FamilyAllogeneicChronic Lymphocytic Leukemia Richter TransformationHematology2024Standard TherapyPoland55
617Bone Marrow FamilyAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland63
618Bone Marrow FamilyAllogeneicFollicular LymphomaHematology2024Standard TherapyPoland48
619Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland65
620Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany58
621Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland70
622Bone Marrow FamilyAllogeneicMyelodysplastic Syndrome - Refractory Cytopenia Of ChildhoodHematology2024Standard TherapyPoland14
623Bone Marrow FamilyAllogeneicMyelodysplastic Syndrome/ Myeloproliferative NeoplasmsHematology2024Standard TherapyGermany61
624Bone Marrow FamilyAllogeneicMyelodysplastic Syndrome-MPNHematology2024Standard TherapyPoland71
625Bone Marrow FamilyAllogeneicMyelofibrosisHematology2024Standard TherapyPoland68
626Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland64
627Bone Marrow FamilyAllogeneicPolycythemia Vera/MyelofibrosisHematology2024Standard TherapyPoland74
628Bone Marrow FamilyAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyGermany62
629Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland68
630Bone Marrow FamilyAllogeneicmyelodysplasiaHematology2024Standard TherapyUnited Kingdom57
631Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany69
632Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA58
633Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA60
634Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland71
635Bone Marrow FamilyAllogeneicHigh risk Myelodysplastic SyndromeHematology2024Standard TherapyGermany69
636Bone Marrow FamilyAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA74
637Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland15
638Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland8
639Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland12
640Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland8
641Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland52
642Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland57
643Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
644Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland5
645Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland54
646Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland56
647Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland3
648Bone MarrowAllogeneicAdrenoleukodystrophyHematology2024Standard TherapyPoland7
649Bone MarrowAllogeneicAdrenoleukodystrophyHematology2024Standard TherapyPoland7
650Bone MarrowAllogeneicAdrenoleukodystrophyHematology2024Standard TherapyPoland9
651Bone MarrowAllogeneicB-Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland7
652Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2024Standard TherapyPoland4
653Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2024Standard TherapyPoland41
654Bone MarrowAllogeneicChronic Lymphocytic Leukemia Richter TransformationHematology2024Standard TherapyPoland55
655Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland67
656Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland12
657Bone MarrowAllogeneicDiffuse Large B-Cell LymphomaHematology2024Standard TherapyPoland61
658Bone MarrowAllogeneicGenetically Determined ThrombocytopeniaHematology2024Standard TherapyPoland4
659Bone MarrowAllogeneicHigh Risk Acute Myeloid LeukaemiaHematology2024Standard TherapyPoland13
660Bone MarrowAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland32
661Bone MarrowAllogeneicInherited Metabolic DiseaseHematology2024Standard TherapyPoland11
662Bone MarrowAllogeneicMds-Rcc RelapseHematology2024Standard TherapyPoland14
663Bone MarrowAllogeneicMixed Cellularity Hodgkin LymphomaHematology2024Standard TherapyPoland43
664Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland14
665Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland8
666Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland14
667Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
668Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland9
669Bone MarrowAllogeneicOsteopetrosis type BHematology2024Standard TherapyPoland13
670Bone MarrowAllogeneicOther LeukemiaHematology2024Standard TherapyPoland9
671Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2024Standard TherapyPoland7
672Bone MarrowAllogeneicPrimary Immunodeficiency Xlp-1Hematology2024Standard TherapyPoland18
673Bone MarrowAllogeneicRelapse T-Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland12
674Bone MarrowAllogeneicSecondary Acute Myelogenous LeukemiaHematology2024Standard TherapyPoland4
675Bone MarrowAllogeneicSecondary Acute Myelogenous LeukemiaHematology2024Standard TherapyPoland15
676Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland7
677Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland3
678Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland10
679Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland21
680Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland18
681Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland49
682Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland16
683Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland24
684Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland13
685Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland14
686Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland21
687Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland7
688Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2024Standard TherapyPoland2
689Bone MarrowAllogeneicSevere Congenital NeutropeniaHematology2024Standard TherapyPoland1
690Bone MarrowAllogeneicShwachman-Diamond SyndromeHematology2024Standard TherapyPoland10
691Bone MarrowAllogeneicSickle Cell Disease Hematology2024Standard TherapyPoland9
692Bone MarrowAllogeneicBiphenotypic Acute Leukemia Hematology2024Standard TherapyUkraine10
693Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland58
694Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyUnited Kingdom12
695Bone MarrowAllogeneichemophagocytic lymphohistiocytosisHematology2024Standard TherapySweden4 months
696Bone MarrowAllogeneicSevere combined immunodeficiencyHematology2024Standard TherapyGermany1
697Bone MarrowAllogeneicBeta-Thalassemia MajorHematology2024Standard TherapyIndia11
698Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyAustria4
699Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyNorway33
700Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapySpain 16
701Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapySwitzerland5
702Bone MarrowAllogeneicT- Acute Lymphoblastic LeukemiaHematology2024Standard TherapyIreland6
703Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland12
704Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2024Standard TherapyUSA4 months
705Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyBelgium50
706Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyFrance31
707Bone MarrowAllogeneicChronic myelomonocytic leukemiaHematology2024Standard TherapyItaly64
708Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyFrance10
709Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland12
710Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyUSA4
711Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyCanada8
712Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland17
713Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyUSA8
714Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyUSA67
715Bone MarrowAllogeneicHodgkins LymphomaHematology2024Standard TherapyUnited Kingdom36
716Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA72
717Bone MarrowAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA9
718Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2024Standard TherapyUSA3
719ApheresisAllogeneicA- ThalassemiaHematology2024Standard TherapyPoland11
720ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland13
721ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland21
722ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland22
723ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland38
724ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany41
725ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland44
726ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland44
727ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland48
728ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland50
729ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany50
730ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland55
731ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland59
732ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany60
733ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland63
734ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland44
735ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland59
736ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland51
737ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland34
738ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland1
739ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland10
740ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland20
741ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland25
742ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland26
743ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland28
744ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland34
745ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland35
746ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland37
747ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland38
748ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland38
749ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland40
750ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland41
751ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland43
752ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland51
753ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland51
754ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland51
755ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland59
756ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland59
757ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
758ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
759ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
760ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland61
761ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland61
762ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
763ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
764ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
765ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
766ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
767ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland67
768ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland67
769ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland68
770ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
771ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
772ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
773ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
774ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland69
775ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
776ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland70
777ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland72
778ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland73
779ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland77
780ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland59
781ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
782ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland58
783ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland54
784ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland29
785ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
786ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland27
787ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
788ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland63
789ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland50
790ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
791ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland30
792ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland68
793ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland77
794ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland60
795ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland47
796ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
797ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
798ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
799ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland61
800ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland64
801ApheresisAllogeneicAcute Myelogenous Leukemia- Core-Binding FactorHematology2024Standard TherapyPoland68
802ApheresisAllogeneicAcute Myelogenous Leukemia, Post MyelofibrosisHematology2024Standard TherapyPoland63
803ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany36
804ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany46
805ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany48
806ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany52
807ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany58
808ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany61
809ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyPoland67
810ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany71
811ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany72
812ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany63
813ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapyGermany32
814ApheresisAutologousAcute Myeloid Leukemia - RelapseHematology2024Standard TherapyGermany68
815ApheresisAllogeneicAcute Myeloid Leukemia RelapseHematology2024Standard TherapyGermany33
816ApheresisAllogeneicAmegakaryocytic/Congenital ThrombocytopeniaHematology2024Standard TherapyPoland63
817ApheresisAllogeneicAnaplastic Large Cell LymphomaHematology2024Standard TherapyPoland52
818ApheresisAllogeneicAngioimmunoblastic T-Cell LymphomaHematology2024Standard TherapyPoland47
819ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland19
820ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2024Standard TherapyPoland62
821ApheresisAllogeneicB-Cell Progenitor Acute Lymphoblastic Leukemia High RiskHematology2024Standard TherapyPoland4
822ApheresisAllogeneicCalr Positive MyelofibrosisHematology2024Standard TherapyPoland61
823ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2024Standard TherapyPoland60
824ApheresisAllogeneicChronic Myelogenous LeukaemiaHematology2024Standard TherapyPoland62
825ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland10
826ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland35
827ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyGermany42
828ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland49
829ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyPoland72
830ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2024Standard TherapyPoland71
831ApheresisAllogeneicFanconi Aplastic AnemiaHematology2024Standard TherapyPoland20
832ApheresisAllogeneicFollicular LymphomaHematology2024Standard TherapyPoland48
833ApheresisAllogeneicHigh Risk Acute Myeloid LeukaemiaHematology2024Standard TherapyPoland15
834ApheresisAllogeneicHigh Risk Myelodysplastic SyndromeHematology2024Standard TherapyPoland69
835ApheresisAllogeneicHigh-Risk Myelodysplastic SyndromeHematology2024Standard TherapyPoland71
836ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland27
837ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland27
838ApheresisAllogeneicHodgkin DiseaseHematology2024Standard TherapyPoland28
839ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyPoland23
840ApheresisAllogeneicHypoplastic Myelodysplastic Syndrome/Acute Myelogenous LeukemiaHematology2024Standard TherapyPoland71
841ApheresisAllogeneicInfant Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland41
842ApheresisAllogeneicKutanes T-Zell-Lymphom, Mycosis FungoidesHematology2024Standard TherapyPoland72
843ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany51
844ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany64
845ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany66
846ApheresisAutologousMantle Cell LymphomaHematology2024Standard TherapyGermany52
847ApheresisAutologousMorbus HodgkinHematology2024Standard TherapyGermany63
848ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyPoland43
849ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany52
850ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany54
851ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany60
852ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany61
853ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
854ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
855ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
856ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
857ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany63
858ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany64
859ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany65
860ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany65
861ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany66
862ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany66
863ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany67
864ApheresisAllogeneicMultiple MyelomaHematology2024Standard TherapyGermany68
865ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany69
866ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany70
867ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany71
868ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany72
869ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany66
870ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
871ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany58
872ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany61
873ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany61
874ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany62
875ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany70
876ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany74
877ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany58
878ApheresisAutologousMultiple MyelomaHematology2024Standard TherapyGermany63
879ApheresisAllogeneicMyelodysplasticHematology2024Standard TherapyPoland68
880ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland20
881ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland22
882ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland54
883ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany58
884ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland60
885ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland62
886ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland65
887ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
888ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
889ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
890ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany69
891ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany69
892ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland70
893ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany71
894ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland73
895ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany60
896ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland53
897ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland69
898ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland59
899ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland60
900ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland49
901ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland52
902ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland63
903ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland66
904ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland58
905ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland67
906ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland65
907ApheresisAllogeneicMyelodysplastic Syndrome + MyelomaHematology2024Standard TherapyGermany67
908ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyPoland40
909ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyPoland58
910ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2024Standard TherapyPoland60
911ApheresisAllogeneicMyelofibrosis Post. Polycythemia VeraHematology2024Standard TherapyPoland66
912ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2024Standard TherapyPoland67
913ApheresisAllogeneicMyelomaHematology2024Standard TherapyGermany65
914ApheresisAllogeneicMyeloproliferative Neoplasms Hematology2024Standard TherapyPoland74
915ApheresisAllogeneicMyeloproliferative Neoplasms/Myelodysplastic SyndromeHematology2024Standard TherapyPoland68
916ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany23
917ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany50
918ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland50
919ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany67
920ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland46
921ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyPoland65
922ApheresisAutologousNon-Hodgkin LymphomaHematology2024Standard TherapyGermany66
923ApheresisAutologousNon-Hodgkin Lymphoma - relapseHematology2024Standard TherapyGermany54
924ApheresisAutologousNonseminomaHematology2024Standard TherapyGermany38
925ApheresisAllogeneicOsteomyelitisHematology2024Standard TherapyPoland65
926ApheresisAllogeneicPost-Et-MyelofibrosisHematology2024Standard TherapyPoland59
927ApheresisAllogeneicPost-Pv-MyelofibrosisHematology2024Standard TherapyPoland64
928ApheresisAutologousPrimary Central Nervous System LymphomaHematology2024Standard TherapyGermany60
929ApheresisAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyPoland52
930ApheresisAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyPoland67
931ApheresisAllogeneicPrimary MyelofibrosisHematology2024Standard TherapyPoland70
932ApheresisAllogeneicRelapsed B-Cell Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland12
933ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland15
934ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland10
935ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyPoland60
936ApheresisAllogeneicSevere Aplastic Anemia Progressed To Myelodysplastic SyndromeHematology2024Standard TherapyPoland21
937ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany63
938ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany64
939ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany56
940ApheresisAutologousHodgkin LymphomaHematology2024Standard TherapyGermany56
941ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany64
942ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany56
943ApheresisAutologousFollicular lymphomaHematology2024Standard TherapyGermany58
944ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
945ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany47
946ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany69
947ApheresisAutologousHodgkin LymphomaHematology2024Standard TherapyGermany38
948ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
949ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany70
950ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany64
951ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany53
952ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany60
953ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany59
954ApheresisAutologousMantle cell lymphomaHematology2024Standard TherapyGermany45
955ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany66
956ApheresisAutologousHodgkin LymphomaHematology2024Standard TherapyGermany33
957ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany64
958ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany59
959ApheresisAllogeneicPrimary myelofibrosisHematology2024Standard TherapyGermany55
960ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany63
961ApheresisAllogeneicBlastic Plasmacytoid DendriticHematology2024Standard TherapyUSA57
962ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland32
963ApheresisAllogeneicMacrofocal multiple myeloma Hematology2024Standard TherapyUSA75
964ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUnited Kingdom62
965ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA52
966ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany48
967ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUnited Kingdom71
968ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyRomania35
969ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyLithuania47
970ApheresisAllogeneicDiffuse large B-cell lymphomaHematology2024Standard TherapyAustralia46
971ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA65
972ApheresisAllogeneicChronic lymphatic leukemiaHematology2024Standard TherapyNorway52
973ApheresisAllogeneicChronic myelogenous leukemiaHematology2024Standard TherapyPoland60
974ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyHungary32
975ApheresisAllogeneicMalignant histiocytosisHematology2024Standard TherapyBulgaria41
976ApheresisAllogeneicMyelodysplastic syndromeHematology2024Standard TherapyUSA78
977ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyHungary20
978ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly58
979ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPortugal67
980ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly63
981ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyLithuania19
982ApheresisAllogeneicHodgkin lymphomaHematology2024Standard TherapyRussia34
983ApheresisAllogeneicchronic lymphocytic leukemia Richters TransformationHematology2024Standard TherapyUnited Kingdom68
984ApheresisAllogeneicmyelodysplasiaHematology2024Standard TherapySweden66
985ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly52
986ApheresisAllogeneicmyelodysplasiaHematology2024Standard TherapyLithuania70
987ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany72
988ApheresisAllogeneicplasma cell leukemiaHematology2024Standard TherapyUSA59
989ApheresisAllogeneicFibrolamellar CarcinomaHematology2024Standard TherapyCzechia41
990ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly59
991ApheresisAllogeneicpost-ET MyelofibroseHematology2024Standard TherapyAustria61
992ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA55
993ApheresisAllogeneicMyeloma MultiplexHematology2024Standard TherapyPoland67
994ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapySpain45
995ApheresisAllogeneicMyelofibroseHematology2024Standard TherapySpain69
996ApheresisAllogeneicMyelofibroseHematology2024Standard TherapyPoland60
997ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyUSA53
998ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance35
999ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly69
1000ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyNorway18
1001ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyGermany51
1002ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland62
1003ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyHungary56
1004ApheresisAllogeneicSevere Aplastic AnemiaHematology2024Standard TherapyUSA19
1005ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapySpain67
1006ApheresisAllogeneicemophagocytic lymphohistiocytosisHematology2024Standard TherapyUnited Kingdom48
1007ApheresisAllogeneicNon-Hodgkin's lymphomaHematology2024Standard TherapyNETHERLANDS61
1008ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany29
1009ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
1010ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyIsrael63
1011ApheresisAllogeneicETP-Acute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland35
1012ApheresisAllogeneicHodgkin lymphomaHematology2024Standard TherapyPoland4
1013ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany23
1014ApheresisAllogeneicFanconi AnemiaHematology2024Standard TherapyUSA27
1015ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA69
1016ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA44
1017ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland49
1018ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA20
1019ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance50
1020ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA74
1021ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyAustria49
1022ApheresisAllogeneicPost-PV MyelofibroseHematology2024Standard TherapyGermany59
1023ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA66
1024ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland58
1025ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany55
1026ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyFrance70
1027ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyFrance54
1028ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA68
1029ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyPoland41
1030ApheresisAllogeneicChronic myelogenous leukemiaHematology2024Standard TherapyUSA31
1031ApheresisAllogeneicOther leukemiaHematology2024Standard TherapyItaly31
1032ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapySweden42
1033ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany43
1034ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany52
1035ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany64
1036ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany60
1037ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany70
1038ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
1039ApheresisAllogeneicPrimary myelofibrosisHematology2024Standard TherapyGermany55
1040ApheresisAutologousAmyloid light-chain amyloidosisHematology2024Standard TherapyGermany55
1041ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany61
1042ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
1043ApheresisAutologousEpstein–Barr virus positive diffuse large B-cell lymphomaHematology2024Standard TherapyGermany63
1044ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany69
1045ApheresisAutologousAngioimmunoblastic T-cell lymphomaHematology2024Standard TherapyGermany58
1046ApheresisAllogeneicAcute lymphoblastic leukemiaHematology2024Standard TherapyGermany19
1047ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany66
1048ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany61
1049ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyCanada16
1050ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany61
1051ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA75
1052ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2024Standard TherapyUSA62
1053ApheresisAllogeneicMyelodysplastic DisordersHematology2024Standard TherapyFrance66
1054ApheresisAllogeneicB-Cell LymphomaHematology2024Standard TherapyCanada70
1055ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly60
1056ApheresisAllogeneicMyeloma MultiplexHematology2024Standard TherapyPoland57
1057ApheresisAllogeneicDiffuse large B-cell lymphomaHematology2024Standard TherapyPoland17
1058ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland48
1059ApheresisAllogeneicChronic lymphocytic leukemiaHematology2024Standard TherapyGermany63
1060ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland65
1061ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA64
1062ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA76
1063ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland44
1064ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland62
1065ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyNETHERLANDS25
1066ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapyUSA42
1067ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyCROATIA66
1068ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA70
1069ApheresisAllogeneicNon-Hodgkin LymphomaHematology2024Standard TherapySwitzerland68
1070ApheresisAllogeneicChronic Myelomonocytic LeukaemiaHematology2024Standard TherapyNETHERLANDS62
1071ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2024Standard TherapyUSA58
1072ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany62
1073ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyBelarus54
1074ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapySpain9
1075ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland66
1076ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance67
1077ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance54
1078ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapySouth Africa54
1079ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany60
1080ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapySweden60
1081ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapySpain67
1082ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany66
1083ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany53
1084ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany65
1085ApheresisAutologousNon-Hodgkin lymphoma, rezidivHematology2024Standard TherapyGermany64
1086ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany57
1087ApheresisAllogeneicAcute myeloid leukemiaHematology2024Standard TherapyGermany66
1088ApheresisAllogeneicAcute lymphoblastic leukemiaHematology2024Standard TherapyGermany50
1089ApheresisAutologousMultiple myelomaHematology2024Standard TherapyGermany57
1090ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA70
1091ApheresisAllogeneicMultiple Organ Dysfunction SyndromeHematology2024Standard TherapyGermany42
1092ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA32
1093ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA76
1094ApheresisAllogeneicHodgkin LymphomaHematology2024Standard TherapyItaly63
1095ApheresisAllogeneicEarly T-cell precursor Acute Lymphoblastic LeukemiaHematology2024Standard TherapyAustralia43
1096ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA72
1097ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyGermany72
1098ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland52
1099ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyUSA73
1100ApheresisAllogeneicMyelofibrosisHematology2024Standard TherapyPoland68
1101ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyItaly63
1102ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyCzechia46
1103ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyFrance64
1104ApheresisAllogeneicPrimary ImmunodeficienciesHematology2024Standard TherapyRussia7
1105ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany68
1106ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany62
1107ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany48
1108ApheresisAllogeneicMyelodysplastic SyndromeHematology2024Standard TherapyUSA63
1109ApheresisAllogeneicAcute Myeloid LeukemiaHematology2024Standard TherapySpain58
1110ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2024Standard TherapyPoland41
1111ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2024Standard TherapyUSA73
1112ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland15
1113ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyGermany65
1114ApheresisAllogeneicAcute Myelogenous LeukemiaHematology2024Standard TherapyPoland38
1115ApheresisAllogeneicPlasmacytomaHematology2024Standard TherapyPoland46
1116ApheresisAutologousMultiple myelomaHematology2024Standard TherapyPortugal60
1117ApheresisAutologousMultiple myelomaHematology2024Standard TherapyPortugal60
1118Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2023Experimental TherapyPoland8
1119Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2023Experimental TherapyPoland16
1120Cord TissueAllogeneic - RelatedAgs (Autism + Epilepsy)Neurology2023Experimental TherapyPoland/Romania15
1121Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania8,5
1122Cord TissueAutologousAutismNeurology2023Experimental TherapyHungary10
1123Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania4
1124Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania10
1125Cord TissueAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania3,2
1126Cord TissueAutologousCerebral PalsyNeurology2023Experimental TherapyRomania2
1127Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2023Experimental TherapyRomania3
1128Cord TissueAllogeneic - UnrelatedDisorders Of Optic NerveOphthalmology2023Experimental TherapyPoland39,1
1129Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2023Experimental TherapyPoland65,1
1130Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2023Experimental TherapyPoland50,8
1131Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2023Experimental TherapyPoland8 months
1132Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2023Experimental TherapyPoland16,2
1133Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland20,8
1134Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland49,8
1135Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland62,7
1136Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2023Experimental TherapyPoland24,1
1137Cord TissueAllogeneic - UnrelatedMucopolysaccharidosis Type IiHematology2023Experimental TherapyPoland4,7
1138Cord TissueAllogeneic - UnrelatedNon-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The UterusGynecology2023Experimental TherapyPoland47
1139Cord TissueAutologousOptic Nerve Atrophy, Tetraparesis, HydrocephalusNeurology2023Experimental TherapyRomania5,5
1140Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2023Experimental TherapyPoland44,8
1141Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2023Experimental TherapyPoland32,11
1142Cord TissueAllogeneic - UnrelatedPolycystic Ovary SyndromeGynecology2023Experimental TherapyPoland39,4
1143Cord TissueAllogeneic - RelatedRight Parietal Closed SchizencephalyNeurology2023Experimental TherapyRomania38
1144Cord TissueAllogeneic - RelatedRp+ Usher SyndromeNeurology2023Experimental TherapyRomania10
1145Cord TissueAllogeneic - RelatedSudden Sensorineural Hearing Loss (Ssnhl)Neurology2023Experimental TherapyRomania1
1146Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary10
1147Cord BloodAllogeneicAutismNeurology2023Experimental TherapyPoland3,3
1148Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania3
1149Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania3
1150Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania10
1151Cord BloodAutologousAutismNeurology2023Experimental TherapyPortugal7
1152Cord BloodAutologousAutismNeurology2023Experimental TherapyPortugal5
1153Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary14
1154Cord BloodAutologousAutismNeurology2023Experimental TherapyRomania10
1155Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary3
1156Cord BloodAllogeneic - RelatedAutismNeurology2023Experimental TherapyRomania3,2
1157Cord BloodAutologousAutismNeurology2023Experimental TherapyHungary5
1158Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2023Standard TherapyUK8
1159Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2023Experimental TherapyHungary5
1160Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2023Standard TherapyUK2,5
1161Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2023Standard TherapyUK2,5
1162Cord BloodAutologousCerebral PalsyNeurology2023Experimental TherapyPoland2,1
1163Cord BloodAllogeneic - RelatedCerebral Palsy Neurology2023Experimental TherapyRomania10
1164Cord BloodAllogeneic - RelatedCerebral Palsy, Psychomotor Retard, Tetraparesis, MicrocephalyNeurology2023Experimental TherapyRomania9
1165Cord BloodAutologousGlobal Developmental Delay Si Truncal AtaxiaNeurology2023Experimental TherapyRomania5
1166Cord BloodAllogeneicNeuroblastomaHematology2023Standard TherapyTurkey2,1
1167Cord BloodAllogeneic - RelatedNeuroblastomaHematology2023Standard TherapyTurkey2,1
1168Cord BloodAutologousOptic Nerve Atrophy, Tetraparesis, HydrocephalusNeurology2023Experimental TherapyRomania5,5
1169Cord BloodAutologousPervasive Developmental DisorderNeurology2023Experimental TherapyPoland3,11
1170Cord BloodAutologousPervasive Developmental DisorderNeurology2023Experimental TherapyPoland8,1
1171Cord BloodAllogeneic - RelatedSpasmodic TorticollisNeurology2023Experimental TherapyRomania41
1172Cord BloodAllogeneicThalassemia MajorHematology2023Standard TherapyTurkey17,4
1173Cord BloodAllogeneic - RelatedThalassemia MajorHematology2023Standard TherapyTurkey17,4
1174Cord BloodAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland5 months
1175Cord BloodAutologousAutismNeurology2023no dataSlovakia2
1176Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland42
1177Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland41
1178Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany35
1179Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland59
1180Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1181Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland51
1182Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland59
1183Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland42
1184Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland21
1185Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1186Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1187Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland39
1188Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1189Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland42
1190Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1191Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1192Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1193Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
1194Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1195Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland56
1196Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1197Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1198Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1199Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1200Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
1201Bone Marrow FamilyAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland30
1202Bone Marrow FamilyAllogeneicChronic Lymphocytic LeukemiaHematology2023Standard TherapyPoland69
1203Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland60
1204Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland70
1205Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland76
1206Bone Marrow FamilyAllogeneicLangerhans Cell SarcomaHematology2023Standard TherapyPoland66
1207Bone Marrow FamilyAllogeneicMultiple MyelomaHematology2023Standard TherapyPoland63
1208Bone Marrow FamilyAllogeneicMycosis FungoidesHematology2023Standard TherapyPoland71
1209Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland71
1210Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1211Bone Marrow FamilyAllogeneicMyelofibrosisHematology2023Standard TherapyPoland70
1212Bone Marrow FamilyAllogeneicNo DataHematology2023Standard TherapyGermany70
1213Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland55
1214Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1215Bone Marrow FamilyAllogeneicSecondary Chronic Myelomonocytic Leukemia To Acute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1216Bone Marrow FamilyAllogeneicSecondary Myelodysplastic Syndrome With Excess Of BlastsHematology2023Standard TherapyPoland15
1217Bone Marrow FamilyAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland71
1218Bone Marrow FamilyAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland5
1219Bone MarrowAllogeneicAcute Leukemia Of Ambiguous Lineage Hematology2023Standard TherapyPoland1
1220Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland11
1221Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland5
1222Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland16
1223Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland28
1224Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland14
1225Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland1
1226Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland25
1227Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland7
1228Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland4
1229Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland8 months
1230Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland12
1231Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland63
1232Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland5
1233Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland12
1234Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland3
1235Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1236Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland14
1237Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
1238Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland11
1239Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland13
1240Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland17
1241Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland32
1242Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
1243Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland12
1244Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland59
1245Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1246Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland14
1247Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1248Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland75
1249Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1250Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland13
1251Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland6
1252Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland17
1253Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland34
1254Bone MarrowAllogeneicAdrenoleukodystrophyHematology2023Standard TherapyPoland7
1255Bone MarrowAllogeneicAdrenoleukodystrophy (Ald) - Siemerling-Creutzfeldt DiseaseHematology2023Standard TherapyPoland4
1256Bone MarrowAllogeneicAmegakaryocytic ThrombocytopeniaHematology2023Standard TherapyPoland6 months
1257Bone MarrowAllogeneicAnemia FanconiHematology2023Standard TherapyPoland6
1258Bone MarrowAllogeneicAplastic AnemiaHematology2023Standard TherapyPoland18
1259Bone MarrowAllogeneicAplastic AnemiaHematology2023Standard TherapyPoland43
1260Bone MarrowAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland12
1261Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2023Standard TherapyPoland12
1262Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland55
1263Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland57
1264Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland40
1265Bone MarrowAllogeneicChronic Myeloid Leukemia Blast CrisisHematology2023Standard TherapyPoland21
1266Bone MarrowAllogeneicClippers SyndromeHematology2023Standard TherapyPoland49
1267Bone MarrowAllogeneicCongenital Amegakaryocytic Thrombocytopenia (Camt)Hematology2023Standard TherapyPoland6 months
1268Bone MarrowAllogeneicFanconi AnemiaHematology2023Standard TherapyPoland8
1269Bone MarrowAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2023Standard TherapyPoland2
1270Bone MarrowAllogeneicHodgkin’s LymphomaHematology2023Standard TherapyPoland23
1271Bone MarrowAllogeneicImmunodeficiency – Xlp1Hematology2023Standard TherapyPoland10
1272Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2023Standard TherapyPoland5
1273Bone MarrowAllogeneicMantle Cell LymphomaHematology2023Standard TherapyPoland68
1274Bone MarrowAllogeneicMetachromatic LeukodystrophyHematology2023Standard TherapyPoland22
1275Bone MarrowAllogeneicMitochondrial Neurogastrointestinal EncephalopathyHematology2023Standard TherapyPoland33
1276Bone MarrowAllogeneicMixed Lineage Acute Leukemia Hematology2023Standard TherapyPoland4
1277Bone MarrowAllogeneicMonocytopenia And Mycobacterial Infection (Monomac) Syndrome Hematology2023Standard TherapyPoland5
1278Bone MarrowAllogeneicMucopolysaccharidosis Type IHematology2023Standard TherapyPoland2
1279Bone MarrowAllogeneicMucopolysaccharidosis Type Ih (Hurler)Hematology2023Standard TherapyPoland8 months
1280Bone MarrowAllogeneicMucopolysaccharidosis Type Iv Hematology2023Standard TherapyPoland5
1281Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland51
1282Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland11
1283Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland14
1284Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland6
1285Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland7
1286Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland19
1287Bone MarrowAllogeneicNo DataHematology2023Standard TherapyPoland3
1288Bone MarrowAllogeneicNo DataHematology2023Standard TherapyPoland2
1289Bone MarrowAllogeneicNo DataHematology2023Standard TherapyPoland61
1290Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland20
1291Bone MarrowAllogeneicOther Immune SystemHematology2023Standard TherapyPoland6
1292Bone MarrowAllogeneicOther Immune SystemHematology2023Standard TherapyPoland6 months
1293Bone MarrowAllogeneicPrimary Combined Severe ImmunodeficiencyHematology2023Standard TherapyPoland14
1294Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2023Standard TherapyPoland3
1295Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2023Standard TherapyPoland4
1296Bone MarrowAllogeneicProlymphocytic LeukemiaHematology2023Standard TherapyPoland55
1297Bone MarrowAllogeneicRelapsed T Cell Acute Lymphoblastic Leukemia (T-All)Hematology2023Standard TherapyPoland5
1298Bone MarrowAllogeneicSecondary LeukemiaHematology2023Standard TherapyPoland20
1299Bone MarrowAllogeneicSecondary Myelofibrosis Post Polycythemia VeraHematology2023Standard TherapyPoland60
1300Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland11
1301Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland4
1302Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland31
1303Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland49
1304Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland8
1305Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland15
1306Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland17
1307Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland81
1308Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland29
1309Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland15
1310Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2023Standard TherapyPoland1
1311Bone MarrowAllogeneicSickle Cell Disease Hematology2023Standard TherapyPoland5
1312Bone MarrowAllogeneicT-Acute Lymphoblastic Leukemia, Ataxia TelangiectasiaHematology2023Standard TherapyPoland8
1313Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland16
1314Bone MarrowAllogeneicThalassemia MajorHematology2023Standard TherapyPoland2
1315Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2023Standard TherapyPoland21
1316Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland1
1317Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland3
1318ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany67
1319ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland37
1320ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland47
1321ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland16
1322ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland58
1323ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland64
1324ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland66
1325ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland11
1326ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland8
1327ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland52
1328ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland51
1329ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany54
1330ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1331ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland40
1332ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany60
1333ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany40
1334ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland51
1335ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland35
1336ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland65
1337ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland47
1338ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany39
1339ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1340ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland37
1341ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1342ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland19
1343ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland20
1344ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland37
1345ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland42
1346ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland48
1347ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany47
1348ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany64
1349ApheresisAutologousAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany61
1350ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland20
1351ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland65
1352ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland40
1353ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland57
1354ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland44
1355ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland54
1356ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyGermany31
1357ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland30
1358ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland60
1359ApheresisAllogeneicAcute Lymphoblastic Leukemia T-Cell; Myelodysplastic SyndromeHematology2023Standard TherapyPoland72
1360ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany58
1361ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany60
1362ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland32
1363ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland28
1364ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1365ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland70
1366ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1367ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland64
1368ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1369ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland41
1370ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1371ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1372ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1373ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1374ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1375ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1376ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland87
1377ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1378ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1379ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
1380ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1381ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland56
1382ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1383ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland33
1384ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1385ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1386ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1387ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1388ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1389ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1390ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland28
1391ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1392ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1393ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1394ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1395ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland31
1396ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1397ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1398ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland82
1399ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1400ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1401ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland59
1402ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland72
1403ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1404ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland41
1405ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1406ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1407ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany61
1408ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland58
1409ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1410ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland51
1411ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland57
1412ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1413ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland75
1414ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1415ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland7
1416ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland52
1417ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland28
1418ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1419ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland37
1420ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland40
1421ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1422ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1423ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1424ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1425ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1426ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1427ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1428ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1429ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1430ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland35
1431ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland48
1432ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1433ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1434ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1435ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland52
1436ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland74
1437ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland70
1438ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1439ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1440ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland70
1441ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland32
1442ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland49
1443ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland20
1444ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1445ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1446ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland79
1447ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1448ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1449ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1450ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
1451ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1452ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland16
1453ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland44
1454ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland68
1455ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1456ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1457ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1458ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1459ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland72
1460ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1461ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1462ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1463ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1464ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland36
1465ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1466ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland69
1467ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1468ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland1
1469ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1470ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1471ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland56
1472ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland11
1473ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1474ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland37
1475ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland40
1476ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland36
1477ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1478ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland53
1479ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1480ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland72
1481ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland22
1482ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1483ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland64
1484ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyGermany38
1485ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland44
1486ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland46
1487ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1488ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland62
1489ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1490ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland37
1491ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1492ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland61
1493ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland68
1494ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland43
1495ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland73
1496ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland63
1497ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1498ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland39
1499ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland60
1500ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1501ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland47
1502ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland38
1503ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland71
1504ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland50
1505ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland67
1506ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland66
1507ApheresisAllogeneicAcute Myeloid LeukemiaHematology2023Standard TherapyPoland65
1508ApheresisAutologousAnaplastic Lymphoma Kinase Positive Anaplastic Large-Cell LymphomaHematology2023Standard TherapyGermany37
1509ApheresisAllogeneicBare Lymphocyte Syndrome Type IiHematology2023Standard TherapyPoland3 months
1510ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland66
1511ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland49
1512ApheresisAutologousB-Cell LymphomaHematology2023Standard TherapyGermany66
1513ApheresisAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland53
1514ApheresisAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland27
1515ApheresisAllogeneicB-Cell Precursor Acute Lymphocytic Leukemia Hematology2023Standard TherapyPoland51
1516ApheresisAllogeneicBeta Thalassemia MajorHematology2023Standard TherapyPoland4
1517ApheresisAllogeneicBlastic Plasmacytoid Dendritic Cell NeoplasmHematology2023Standard TherapyPoland66
1518ApheresisAllogeneicCell NeoplasmHematology2023Standard TherapyGermany47
1519ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2023Standard TherapyPoland61
1520ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland43
1521ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyGermany36
1522ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland62
1523ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland59
1524ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland37
1525ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland41
1526ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland54
1527ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland61
1528ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyPoland54
1529ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2023Standard TherapyGermany28
1530ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland62
1531ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland65
1532ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2023Standard TherapyPoland64
1533ApheresisAutologousComposite LymphomaHematology2023Standard TherapyGermany71
1534ApheresisAllogeneicCongenital Pulmonary Lymphangiectasia Hematology2023Standard TherapyPoland50
1535ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2023Standard TherapyGermany59
1536ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2023Standard TherapyPoland50
1537ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2023Standard TherapyGermany70
1538ApheresisAllogeneicEwing SarcomaHematology2023Standard TherapyPoland62
1539ApheresisAutologousFollicular LymphomaHematology2023Standard TherapyGermany62
1540ApheresisAllogeneicFollicular LymphomaHematology2023Standard TherapyPoland53
1541ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2023Standard TherapyPoland4 months
1542ApheresisAutologousHodgkin - RelapseHematology2023Standard TherapyGermany43
1543ApheresisAllogeneicHuntington's Disease (Hd)Hematology2023Standard TherapyGermany36
1544ApheresisAllogeneicHypoplastic Myelodysplastic SyndromeHematology2023Standard TherapyPoland27
1545ApheresisAllogeneicImmunodeficiencyHematology2023Standard TherapyPoland4
1546ApheresisAllogeneicInherited Immune System DisorderHematology2023Standard TherapyPoland16
1547ApheresisAllogeneicLangerhans Cell SarcomaHematology2023Standard TherapyPoland66
1548ApheresisAutologousLight-Chain AmyloidosisHematology2023Standard TherapyGermany62
1549ApheresisAllogeneicMacrofocal Multiple Myeloma Hematology2023Standard TherapyPoland94
1550ApheresisAutologousMantle Cell LymphomaHematology2023Standard TherapyGermany54
1551ApheresisAutologousMantle Cell LymphomaHematology2023Standard TherapyGermany64
1552ApheresisAllogeneicMast Cell Sarcoma, Systemic Mastocytosis NrHematology2023Standard TherapyPoland51
1553ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2023Standard TherapyPoland64
1554ApheresisAutologousMorbus HodgkinHematology2023Standard TherapyGermany43
1555ApheresisAutologousMorbus HodgkinHematology2023Standard TherapyGermany57
1556ApheresisAllogeneicMucopolysaccharidosis /Myelodysplastic Syndrome OverlapHematology2023Standard TherapyPoland71
1557ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany47
1558ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany53
1559ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany65
1560ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany60
1561ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1562ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1563ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany72
1564ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany61
1565ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany68
1566ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany54
1567ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany67
1568ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany69
1569ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany61
1570ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1571ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1572ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany61
1573ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany64
1574ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany69
1575ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany58
1576ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany56
1577ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany66
1578ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1579ApheresisAllogeneicMultiple MyelomaHematology2023Standard TherapyPoland56
1580ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany53
1581ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany66
1582ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1583ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1584ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany64
1585ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany63
1586ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany68
1587ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany60
1588ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany42
1589ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany62
1590ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany50
1591ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1592ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany56
1593ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany64
1594ApheresisAutologousMultiple MyelomaHematology2023Standard TherapyGermany59
1595ApheresisAllogeneicMycosis FungoidesHematology2023Standard TherapyPoland62
1596ApheresisAllogeneicMyelodysplastic DisordersHematology2023Standard TherapyPoland57
1597ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland71
1598ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland64
1599ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland67
1600ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland56
1601ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland41
1602ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland70
1603ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland57
1604ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland70
1605ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland47
1606ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland29
1607ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1608ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1609ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland40
1610ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland56
1611ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland69
1612ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland59
1613ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland56
1614ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1615ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1616ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland63
1617ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland64
1618ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland64
1619ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland63
1620ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland65
1621ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland68
1622ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland44
1623ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1624ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland48
1625ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland45
1626ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland67
1627ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland69
1628ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland72
1629ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland53
1630ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland71
1631ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland66
1632ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland57
1633ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland74
1634ApheresisAllogeneicMyelodysplastic SyndromeHematology2023Standard TherapyPoland72
1635ApheresisAllogeneicMyelodysplastic Syndrome Lb High RiskHematology2023Standard TherapyPoland58
1636ApheresisAllogeneicMyelodysplastic Syndrome With Multilineage DysplasiaHematology2023Standard TherapyPoland68
1637ApheresisAllogeneicMyelodysplastic Syndrome/Acute Myelogenous LeukemiaHematology2023Standard TherapyPoland42
1638ApheresisAllogeneicMyelodysplastic Syndrome-Eb1Hematology2023Standard TherapyPoland48
1639ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland73
1640ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland76
1641ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland70
1642ApheresisAllogeneicMyelodysplastic Syndromes (Mds)Hematology2023Standard TherapyPoland5
1643ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland65
1644ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland56
1645ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland70
1646ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland69
1647ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland61
1648ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland70
1649ApheresisAllogeneicMyelofibrosisHematology2023Standard TherapyPoland68
1650ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2023Standard TherapyPoland50
1651ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2023Standard TherapyPoland54
1652ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2023Standard TherapyPoland60
1653ApheresisAllogeneicMyeloma MultiplexHematology2023Standard TherapyPoland63
1654ApheresisAutologousNo DataHematology2023Standard TherapyGermany69
1655ApheresisAutologousNo DataHematology2023Standard TherapyGermany53
1656ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland50
1657ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland23
1658ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland39
1659ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland2
1660ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland52
1661ApheresisAllogeneicNo DataHematology2023Standard TherapyPoland61
1662ApheresisAutologousNo DataHematology2023Standard TherapyGermany60
1663ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland71
1664ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland44
1665ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland72
1666ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland66
1667ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland33
1668ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland42
1669ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland63
1670ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland19
1671ApheresisAllogeneicNon-Hodgkin LymphomaHematology2023Standard TherapyPoland54
1672ApheresisAutologousNonseminoma, RelapseHematology2023Standard TherapyGermany48
1673ApheresisAllogeneicOrofacial Myofunctional Disorders (Omds), Primary Myelofibrosis (Pmf)Hematology2023Standard TherapyPoland69
1674ApheresisAllogeneicOsteomyelofibrosisHematology2023Standard TherapyPoland60
1675ApheresisAllogeneicOther Immune SystemHematology2023Standard TherapyPoland71
1676ApheresisAllogeneicOther MalignancyHematology2023Standard TherapyPoland49
1677ApheresisAllogeneicOther MyelofibrosisHematology2023Standard TherapyPoland56
1678ApheresisAllogeneicOther Non-Malignant DiseaseHematology2023Standard TherapyPoland70
1679ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2023Standard TherapyPoland36
1680ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2023Standard TherapyPoland47
1681ApheresisAutologousPlasma Cell LeukemiaHematology2023Standard TherapyGermany70
1682ApheresisAutologousPlasma Cell LeukemiaHematology2023Standard TherapyGermany56
1683ApheresisAutologousPlasmacytomaHematology2023Standard TherapyGermany63
1684ApheresisAllogeneicPost Therapeutic Myelodysplastic Syndrome /Acute Myelogenous Leukemia After Chronic Lymphocytic LeukemiaHematology2023Standard TherapyPoland60
1685ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2023Standard TherapyPoland38
1686ApheresisAllogeneicPra B-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland20
1687ApheresisAllogeneicPre-B-Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland41
1688ApheresisAllogeneicPre-B-Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland61
1689ApheresisAllogeneicPre-B-Acute Myelogenous LeukemiaHematology2023Standard TherapyPoland11
1690ApheresisAutologousPrimary Central Nervous System LymphomaHematology2023Standard TherapyGermany63
1691ApheresisAutologousPrimary Central Nervous System LymphomaHematology2023Standard TherapyGermany73
1692ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyGermany70
1693ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland68
1694ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland68
1695ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland31
1696ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland63
1697ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyGermany46
1698ApheresisAllogeneicPrimary MyelofibrosisHematology2023Standard TherapyPoland68
1699ApheresisAllogeneicRelapsed B-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland11
1700ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2023Standard TherapyPoland55
1701ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland58
1702ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland36
1703ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland62
1704ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland9
1705ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland28
1706ApheresisAllogeneicSevere Aplastic AnemiaHematology2023Standard TherapyPoland17
1707ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2023Standard TherapyPoland1
1708ApheresisAllogeneicSystemic Mastocytosis Hematology2023Standard TherapyPoland63
1709ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland15
1710ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland28
1711ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland12
1712ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland65
1713ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2023Standard TherapyPoland18
1714ApheresisAllogeneicT-Cell LymphomaHematology2023Standard TherapyPoland65
1715ApheresisAllogeneicThalassemia MajorHematology2023Standard TherapyPoland2
1716ApheresisAllogeneicTreatment-Related Myelodysplastic Syndrome Hematology2023Standard TherapyPoland67
1717ApheresisAllogeneicTreatment-Related Myelodysplastic Syndrome Hematology2023Standard TherapyPoland64
1718ApheresisAllogeneicWiskott-Aldrich SyndromeHematology2023Standard TherapyPoland2
1719Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland15
1720Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland6
1721Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland12
1722Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2022Experimental TherapyPoland7
1723Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2022Experimental TherapyPoland2
1724Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host Disease; Acute Lymphoblastic LeukemiaHematology2022Experimental TherapyPoland4,6
1725Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host Disease; Acute Lymphoblastic LeukemiaHematology2022Experimental TherapyPoland5,4
1726Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland42,8
1727Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland60,5
1728Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland69,7
1729Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland70,5
1730Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland54,2
1731Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2022Experimental TherapyPoland76,1
1732Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,3
1733Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland9,1
1734Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland3,9
1735Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,3
1736Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,8
1737Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7
1738Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland12,8
1739Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,1
1740Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland5,3
1741Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland4,8
1742Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland7
1743Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyRomania14
1744Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland4,9
1745Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland2,6
1746Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,9
1747Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,6
1748Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland5,5
1749Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,4
1750Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,11
1751Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland3,5
1752Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland/Romania6,7
1753Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,8
1754Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,8
1755Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland/Romania8
1756Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland13,7
1757Cord TissueAllogeneic - RelatedAutismNeurology2022Experimental TherapyPoland/Romania10,2
1758Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,4
1759Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,2
1760Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland12,4
1761Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland10,4
1762Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland6,11
1763Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland5,3
1764Cord TissueAllogeneic - UnrelatedAutismNeurology2022Experimental TherapyPoland7,5
1765Cord TissueAllogeneic - UnrelatedBone Marrow Transplant RejectionHematology2022Experimental TherapyPoland2,5
1766Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland8
1767Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,3
1768Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland12,3
1769Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,5
1770Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,6
1771Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,4
1772Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland7,5
1773Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland5,11
1774Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,4
1775Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,1
1776Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2022Experimental TherapyRomania3
1777Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,9
1778Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,8
1779Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland1,5
1780Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland2,4
1781Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland3,3
1782Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland11,8
1783Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland5
1784Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland7
1785Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland7,5
1786Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2022Experimental TherapyPoland1,8
1787Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2022Experimental TherapyPoland21,2
1788Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2022Experimental TherapyPoland51,4
1789Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2022Experimental TherapyPoland8,3
1790Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2022Experimental TherapyPoland18,4
1791Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2022Experimental TherapyPoland6,5
1792Cord TissueAllogeneic - UnrelatedEpilepsy; Global Developmental Delay; Hypoxic EncephalopathyNeurology2022Experimental TherapyPoland3,6
1793Cord TissueAllogeneic - UnrelatedEpileptic EncephalopathyNeurology2022Experimental TherapyPoland2,1
1794Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2022Experimental TherapyPoland10,2
1795Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2022Experimental TherapyPoland56,3
1796Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2022Experimental TherapyPoland38,7
1797Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2022Experimental TherapyPoland49,1
1798Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2022Experimental TherapyPoland1,1
1799Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2022Experimental TherapyPoland2,11
1800Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2022Experimental TherapyPoland16,1
1801Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland2,7
1802Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland11,7
1803Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland4,2
1804Cord TissueAllogeneic - RelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyRomania3
1805Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland2,1
1806Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland2,3
1807Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland4,7
1808Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2022Experimental TherapyPoland7,5
1809Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland47,1
1810Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland22,11
1811Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland49,1
1812Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2022Experimental TherapyPoland54,6
1813Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2022Experimental TherapyPoland62,9
1814Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2022Experimental TherapyPoland2,3
1815Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2022Experimental TherapyPoland1,4
1816Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2022Experimental TherapyPoland25,7
1817Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2022Experimental TherapyPoland14,1
1818Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2022Experimental TherapyPoland26,1
1819Cord TissueAllogeneic - UnrelatedOvarian DysfunctionGynecology2022Experimental TherapyPoland37,11
1820Cord TissueAllogeneic - UnrelatedPremature Ovarian Failure; Status After Oncological Treatment Of Breast CancerGynecology2022Experimental TherapyPoland45,2
1821Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2022Experimental TherapyPoland41,3
1822Cord TissueAllogeneic - UnrelatedSequelae Of Spinal Cord Injury; Condition After A Spinal Cord InjuryNeurology2022Experimental TherapyPoland23,9
1823Cord TissueAllogeneic - UnrelatedSpasmic Paralysis Of The LimbsNeurology2022Experimental TherapyPoland33,9
1824Cord TissueAllogeneic - UnrelatedSpastic Limb ParalysisNeurology2022Experimental TherapyPoland30,11
1825Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2022Experimental TherapyPoland12,11
1826Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2022Experimental TherapyPoland20
1827Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2022Experimental TherapyPoland39,11
1828Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2022Experimental TherapyPoland35,6
1829Cord BloodAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany46
1830Cord BloodAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland9
1831Cord BloodAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany2,5
1832Cord BloodAutologousAutismNeurology2022Experimental TherapyPoland7
1833Cord BloodAutologousAutismNeurology2022Experimental TherapyHungary13
1834Cord BloodAutologousAutismNeurology2022Experimental TherapyPoland8,8
1835Cord BloodAutologousAutismNeurology2022Experimental TherapyRomania5
1836Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2022Experimental TherapyUK11
1837Cord BloodAllogeneic - RelatedChronic Myelogenous LeukemiaHematology2022Standard TherapyTurkey19
1838Cord BloodAutologousHydrocephalusNeurology2022Experimental TherapyRomania6
1839Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2022Standard TherapyTurkey7,7
1840Cord BloodAllogeneic - RelatedThalassemia MajorHematology2022Standard TherapyTurkey19,2
1841Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland3
1842Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland68
1843Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland1
1844Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1845Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland64
1846Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland79
1847Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland23
1848Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1849Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
1850Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
1851Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland46
1852Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1853Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
1854Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
1855Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
1856Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
1857Bone Marrow FamilyAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland54
1858Bone Marrow FamilyAllogeneicBlastic Plasmacytoid Dendritic Cell NeoplasmHematology2022Standard TherapyPoland55
1859Bone Marrow FamilyAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland3
1860Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland60
1861Bone Marrow FamilyAllogeneicChronic Myelomonocytic Leukemia, Type 2Hematology2022Standard TherapyPoland68
1862Bone Marrow FamilyAllogeneicLeukocyte Adhesion DeficiencyHematology2022Standard TherapyPoland33
1863Bone Marrow FamilyAllogeneicMycosis FungoidesHematology2022Standard TherapyPoland62
1864Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
1865Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland66
1866Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland29
1867Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland67
1868Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
1869Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland69
1870Bone Marrow FamilyAllogeneicMyelofibrosisHematology2022Standard TherapyPoland64
1871Bone Marrow FamilyAllogeneicMyelofibrosis Post Essential ThrombocythemiaHematology2022Standard TherapyPoland64
1872Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2022Standard TherapyPoland49
1873Bone Marrow FamilyAllogeneicT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyPoland73
1874Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland3
1875Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland2
1876Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland37
1877Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland16
1878Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland9
1879Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland14
1880Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
1881Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland6
1882Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland38
1883Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1884Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1885Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1886Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland4
1887Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland25
1888Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland8
1889Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland6
1890Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland20
1891Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1892Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
1893Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland15
1894Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland11
1895Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland15
1896Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
1897Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland18
1898Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
1899Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland12
1900Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland44
1901Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland18
1902Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland75
1903Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
1904Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
1905Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland23
1906Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland36
1907Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland17
1908Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
1909Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
1910Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland12
1911Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland16
1912Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland58
1913Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
1914Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland25
1915Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland30
1916Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland18
1917Bone MarrowAllogeneicAdenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) Hematology2022Standard TherapyPoland3 months
1918Bone MarrowAllogeneicAmyloidosisHematology2022Standard TherapyPoland9
1919Bone MarrowAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland19
1920Bone MarrowAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland49
1921Bone MarrowAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
1922Bone MarrowAllogeneicBone Marrow Failure Syndrome Hematology2022Standard TherapyPoland11
1923Bone MarrowAllogeneicChediak-Higashi-SyndromeHematology2022Standard TherapyPoland10
1924Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland37
1925Bone MarrowAllogeneicCombined ImmunodeficiencyHematology2022Standard TherapyPoland7
1926Bone MarrowAllogeneicCommon Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung DiseaseHematology2022Standard TherapyPoland11
1927Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2022Standard TherapyPoland11
1928Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2022Standard TherapyPoland4
1929Bone MarrowAllogeneicDock8 DeficiencyHematology2022Standard TherapyPoland1
1930Bone MarrowAllogeneicEarly Isolated All Bm RelapseHematology2022Standard TherapyPoland6
1931Bone MarrowAllogeneicFanconi AnemiaHematology2022Standard TherapyPoland5
1932Bone MarrowAllogeneicFanconi AnemiaHematology2022Standard TherapyPoland7
1933Bone MarrowAllogeneicFanconi AnemiaHematology2022Standard TherapyPoland16
1934Bone MarrowAllogeneicGriscelli Syndrome Type 2Hematology2022Standard TherapyPoland2 months
1935Bone MarrowAllogeneicHemophagocytic LymphocytosisHematology2022Standard TherapyPoland1
1936Bone MarrowAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2022Standard TherapyPoland46
1937Bone MarrowAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland57
1938Bone MarrowAllogeneicInfant Acute Lymphoblastic Leukemia With Kmt2a Gene RearrangementHematology2022Standard TherapyPoland7 months
1939Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2022Standard TherapyPoland1
1940Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2022Standard TherapyPoland1
1941Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland49
1942Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland16
1943Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
1944Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
1945Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland14
1946Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland15
1947Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland51
1948Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland8
1949Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland12
1950Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
1951Bone MarrowAllogeneicMyelofibrosisHematology2022Standard TherapyPoland56
1952Bone MarrowAllogeneicMyelofibrosisHematology2022Standard TherapyPoland17
1953Bone MarrowAllogeneicNhl (Non-Hodgkin's Lymphoma)Hematology2022Standard TherapyPoland37
1954Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2022Standard TherapyPoland9
1955Bone MarrowAllogeneicNo DataHematology2022Standard TherapyPoland13
1956Bone MarrowAllogeneicNo DataHematology2022Standard TherapyPoland11
1957Bone MarrowAllogeneicNo DataHematology2022Standard TherapyPoland3
1958Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland53
1959Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland37
1960Bone MarrowAllogeneicOsteopetrosisHematology2022Standard TherapyPoland2
1961Bone MarrowAllogeneicOther Immune System DisordersHematology2022Standard TherapyPoland1
1962Bone MarrowAllogeneicOther Non-Malignant DiseaseHematology2022Standard TherapyPoland8
1963Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2022Standard TherapyPoland17
1964Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria With Marrow FailureHematology2022Standard TherapyPoland10
1965Bone MarrowAllogeneicPhiladelphia-Positive Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
1966Bone MarrowAllogeneicPre-B Acute Lymphoblastic Leukemia Hematology2022Standard TherapyPoland32
1967Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2022Standard TherapyPoland3
1968Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2022Standard TherapyPoland9 months
1969Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland46
1970Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland6
1971Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland15
1972Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland65
1973Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland12
1974Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland68
1975Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland15
1976Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland18
1977Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland11
1978Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland19
1979Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland6
1980Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland11
1981Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland35
1982Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland11
1983Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland5
1984Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland30
1985Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland14
1986Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland49
1987Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2022Standard TherapyPoland3 months
1988Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2022Standard TherapyPoland2 months
1989Bone MarrowAllogeneicShwachman-Diamond Syndrome – Sds Hematology2022Standard TherapyPoland7
1990Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland1
1991Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2022Standard TherapyPoland16
1992Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2022Standard TherapyPoland1
1993Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2022Standard TherapyPoland3
1994Bone MarrowAllogeneicX-Linked Congenital DyskeratosisHematology2022Standard TherapyPoland2
1995ApheresisAllogeneicAcute Biphenotypic LeukemiaHematology2022Standard TherapyPoland22
1996ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland41
1997ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland55
1998ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland4
1999ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland29
2000ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland59
2001ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland9
2002ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland57
2003ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland24
2004ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland36
2005ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland24
2006ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland47
2007ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland25
2008ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland29
2009ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland7
2010ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland13
2011ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland7
2012ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland8
2013ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
2014ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland35
2015ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland67
2016ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland69
2017ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland65
2018ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland10
2019ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland49
2020ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland75
2021ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland57
2022ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland14
2023ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland58
2024ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland54
2025ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland58
2026ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany29
2027ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany36
2028ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany57
2029ApheresisAllogeneicAcute MyelofibrosisHematology2022Standard TherapyPoland55
2030ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland69
2031ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
2032ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
2033ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland69
2034ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland30
2035ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
2036ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland74
2037ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland45
2038ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
2039ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
2040ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland78
2041ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland42
2042ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
2043ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland51
2044ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland69
2045ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland25
2046ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland57
2047ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
2048ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
2049ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
2050ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland37
2051ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland38
2052ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
2053ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
2054ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
2055ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2056ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland13
2057ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2058ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland46
2059ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
2060ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
2061ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland59
2062ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland44
2063ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland16
2064ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland49
2065ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
2066ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
2067ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland17
2068ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
2069ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
2070ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland31
2071ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland30
2072ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland58
2073ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland74
2074ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
2075ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
2076ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
2077ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
2078ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland53
2079ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
2080ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2081ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2082ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland77
2083ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland34
2084ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
2085ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2086ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2087ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland76
2088ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
2089ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
2090ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland41
2091ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
2092ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
2093ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland11
2094ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
2095ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland25
2096ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
2097ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
2098ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
2099ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland73
2100ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
2101ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland10
2102ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
2103ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland59
2104ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland45
2105ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
2106ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
2107ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
2108ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland53
2109ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
2110ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland58
2111ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
2112ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
2113ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
2114ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
2115ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
2116ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
2117ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland57
2118ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland70
2119ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
2120ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
2121ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland28
2122ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland88
2123ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland68
2124ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
2125ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
2126ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
2127ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland54
2128ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland71
2129ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
2130ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland1
2131ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
2132ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland66
2133ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
2134ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland40
2135ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland36
2136ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland37
2137ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland26
2138ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland20
2139ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland74
2140ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland55
2141ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland56
2142ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
2143ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland13
2144ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland65
2145ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland48
2146ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland67
2147ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland52
2148ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland50
2149ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
2150ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland35
2151ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland61
2152ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland47
2153ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland34
2154ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
2155ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland60
2156ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland62
2157ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland64
2158ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland29
2159ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
2160ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland1
2161ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland39
2162ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland43
2163ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland63
2164ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyPoland21
2165ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany58
2166ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany45
2167ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany63
2168ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany54
2169ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany48
2170ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany61
2171ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany27
2172ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany61
2173ApheresisAllogeneicAcute Myeloid LeukemiaHematology2022Standard TherapyGermany66
2174ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2022Standard TherapyGermany47
2175ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2022Standard TherapyGermany55
2176ApheresisAllogeneicAcute Promyelocytic LeukemiaHematology2022Standard TherapyPoland49
2177ApheresisAllogeneicAcute Promyelocytic LeukemiaHematology2022Standard TherapyPoland40
2178ApheresisAllogeneicAlk-Positive Anaplastic T-Cell LymphomaHematology2022Standard TherapyPoland15
2179ApheresisAutologousAnaplastic Large Cell LymphomaHematology2022Standard TherapyGermany22
2180ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland22
2181ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland16
2182ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyPoland17
2183ApheresisAllogeneicAplastic AnemiaHematology2022Standard TherapyGermany67
2184ApheresisAllogeneicAtypical Chronic Myeloid Leukemia Hematology2022Standard TherapyPoland62
2185ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland46
2186ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland18
2187ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany54
2188ApheresisAllogeneicBeta Thalassemia MajorHematology2022Standard TherapyPoland11
2189ApheresisAllogeneicC-All Rez (Acute Lymphoblastic Leukemia)Hematology2022Standard TherapyPoland66
2190ApheresisAllogeneicC-All Rez (Acute Lymphoblastic Leukemia)Hematology2022Standard TherapyPoland5
2191ApheresisAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland3
2192ApheresisAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland3
2193ApheresisAllogeneicChronic Granulomatous DiseaseHematology2022Standard TherapyPoland5
2194ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2022Standard TherapyPoland63
2195ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2022Standard TherapyPoland59
2196ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2022Standard TherapyGermany58
2197ApheresisAllogeneicChronic Lymphocytic Leukemia Richter Transformation 7/22Hematology2022Standard TherapyPoland44
2198ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland64
2199ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland67
2200ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland63
2201ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland59
2202ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland64
2203ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2022Standard TherapyPoland60
2204ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland70
2205ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland54
2206ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland63
2207ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland54
2208ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland71
2209ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2022Standard TherapyPoland67
2210ApheresisAllogeneicChronic Myelomonocytic Leukemia, Type 0 (Cmml-0)Hematology2022Standard TherapyPoland64
2211ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2022Standard TherapyPoland66
2212ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2022Standard TherapyPoland72
2213ApheresisAllogeneicCombined Immunodeficiency Syndrome With Hyper-IgmHematology2022Standard TherapyPoland6
2214ApheresisAllogeneicCongenital Dyserythropoietic AnemiaHematology2022Standard TherapyPoland2
2215ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany68
2216ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany65
2217ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany69
2218ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany50
2219ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany56
2220ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany65
2221ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2022Standard TherapyGermany47
2222ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2022Standard TherapyGermany66
2223ApheresisAutologousDiffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic LeukemiaHematology2022Standard TherapyGermany66
2224ApheresisAutologousGerm Cell TumorHematology2022Standard TherapyGermany39
2225ApheresisAutologousGerm Cell TumorHematology2022Standard TherapyGermany33
2226ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2022Standard TherapyPoland12
2227ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2022Standard TherapyPoland21
2228ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland26
2229ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland31
2230ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland53
2231ApheresisAllogeneicHodgkin LymphomaHematology2022Standard TherapyPoland25
2232ApheresisAutologousHodgkin LymphomaHematology2022Standard TherapyGermany67
2233ApheresisAutologousHodgkin Lymphoma-RelapseHematology2022Standard TherapyGermany69
2234ApheresisAutologousHodgkin Lymphoma-RelapseHematology2022Standard TherapyGermany48
2235ApheresisAllogeneicHypoplastic Myelodysplastic SyndromeHematology2022Standard TherapyPoland26
2236ApheresisAllogeneicImmunodeficiencyHematology2022Standard TherapyPoland3
2237ApheresisAllogeneicJuvenile Myelomonocytic LeukemiaHematology2022Standard TherapyPoland5
2238ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany64
2239ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany61
2240ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany52
2241ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany44
2242ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany53
2243ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany49
2244ApheresisAutologousMantle Cell LymphomaHematology2022Standard TherapyGermany64
2245ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2022Standard TherapyPoland64
2246ApheresisAutologousMorbus HodgkinHematology2022Standard TherapyGermany36
2247ApheresisAutologousMorbus HodgkinHematology2022Standard TherapyGermany62
2248ApheresisAutologousMorbus Hodgkin-RelapseHematology2022Standard TherapyGermany63
2249ApheresisAllogeneicMucopolysaccharidosisHematology2022Standard TherapyPoland2
2250ApheresisAllogeneicMucopolysaccharidosis Type IHematology2022Standard TherapyPoland3
2251ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany58
2252ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany53
2253ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany57
2254ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany64
2255ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany50
2256ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany67
2257ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany55
2258ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany73
2259ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany63
2260ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany65
2261ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany58
2262ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany37
2263ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany47
2264ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany68
2265ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany53
2266ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany60
2267ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany60
2268ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany47
2269ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany59
2270ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany64
2271ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany59
2272ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany52
2273ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany73
2274ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany68
2275ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany63
2276ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany66
2277ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany50
2278ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany69
2279ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany57
2280ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany55
2281ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany61
2282ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany64
2283ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany71
2284ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany61
2285ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany62
2286ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany60
2287ApheresisAutologousMultiple MyelomaHematology2022Standard TherapyGermany33
2288ApheresisAllogeneicMultiple Myeloma - RelapseHematology2022Standard TherapyGermany43
2289ApheresisAutologousMultiple Myeloma Angioimmunoblastic T-Cell LymphomaHematology2022Standard TherapyGermany62
2290ApheresisAllogeneicMycosis FungoidesHematology2022Standard TherapyPoland64
2291ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2292ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland69
2293ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland76
2294ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland45
2295ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
2296ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland72
2297ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland70
2298ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland45
2299ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland73
2300ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland21
2301ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland46
2302ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
2303ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
2304ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland49
2305ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2306ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
2307ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
2308ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland72
2309ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland33
2310ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland3
2311ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2312ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland16
2313ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland66
2314ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
2315ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland71
2316ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2317ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland48
2318ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2319ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland48
2320ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland73
2321ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland69
2322ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland79
2323ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland54
2324ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland44
2325ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland63
2326ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland56
2327ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2328ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland72
2329ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2330ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland64
2331ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland65
2332ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland70
2333ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland66
2334ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland88
2335ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland67
2336ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland52
2337ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland57
2338ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland62
2339ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland36
2340ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland61
2341ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyPoland11
2342ApheresisAllogeneicMyelodysplastic SyndromeHematology2022Standard TherapyGermany61
2343ApheresisAllogeneicMyelodysplastic Syndrome - Raeb2Hematology2022Standard TherapyPoland62
2344ApheresisAllogeneicMyelodysplastic Syndrome RcHematology2022Standard TherapyPoland3
2345ApheresisAllogeneicMyelodysplastic Syndrome With Excess Blasts 1Hematology2022Standard TherapyPoland59
2346ApheresisAllogeneicMyelodysplastic Syndrome With Excess Blasts 2Hematology2022Standard TherapyPoland67
2347ApheresisAllogeneicMyelodysplastic Syndrome With FibrosisHematology2022Standard TherapyPoland72
2348ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland58
2349ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland69
2350ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland57
2351ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland64
2352ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland73
2353ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland67
2354ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland66
2355ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland69
2356ApheresisAllogeneicMyelofibrosisHematology2022Standard TherapyPoland60
2357ApheresisAllogeneicMyelofibrosis Myeloid MetaplasiaHematology2022Standard TherapyPoland69
2358ApheresisAllogeneicMyelofibrosis Post Essential ThrombocythemiaHematology2022Standard TherapyPoland64
2359ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2022Standard TherapyPoland58
2360ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2022Standard TherapyPoland72
2361ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2022Standard TherapyPoland73
2362ApheresisAutologousMyelomaHematology2022Standard TherapyGermany54
2363ApheresisAllogeneicMyeloma MultiplexHematology2022Standard TherapyPoland31
2364ApheresisAllogeneicMyeloproliferative Neoplasms With Acute Myeloid LeukemiaHematology2022Standard TherapyGermany59
2365ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland50
2366ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland37
2367ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland64
2368ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland59
2369ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland21
2370ApheresisAllogeneicNo DataHematology2022Standard TherapyPoland38
2371ApheresisAutologousNodular Lymphocyte Predominant Hodgkin LymphomaHematology2022Standard TherapyGermany31
2372ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland73
2373ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland61
2374ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland53
2375ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland18
2376ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland28
2377ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland55
2378ApheresisAllogeneicNon-Hodgkin LymphomaHematology2022Standard TherapyPoland59
2379ApheresisAutologousNon-Hodgkin LymphomaHematology2022Standard TherapyGermany52
2380ApheresisAllogeneicOsteomyelofibrosisHematology2022Standard TherapyPoland59
2381ApheresisAllogeneicOsteomyelofibrosisHematology2022Standard TherapyPoland59
2382ApheresisAllogeneicOther Immune SystemHematology2022Standard TherapyPoland46
2383ApheresisAllogeneicOther MalignancyHematology2022Standard TherapyPoland72
2384ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2022Standard TherapyPoland32
2385ApheresisAllogeneicPlasma Cell DisorderHematology2022Standard TherapyPoland56
2386ApheresisAllogeneicPlasma Cell LeukemiaHematology2022Standard TherapyPoland58
2387ApheresisAllogeneicPost-Essential Thrombocythemia-MyelofibrosisHematology2022Standard TherapyPoland64
2388ApheresisAllogeneicPost–Polycythemia Vera Myelofibrosis (Post-Pv Mf) Hematology2022Standard TherapyPoland48
2389ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany65
2390ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany65
2391ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany58
2392ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany39
2393ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany67
2394ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany37
2395ApheresisAutologousPrimary Central Nervous System LymphomaHematology2022Standard TherapyGermany69
2396ApheresisAllogeneicPrimary MyelofibrosisHematology2022Standard TherapyPoland62
2397ApheresisAllogeneicPrimary MyelofibrosisHematology2022Standard TherapyPoland66
2398ApheresisAllogeneicPrimary MyelofibrosisHematology2022Standard TherapyPoland70
2399ApheresisAllogeneicPrimary Refractory T-Cell LymphomaHematology2022Standard TherapyPoland55
2400ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2022Standard TherapyPoland58
2401ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2022Standard TherapyGermany51
2402ApheresisAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland53
2403ApheresisAllogeneicSevere Aplastic AnemiaHematology2022Standard TherapyPoland45
2404ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2022Standard TherapyPoland3 months
2405ApheresisAllogeneicSezary SyndromeHematology2022Standard TherapyPoland59
2406ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2022Standard TherapyPoland6
2407ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2022Standard TherapyGermany37
2408ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2022Standard TherapyGermany30
2409ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2022Standard TherapyGermany46
2410ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany52
2411ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany51
2412ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany52
2413ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2022Standard TherapyGermany60
2414ApheresisAutologousTesticular CancerHematology2022Standard TherapyGermany48
2415ApheresisAllogeneicThalassemia MajorHematology2022Standard TherapyPoland15
2416Adipose TissueAutologousGonarthrosisOrthopedy2022Experimental TherapyPoland60,11
2417Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2022Experimental TherapyPoland41,9
2418Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2022Experimental TherapyPoland30,1
2419Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2022Experimental TherapyPoland53
2420Skeletal Muscle Allogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Genetic disorder2021Experimental TherapyPoland7
2421Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2021Experimental TherapyPoland7,8
2422Cord TissueAllogeneic - UnrelatedAcute Myeloid Leukemia - Transplantation FailureHematology2021Experimental TherapyPoland13,5
2423Cord TissueAllogeneic - UnrelatedAgs (Autism + Epilepsy)Neurology2021Experimental TherapyPoland13,3
2424Cord TissueAllogeneic - UnrelatedAgs (Autism + Epilepsy)Neurology2021Experimental TherapyRomania13
2425Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland74,4
2426Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland64,11
2427Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland70,11
2428Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland59,2
2429Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland47,9
2430Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2431Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2432Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland66,8
2433Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland28,4
2434Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2435Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2436Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2437Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2438Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2439Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2440Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2441Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2442Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2443Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2444Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland54,11
2445Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2446Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2447Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2448Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2449Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland55,2
2450Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2451Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland70,5
2452Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland54,2
2453Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland58,11
2454Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2455Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2456Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Clinical Trial ALSTEMPolandno data
2457Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland62,4
2458Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2021Experimental TherapyPoland74,6
2459Cord TissueAllogeneic - RelatedAutismNeurology2021Experimental TherapyPoland4
2460Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland9,2
2461Cord TissueAllogeneic - RelatedAutismNeurology2021Experimental TherapyPoland10
2462Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland4,6
2463Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland15,5
2464Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPolandno data
2465Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland7,11
2466Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland6,9
2467Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland4,9
2468Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland12,5
2469Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland12,1
2470Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland7,5
2471Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland8,7
2472Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland11,1
2473Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland5,3
2474Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland4,5
2475Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland8,11
2476Cord TissueAllogeneic - UnrelatedAutismNeurology2021Experimental TherapyPoland6,4
2477Cord TissueAllogeneic - UnrelatedBone Marrow Transplant Rejection; Graft Versus Host DiseaseHematology2021Experimental TherapyPoland6,8
2478Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2021Experimental TherapyPoland59
2479Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland3,1
2480Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland7,1
2481Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland5
2482Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland17
2483Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland6,6
2484Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland6,1
2485Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland1,9
2486Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland11
2487Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland7,11
2488Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland12
2489Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland1,9
2490Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,9
2491Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland7,9
2492Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland1,7
2493Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland4,1
2494Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,11
2495Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland11,4
2496Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland4,3
2497Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland4,1
2498Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland2,11
2499Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland11,6
2500Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,1
2501Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland2
2502Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland3,4
2503Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland9 months
2504Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland2,1
2505Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland23,3
2506Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland22,9
2507Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland3,11
2508Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland5,5
2509Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland8
2510Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyRomania11 months
2511Cord TissueAllogeneic - UnrelatedCerebral Palsy; Developmental DelayNeurology2021Experimental TherapyPoland12,2
2512Cord TissueAllogeneic - UnrelatedCerebral Palsy; Devic SyndromeNeurology2021Experimental TherapyPoland32,5
2513Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2021Experimental TherapyPoland2,6
2514Cord TissueAllogeneic - UnrelatedCondition After Cerebral InfarctionNeurology2021Experimental TherapyPoland42,7
2515Cord TissueAllogeneic - UnrelatedCondition After Knee InjuryOrthopedy2021Experimental TherapyPoland54,5
2516Cord TissueAllogeneic - UnrelatedCondition After Knee InjuryOrthopedy2021Experimental TherapyPoland40,4
2517Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2021Experimental TherapyPoland69,4
2518Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2021Experimental TherapyPoland55,2
2519Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2021Experimental TherapyPoland50,2
2520Cord TissueAllogeneic - UnrelatedDegenerative Disease Of The SpineOrthopedy2021Experimental TherapyPoland51,2
2521Cord TissueAllogeneic - UnrelatedDegenerative Disease Of The SpineOrthopedy2021Experimental TherapyPoland56,2
2522Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2021Experimental TherapyPoland6,5
2523Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2021Experimental TherapyPoland27,2
2524Cord TissueAllogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Hematology2021Experimental TherapyTurkey25
2525Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2021Experimental TherapyPoland35,2
2526Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2021Experimental TherapyPoland2,4
2527Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2021Experimental TherapyPoland6,5
2528Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2529Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2530Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2531Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2532Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPoland21,11
2533Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2534Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2535Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2536Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2537Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2538Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2539Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2540Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2541Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2542Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2543Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2544Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Clinical Trial BIOOPAPolandno data
2545Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2546Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2547Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2548Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2021Experimental TherapyPolandno data
2549Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland6,7
2550Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland9,8
2551Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland9,7
2552Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland2,11
2553Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2021Experimental TherapyPoland5,11
2554Cord TissueAllogeneic - UnrelatedEpileptic Encephalopathy; Global Developmental DelayNeurology2021Experimental TherapyPoland2,8
2555Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2021Experimental TherapyPoland5,7
2556Cord TissueAllogeneic - RelatedGlobal Developmental DelayNeurology2021Experimental TherapyPoland2
2557Cord TissueAllogeneic - UnrelatedGlobal Developmental Delay; EncephalopathyNeurology2021Experimental TherapyPoland2,9
2558Cord TissueAllogeneic - UnrelatedGlobal Developmental Delay; EncephalopathyNeurology2021Experimental TherapyPoland7,8
2559Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland59,11
2560Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland48,6
2561Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland53,6
2562Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland40
2563Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland62,11
2564Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland63
2565Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland72,5
2566Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland58,1
2567Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland46,3
2568Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland50,2
2569Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland51,2
2570Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2021Experimental TherapyPoland52,5
2571Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2021Experimental TherapyPoland4,7
2572Cord TissueAllogeneic - UnrelatedHemiparesisNeurology2021Experimental TherapyPoland37,3
2573Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2021Experimental TherapyPoland30,5
2574Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2021Experimental TherapyPoland7 months
2575Cord TissueAllogeneic - UnrelatedInternal Damage To The Knee JointOrthopedy2021Experimental TherapyPoland44,8
2576Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5,7
2577Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland10,1
2578Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5,5
2579Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland4
2580Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland2
2581Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland9,5
2582Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland4,5
2583Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5
2584Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland5,6
2585Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical DevelopmentNeurology2021Experimental TherapyPoland1,1
2586Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2021Experimental TherapyPoland1,6
2587Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2021Experimental TherapyPoland50,7
2588Cord TissueAllogeneic - UnrelatedNervous System DegenerationNeurology2021Experimental TherapyPoland56,9
2589Cord TissueAllogeneic - UnrelatedNon-Hodkin Lymphoma; Chronic Graft Versus Host DiseaseHematology2021Experimental TherapyPoland14,8
2590Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland13,7
2591Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland26,4
2592Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland45,1
2593Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland27,3
2594Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2021Experimental TherapyPoland22,2
2595Cord TissueAllogeneic - UnrelatedOsteoarthritisOrthopedy2021Experimental TherapyPoland57,2
2596Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2021Experimental TherapyPoland29,7
2597Cord TissueAllogeneic - UnrelatedSoft Tissue DiseasesOrthopedy2021Experimental TherapyPoland68,4
2598Cord TissueAllogeneic - UnrelatedSoft Tissue DiseasesOrthopedy2021Experimental TherapyPoland52,7
2599Cord TissueAllogeneic - UnrelatedSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2021Experimental TherapyPoland24,11
2600Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2021Experimental TherapyPoland24
2601Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2021Experimental TherapyPoland4,1
2602Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2021Experimental TherapyPoland30,8
2603Cord TissueAllogeneic - UnrelatedThermal InjuryDermatology2021Clinical Trial BIOOPAPolandno data
2604Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2605Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2606Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2607Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2608Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2609Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2610Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2611Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2612Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2613Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2614Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2615Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2616Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Clinical Trial BIOOPAPolandno data
2617Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2618Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2619Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2620Cord TissueAllogeneic - UnrelatedVenous Leg UlcerDermatology2021Experimental TherapyPolandno data
2621Cord BloodAutologousAutismNeurology2021Experimental TherapyPoland5,8
2622Cord BloodAutologousAutismNeurology2021Experimental TherapyPoland9,7
2623Cord BloodAllogeneic - RelatedAutismNeurology2021Experimental TherapyPoland7
2624Cord BloodAutologousAutismNeurology2021Experimental TherapyPoland4,1
2625Cord BloodAutologousAutismNeurology2021Experimental TherapyRomania3,9
2626Cord BloodAutologousAutismNeurology2021Experimental TherapyRomania5,2
2627Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany7
2628Cord BloodAllogeneic - RelatedAutismNeurology2021Experimental TherapyGermany8
2629Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany9
2630Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany7
2631Cord BloodAutologousAutismNeurology2021Experimental TherapyGermany6
2632Cord BloodAllogeneic - UnrelatedCerebral PalsyNeurology2021Experimental TherapyPoland9
2633Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2021Experimental TherapyPoland6
2634Cord BloodAllogeneic - RelatedDiamond Blackfan AnemiaHematology2021Standard TherapyTurkey3,12
2635Cord BloodAutologousFanconi AnemiaHematology2021Standard TherapyGermany7
2636Cord BloodAllogeneic - RelatedImmune Failure-Cd40 L DeficiencyHematology2021Standard TherapyTurkey12,4
2637Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey5,6
2638Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey16,6
2639Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey7,3
2640Cord BloodAllogeneic - RelatedThalassemia MajorHematology2021Standard TherapyTurkey16
2641Cord BloodAutologousAutismNeurology2021no dataSlovakia4
2642Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland58
2643Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland33
2644Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2645Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2646Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2647Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2648Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland74
2649Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2650Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland67
2651Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2652Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2653Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2654Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2655Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2656Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland74
2657Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2658Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2659Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland34
2660Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland64
2661Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland36
2662Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland39
2663Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland71
2664Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland64
2665Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
2666Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2667Bone Marrow FamilyAllogeneicMyelofibrosisHematology2021Standard TherapyPoland52
2668Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2021Standard TherapyPoland48
2669Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland50
2670Bone Marrow FamilyAllogeneicRefractory CytopeniaHematology2021Standard TherapyPoland45
2671Bone Marrow FamilyAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland2
2672Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland11
2673Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland17
2674Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland1
2675Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland8
2676Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland1
2677Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland11
2678Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland4
2679Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland6
2680Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland1
2681Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland47
2682Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2683Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland6
2684Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2685Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland2
2686Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2687Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland2
2688Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2689Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland31
2690Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland4
2691Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland15
2692Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2693Bone MarrowAllogeneicAdrenoleukodystrophyMetabolic2021Standard TherapyPoland8
2694Bone MarrowAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland32
2695Bone MarrowAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland19
2696Bone MarrowAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland49
2697Bone MarrowAllogeneicAplastic Anemia; Paroxysmal Nocturnal HemoglobinuriaHematology2021Standard TherapyPoland32
2698Bone MarrowAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland16
2699Bone MarrowAllogeneicBcr-Abl Pos. AllHematology2021Standard TherapyPoland51
2700Bone MarrowAllogeneicBeta Thalassemia MajorHematology2021Standard TherapyPoland14
2701Bone MarrowAllogeneicCartilage Hair HypoplasiaHematology2021Standard TherapyPoland7
2702Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland2
2703Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland1
2704Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland2
2705Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland44
2706Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland64
2707Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland47
2708Bone MarrowAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland53
2709Bone MarrowAllogeneicCombined ImmunodeficiencyHematology2021Standard TherapyPoland1
2710Bone MarrowAllogeneicCombined Immunodeficiency Syndrome With Hyper-IgmHematology2021Standard TherapyPoland5
2711Bone MarrowAllogeneicFanconi AnemiaHematology2021Standard TherapyPoland4
2712Bone MarrowAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2021Standard TherapyPoland3
2713Bone MarrowAllogeneicHurler SyndromeHematology2021Standard TherapyPoland3
2714Bone MarrowAllogeneicImmunodeficiencyHematology2021Standard TherapyPoland2
2715Bone MarrowAllogeneicInherited Immune System DisorderHematology2021Standard TherapyPoland1
2716Bone MarrowAllogeneicIpex- Other ImmuneHematology2021Standard TherapyPoland20
2717Bone MarrowAllogeneicLeukemia Lymphoblastic AcutaHematology2021Standard TherapyPoland6
2718Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
2719Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland10
2720Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland2
2721Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland30
2722Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland67
2723Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland59
2724Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland59
2725Bone MarrowAllogeneicNo DataHematology2021Standard TherapyPoland69
2726Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland55
2727Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland14
2728Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland41
2729Bone MarrowAllogeneicOsteopetrosisHematology2021Standard TherapyPoland7
2730Bone MarrowAllogeneicOther Leukemia SpecifyHematology2021Standard TherapyPoland35
2731Bone MarrowAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland72
2732Bone MarrowAllogeneicRefractory CytopeniaHematology2021Standard TherapyPoland7
2733Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland23
2734Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland53
2735Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland12
2736Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland5
2737Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland13
2738Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland12
2739Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland32
2740Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
2741Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
2742Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2021Standard TherapyPoland9 months
2743ApheresisAllogeneicAcute Biphenotypic LeukemiaHematology2021Standard TherapyPoland28
2744ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland17
2745ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland73
2746ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland38
2747ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland31
2748ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland24
2749ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland27
2750ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland54
2751ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland51
2752ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland65
2753ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland47
2754ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland10
2755ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland23
2756ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland5
2757ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland28
2758ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland58
2759ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland13
2760ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland55
2761ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland42
2762ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland20
2763ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland58
2764ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland52
2765ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland68
2766ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland32
2767ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland19
2768ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland61
2769ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland42
2770ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland3
2771ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland29
2772ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland8
2773ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland54
2774ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland20
2775ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland6
2776ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland61
2777ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland24
2778ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland66
2779ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland38
2780ApheresisAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2021Standard TherapyPoland38
2781ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2782ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2783ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland23
2784ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2785ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2786ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland73
2787ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2788ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2789ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2790ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland24
2791ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland50
2792ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2793ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2794ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2795ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2796ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2797ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland45
2798ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland70
2799ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2800ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland70
2801ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2802ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland37
2803ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland21
2804ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2805ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland20
2806ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland43
2807ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2808ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2809ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2810ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2811ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2812ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2813ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2814ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2815ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2816ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2817ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2818ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland73
2819ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2820ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland32
2821ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2822ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2823ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2824ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2825ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland38
2826ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2827ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2828ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2829ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2830ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland28
2831ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2832ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland52
2833ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2834ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2835ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2836ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland45
2837ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2838ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland71
2839ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2840ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland29
2841ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2842ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland30
2843ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2844ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2845ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2846ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland60
2847ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2848ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland30
2849ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2850ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland44
2851ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2852ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland41
2853ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2854ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland47
2855ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2856ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland42
2857ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2858ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2859ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland37
2860ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland67
2861ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2862ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2863ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland12
2864ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland70
2865ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland38
2866ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2867ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2868ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland39
2869ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2870ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2871ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland58
2872ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2873ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2874ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2875ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland48
2876ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2877ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2878ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2879ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland57
2880ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland65
2881ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland49
2882ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2883ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2884ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland59
2885ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland40
2886ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2887ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland73
2888ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2889ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2890ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland3
2891ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland25
2892ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2893ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2894ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland51
2895ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland50
2896ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland62
2897ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland69
2898ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland35
2899ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2900ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland14
2901ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland49
2902ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland80
2903ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2904ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland31
2905ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland32
2906ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2907ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland64
2908ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland10
2909ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland67
2910ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland57
2911ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland55
2912ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland68
2913ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland61
2914ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland17
2915ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland46
2916ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland34
2917ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland39
2918ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland53
2919ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland63
2920ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland22
2921ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland56
2922ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland42
2923ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland66
2924ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland52
2925ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyPoland13
2926ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany32
2927ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany61
2928ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany72
2929ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany55
2930ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany57
2931ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany62
2932ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany46
2933ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany63
2934ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany65
2935ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany71
2936ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany53
2937ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany57
2938ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany50
2939ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany32
2940ApheresisAllogeneicAcute Myeloid LeukemiaHematology2021Standard TherapyGermany71
2941ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2021Standard TherapyGermany65
2942ApheresisAutologousAmyloidosisHematology2021Standard TherapyGermany63
2943ApheresisAllogeneicAnaplastic Large Cell LymphomaHematology2021Standard TherapyGermany56
2944ApheresisAutologousAngioimmunoblastic T-Cell LymphomaHematology2021Standard TherapyGermany62
2945ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland54
2946ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland7
2947ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland40
2948ApheresisAllogeneicAplastic AnemiaHematology2021Standard TherapyPoland14
2949ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland36
2950ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany59
2951ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany33
2952ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany63
2953ApheresisAutologousB-Cell LymphomaHematology2021Standard TherapyGermany49
2954ApheresisAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland28
2955ApheresisAllogeneicChronic Granulomatous DiseaseHematology2021Standard TherapyPoland11
2956ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2021Standard TherapyPoland62
2957ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2021Standard TherapyPoland60
2958ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2021Standard TherapyPoland63
2959ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland52
2960ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland45
2961ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland37
2962ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland62
2963ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland64
2964ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland74
2965ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland31
2966ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland63
2967ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2021Standard TherapyPoland18
2968ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland68
2969ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland59
2970ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland67
2971ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland62
2972ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland34
2973ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland70
2974ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2021Standard TherapyPoland71
2975ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2021Standard TherapyGermany67
2976ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2021Standard TherapyPoland62
2977ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2021Standard TherapyPoland50
2978ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2021Standard TherapyGermany68
2979ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2021Standard TherapyGermany63
2980ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2021Standard TherapyGermany65
2981ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2021Standard TherapyGermany65
2982ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2021Standard TherapyGermany71
2983ApheresisAllogeneicFarber DiseaseHematology2021Standard TherapyPoland9
2984ApheresisAllogeneicFollicular LymphomaHematology2021Standard TherapyPoland54
2985ApheresisAutologousFollicular LymphomaHematology2021Standard TherapyGermany55
2986ApheresisAutologousFollicular LymphomaHematology2021Standard TherapyGermany64
2987ApheresisAutologousFollicular LymphomaHematology2021Standard TherapyGermany50
2988ApheresisAutologousGerm Cell TumorHematology2021Standard TherapyGermany28
2989ApheresisAllogeneicHemophagocytic Lymphohistiocytosis (Hlh)Hematology2021Standard TherapyPoland23
2990ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland41
2991ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland40
2992ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland27
2993ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland19
2994ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland26
2995ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyPoland32
2996ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyGermany21
2997ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyGermany37
2998ApheresisAutologousHodgkin LymphomaHematology2021Standard TherapyGermany30
2999ApheresisAllogeneicHodgkin LymphomaHematology2021Standard TherapyGermany47
3000ApheresisAutologousHodgkin LymphomaHematology2021Standard TherapyGermany36
3001ApheresisAutologousHodgkin LymphomaHematology2021Standard TherapyGermany30
3002ApheresisAllogeneicHurler SyndromeHematology2021Standard TherapyPoland2
3003ApheresisAllogeneicImmunodeficiencyHematology2021Standard TherapyPoland12
3004ApheresisAllogeneicLeukemiaHematology2021Standard TherapyPoland63
3005ApheresisAllogeneicLymphomaHematology2021Standard TherapyPoland58
3006ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany66
3007ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany57
3008ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany66
3009ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany57
3010ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany63
3011ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany56
3012ApheresisAutologousMantle Cell LymphomaHematology2021Standard TherapyGermany65
3013ApheresisAllogeneicMetachromatic LeukodystrophyHematology2021Standard TherapyPoland60
3014ApheresisAutologousMorbus HodgkinHematology2021Standard TherapyGermany36
3015ApheresisAutologousMorbus HodgkinHematology2021Standard TherapyGermany50
3016ApheresisAutologousMorbus HodgkinHematology2021Standard TherapyGermany21
3017ApheresisAllogeneicMucopolysaccharidosisHematology2021Standard TherapyPoland2
3018ApheresisAllogeneicMultiple MyelomaHematology2021Standard TherapyPoland44
3019ApheresisAllogeneicMultiple MyelomaHematology2021Standard TherapyPoland60
3020ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany70
3021ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany71
3022ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany53
3023ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany51
3024ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
3025ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany65
3026ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany62
3027ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
3028ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany66
3029ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany50
3030ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany65
3031ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany50
3032ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany47
3033ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany43
3034ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany66
3035ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany56
3036ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany65
3037ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany51
3038ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
3039ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany62
3040ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany68
3041ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany70
3042ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany70
3043ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany38
3044ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
3045ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany63
3046ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany71
3047ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany52
3048ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany63
3049ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
3050ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany68
3051ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
3052ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany58
3053ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
3054ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany60
3055ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany58
3056ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany67
3057ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany62
3058ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany42
3059ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany61
3060ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany67
3061ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany57
3062ApheresisAutologousMultiple MyelomaHematology2021Standard TherapyGermany68
3063ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland68
3064ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland41
3065ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland60
3066ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland8
3067ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland61
3068ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland62
3069ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland68
3070ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
3071ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland56
3072ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland62
3073ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland57
3074ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland47
3075ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
3076ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland29
3077ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
3078ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
3079ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
3080ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland59
3081ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland50
3082ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland59
3083ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland28
3084ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland68
3085ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
3086ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland54
3087ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
3088ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland52
3089ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
3090ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland75
3091ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland72
3092ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland62
3093ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland40
3094ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland65
3095ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland67
3096ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland72
3097ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland64
3098ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland64
3099ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland53
3100ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland53
3101ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland73
3102ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
3103ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland8
3104ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
3105ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland26
3106ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland56
3107ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland63
3108ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland61
3109ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland70
3110ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyPoland66
3111ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyGermany48
3112ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyGermany58
3113ApheresisAllogeneicMyelodysplastic SyndromeHematology2021Standard TherapyGermany59
3114ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland62
3115ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland63
3116ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland64
3117ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland66
3118ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland65
3119ApheresisAllogeneicMyelofibrosisHematology2021Standard TherapyPoland56
3120ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland75
3121ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland65
3122ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland51
3123ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland63
3124ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland75
3125ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2021Standard TherapyPoland64
3126ApheresisAllogeneicMyeloma MultiplexHematology2021Standard TherapyPoland48
3127ApheresisAllogeneicMyeloma MultiplexHematology2021Standard TherapyPoland53
3128ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2021Standard TherapyPoland67
3129ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2021Standard TherapyPoland58
3130ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2021Standard TherapyGermany51
3131ApheresisAllogeneicNo DataHematology2021Standard TherapyPoland64
3132ApheresisAllogeneicNo DataHematology2021Standard TherapyPoland57
3133ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland30
3134ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland51
3135ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland58
3136ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland56
3137ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland58
3138ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland50
3139ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland53
3140ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland20
3141ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland64
3142ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyPoland66
3143ApheresisAllogeneicNon-Hodgkin LymphomaHematology2021Standard TherapyGermany62
3144ApheresisAutologousNon-Hodgkin LymphomaHematology2021Standard TherapyGermany61
3145ApheresisAutologousNon-Hodgkin LymphomaHematology2021Standard TherapyGermany49
3146ApheresisAllogeneicNon-Hodgkin-Lymphoma-RelapseHematology2021Standard TherapyGermany62
3147ApheresisAllogeneicOsteomyelitisHematology2021Standard TherapyPoland47
3148ApheresisAllogeneicOsteomyelofibrosisHematology2021Standard TherapyPoland69
3149ApheresisAllogeneicOsteomyelofibrosisHematology2021Standard TherapyPoland43
3150ApheresisAutologousOsteosclerotic MyelomaHematology2021Standard TherapyGermany54
3151ApheresisAllogeneicOther Myelodysplastic SyndromesHematology2021Standard TherapyPoland65
3152ApheresisAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland68
3153ApheresisAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland70
3154ApheresisAllogeneicOther MyelofibrosisHematology2021Standard TherapyPoland72
3155ApheresisAllogeneicOther Plasma Cell DisorderHematology2021Standard TherapyPoland67
3156ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2021Standard TherapyPoland45
3157ApheresisAllogeneicPhiladelphia-Positive Acute Lymphoblastic LeukemiaHematology2021Standard TherapyPoland61
3158ApheresisAllogeneicPolycythemia VeraHematology2021Standard TherapyPoland65
3159ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany71
3160ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany66
3161ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany62
3162ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany53
3163ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany44
3164ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany54
3165ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany65
3166ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany65
3167ApheresisAutologousPrimary Central Nervous System LymphomaHematology2021Standard TherapyGermany60
3168ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland66
3169ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland63
3170ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland62
3171ApheresisAllogeneicPrimary MyelofibrosisHematology2021Standard TherapyPoland64
3172ApheresisAllogeneicProlymphocytic LeukemiaHematology2021Standard TherapyPoland68
3173ApheresisAllogeneicProlymphocytic LeukemiaHematology2021Standard TherapyPoland64
3174ApheresisAllogeneicRefractory CytopeniaHematology2021Standard TherapyPoland6
3175ApheresisAllogeneicSecondary Acute Lymphoblastic Leukemia From Chronic Myeloid LeukemiaHematology2021Standard TherapyPoland58
3176ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany70
3177ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany64
3178ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany39
3179ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2021Standard TherapyGermany60
3180ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland35
3181ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland58
3182ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland41
3183ApheresisAllogeneicSevere Aplastic AnemiaHematology2021Standard TherapyPoland38
3184ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
3185ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2021Standard TherapyPoland1
3186ApheresisAllogeneicT-Cell Lymphoblastic LymphomaHematology2021Standard TherapyGermany26
3187ApheresisAllogeneicT-Cell Lymphoblastic LymphomaHematology2021Standard TherapyGermany37
3188ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany54
3189ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany66
3190ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany66
3191ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2021Standard TherapyGermany29
3192ApheresisAllogeneicT-Cell-LymphomaHematology2021Standard TherapyPoland45
3193ApheresisAutologousTesticular CancerHematology2021Standard TherapyGermany33
3194ApheresisAllogeneicΒ - ThalassemiaHematology2021Standard TherapyPoland17
3195Adipose TissueAutologousGonarthrosisOrthopedy2021Experimental TherapyPoland51,1
3196Adipose TissueAutologousGonarthrosisOrthopedy2021Experimental TherapyPoland44,4
3197Adipose TissueAutologousGonarthrosisOrthopedy2021Experimental TherapyPoland35,8
3198Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2021Experimental TherapyPoland40.9
3199Adipose TissueAutologousSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2021Experimental TherapyPoland27,5
3200Placenta bloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,6
3201Cord TissueAllogeneic - Unrelated Covid-19Pulmonology2020Experimental TherapyPoland84,5
3202Cord TissueAllogeneic - UnrelatedAcquired Epileptic AphasiaNeurology2020Experimental TherapyPoland4,11
3203Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2020Experimental TherapyPoland8,11
3204Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2020Experimental TherapyPoland8
3205Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2020Experimental TherapyPoland2,4
3206Cord TissueAllogeneic - UnrelatedAcute Respiratory Distress Syndrome; Covid-19Pulmonology2020Experimental TherapyPoland53
3207Cord TissueAllogeneic - UnrelatedAcute Respiratory Distress Syndrome; Covid-19Pulmonology2020Experimental TherapyPoland66,11
3208Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2020Experimental TherapyPoland8,1
3209Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2020Experimental TherapyPoland36,6
3210Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland53,2
3211Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland54,4
3212Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland48,1
3213Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland64,11
3214Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland62,9
3215Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland69,1
3216Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland52,11
3217Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland58
3218Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland59,7
3219Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland52,7
3220Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland62,5
3221Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland59,6
3222Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland59,1
3223Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2020Experimental TherapyPoland58,1
3224Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland4,3
3225Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,1
3226Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland8,7
3227Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,6
3228Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland9,11
3229Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland4,9
3230Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland6,1
3231Cord TissueAllogeneic - RelatedAutismNeurology2020Experimental TherapyPoland8
3232Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,1
3233Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland7,1
3234Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland5,1
3235Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland9,4
3236Cord TissueAllogeneic - RelatedAutismNeurology2020Experimental TherapyRomania13
3237Cord TissueAllogeneic - RelatedAutismNeurology2020Experimental TherapyPoland10
3238Cord TissueAllogeneic - UnrelatedAutismNeurology2020Experimental TherapyPoland6,5
3239Cord TissueAllogeneic - UnrelatedBone Marrow Transplant RejectionHematology2020Experimental TherapyPoland14,2
3240Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2020Experimental TherapyPoland57,11
3241Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland17,2
3242Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,4
3243Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,7
3244Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland5
3245Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,7
3246Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland8,7
3247Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland15,6
3248Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2020Experimental TherapyPoland6
3249Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland3,1
3250Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,7
3251Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland13
3252Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland2,9
3253Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,1
3254Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland8,3
3255Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland7,11
3256Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland4,4
3257Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2020Experimental TherapyPoland4
3258Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland6,11
3259Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland4,11
3260Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland18,2
3261Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland5,8
3262Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2020Experimental TherapyPoland10,9
3263Cord TissueAllogeneic - UnrelatedCerebral Palsy; Developmental DelayNeurology2020Experimental TherapyPoland5,9
3264Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2020Experimental TherapyPoland9,8
3265Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2020Experimental TherapyPoland1,7
3266Cord TissueAllogeneic - UnrelatedChondromalaciaOrthopedy2020Experimental TherapyPoland61,7
3267Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2020Experimental TherapyPoland4,7
3268Cord TissueAllogeneic - UnrelatedCondition After Knee InjuryOrthopedy2020Experimental TherapyPoland42,1
3269Cord TissueAllogeneic - UnrelatedCovid-19Pulmonology2020Experimental TherapyPoland74,5
3270Cord TissueAllogeneic - UnrelatedCovid-19Pulmonology2020Experimental TherapyPoland76,2
3271Cord TissueAllogeneic - UnrelatedCovid-19; Severe Pneumonia; Acute Respiratory FailurePulmonology2020Experimental TherapyPoland59,5
3272Cord TissueAllogeneic - UnrelatedCoxarthrosisOrthopedy2020Experimental TherapyPoland46,4
3273Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2020Experimental TherapyPoland5,8
3274Cord TissueAllogeneic - RelatedDevelopmental DelayNeurology2020Experimental TherapyRomania13
3275Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2020Experimental TherapyPoland6
3276Cord TissueAllogeneic - UnrelatedDisorder Of Brain, Unspecified; AdrenoleukodystrophyNeurology2020Experimental TherapyPoland11,9
3277Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2020Experimental TherapyPoland26,6
3278Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland35,6
3279Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland44
3280Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland35,3
3281Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland29,3
3282Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland30,9
3283Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland5,3
3284Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland17,11
3285Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2020Experimental TherapyPoland21,5
3286Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2020Experimental TherapyPoland10,9
3287Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2020Experimental TherapyPoland2,1
3288Cord TissueAllogeneic - UnrelatedEpilepsy; Developmental DelayNeurology2020Experimental TherapyPoland15,8
3289Cord TissueAllogeneic - UnrelatedEpilepsy; Encephalopathy; Developmental DelayNeurology2020Experimental TherapyPoland7,1
3290Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2020Experimental TherapyPoland40,5
3291Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2020Experimental TherapyPoland6,4
3292Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland61,8
3293Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland62,8
3294Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland62,11
3295Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland60,1
3296Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland73,6
3297Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland63,8
3298Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland60,3
3299Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland64,8
3300Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland57,5
3301Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland53,9
3302Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland56,9
3303Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland63,7
3304Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland49,9
3305Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland58
3306Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland61,4
3307Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland60,2
3308Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2020Experimental TherapyPoland50,8
3309Cord TissueAllogeneic - UnrelatedGraft Versus Host DiseaseHematology2020Experimental TherapyPortugal18
3310Cord TissueAllogeneic - UnrelatedGraft Versus Host Disease; Transplantation FailureHematology2020Experimental TherapyPoland2,9
3311Cord TissueAllogeneic - UnrelatedGuillain-Barré SyndromeNeurology2020Experimental TherapyPoland43,5
3312Cord TissueAllogeneic - UnrelatedHead InjuryNeurology2020Experimental TherapyPoland16,3
3313Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2020Experimental TherapyPoland2,11
3314Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2020Experimental TherapyPoland5,4
3315Cord TissueAllogeneic - UnrelatedHypoxic Encephalopathy; Drug-Resistant EpilepsyNeurology2020Experimental TherapyPoland20,9
3316Cord TissueAllogeneic - UnrelatedLimb UlcerationDermatology2020Experimental TherapyPoland82,7
3317Cord TissueAllogeneic - UnrelatedMacular DegenerationOphthalmology2020Experimental TherapyPoland20,8
3318Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2020Experimental TherapyPoland56,4
3319Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2020Experimental TherapyPoland8,11
3320Cord TissueAllogeneic - UnrelatedMyelomeningocele; Arnold-Chiari MalformationNeurology2020Experimental TherapyPoland2,5
3321Cord TissueAllogeneic - UnrelatedMyelomeningocele; HydrocephalusNeurology2020Experimental TherapyPoland2,11
3322Cord TissueAllogeneic - UnrelatedMyoclonic Epilepsy With Ragged Red FibersNeurology2020Experimental TherapyPoland23,4
3323Cord TissueAllogeneic - UnrelatedNo Bone AdhesionOrthopedy2020Experimental TherapyPoland69,5
3324Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland16,3
3325Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland66,3
3326Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland23,11
3327Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland27,1
3328Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland31,9
3329Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland58,3
3330Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2020Experimental TherapyPoland41,2
3331Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2020Experimental TherapyPoland41,2
3332Cord TissueAllogeneic - UnrelatedOsteoarthritisOrthopedy2020Experimental TherapyPoland56,5
3333Cord TissueAllogeneic - UnrelatedOther Specific Cartilage DiseasesOrthopedy2020Experimental TherapyPoland39,4
3334Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2020Experimental TherapyPoland4,1
3335Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System - Global Development Delay And MicrocephalyNeurology2020Experimental TherapyPoland2,11
3336Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Congenital Genetic DefectNeurology2020Experimental TherapyPoland2,6
3337Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Congenital Genetic DefectNeurology2020Experimental TherapyPoland5,2
3338Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Cornelia De Lange SyndromeNeurology2020Experimental TherapyPoland4,4
3339Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic EncephalopathyNeurology2020Experimental TherapyPoland4,3
3340Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System; LissencephalyNeurology2020Experimental TherapyPoland6,4
3341Cord TissueAllogeneic - UnrelatedOther Sphingolipidoses; Krabbe's LeukodystrophyNeurology2020Experimental TherapyPoland4
3342Cord TissueAllogeneic - UnrelatedOther Spinal Muscular Atrophy And Related Syndromes; Bulbar PalsyNeurology2020Experimental TherapyPolandno data
3343Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2020Experimental TherapyPoland43,11
3344Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2020Experimental TherapyPoland33,7
3345Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2020Experimental TherapyPoland61,5
3346Cord TissueAllogeneic - UnrelatedSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2020Experimental TherapyPoland59,6
3347Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2020Experimental TherapyPoland11 months
3348Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2020Experimental TherapyPoland1,3
3349Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2020Experimental TherapyPoland33,2
3350Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2020Experimental TherapyPoland37,11
3351Cord TissueAllogeneic - UnrelatedState After EncephalitisNeurology2020Experimental TherapyPoland3,8
3352Cord TissueAllogeneic - UnrelatedTendon InjuryOrthopedy2020Experimental TherapyPoland29
3353Cord TissueAllogeneic - UnrelatedTransplantation Failure; Coexisting Viral InfectionsHematology2020Experimental TherapyPoland13,1
3354Cord TissueAllogeneicno datano data2020no dataSlovakia63
3355Cord BloodAutologousAutismNeurology2020Experimental TherapyPolandno data
3356Cord BloodAutologousAutismNeurology2020Experimental TherapyGermany9
3357Cord BloodAutologousAutismNeurology2020Experimental TherapyGermany5
3358Cord BloodAutologousB-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyUK5
3359Cord BloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,2
3360Cord BloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,9
3361Cord BloodAutologousCerebral PalsyNeurology2020Experimental TherapyPoland2,4
3362Cord BloodAllogeneic - RelatedSevere Aplastic AnemiaHematology2020Standard TherapyPolandno data
3363Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey3,4
3364Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey3,4
3365Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey4,4
3366Cord BloodAllogeneic - RelatedThalassemia MajorHematology2020Standard TherapyTurkey4,4
3367Cord BloodAllogeneicno datano data2020no dataSlovakia63
3368Cord BloodAutologousDrowning - Persistent Vegetative State, DecorticationNeurology2020no dataCzechia2
3369Bone Marrow FamilyAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2020Standard TherapyGermany57
3370Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland69
3371Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland48
3372Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3373Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3374Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3375Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland38
3376Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3377Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany76
3378Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2020Standard TherapyGermany61
3379Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2020Standard TherapyGermany68
3380Bone Marrow FamilyAllogeneicChronic Myelomonocytic LeukemiaHematology2020Standard TherapyPoland63
3381Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2020Standard TherapyPoland35
3382Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland71
3383Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland31
3384Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland62
3385Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland59
3386Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3387Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3388Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland70
3389Bone Marrow FamilyAllogeneicT-Cell Lymphoblastic LeukemiaHematology2020Standard TherapyGermany24
3390Bone Marrow (Apheresismily donor)AllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland68
3391Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland14
3392Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland1
3393Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland52
3394Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland66
3395Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland4
3396Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland15
3397Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland5
3398Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland3
3399Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland62
3400Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland47
3401Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland1
3402Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland16
3403Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland43
3404Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland9
3405Bone MarrowAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland10
3406Bone MarrowAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland27
3407Bone MarrowAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland23
3408Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2020Standard TherapyPoland6
3409Bone MarrowAllogeneicCongenital NeutropeniaHematology2020Standard TherapyPoland2
3410Bone MarrowAllogeneicFamilial Hemophagocytic Lymphohistiocytosis Type 2Hematology2020Standard TherapyPoland8
3411Bone MarrowAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland11
3412Bone MarrowAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland6
3413Bone MarrowAllogeneicImmune Deficiency; NeutropeniaHematology2020Standard TherapyPoland4
3414Bone MarrowAllogeneicMetachromatic LeukodystrophyHematology2020Standard TherapyPoland6
3415Bone MarrowAllogeneicMucopolysaccharidosis Type IHematology2020Standard TherapyPoland2
3416Bone MarrowAllogeneicMucopolysaccharidosis Type IiHematology2020Standard TherapyPoland1
3417Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland52
3418Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland54
3419Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland3
3420Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland28
3421Bone MarrowAllogeneicNo DataHematology2020Standard TherapyPoland1
3422Bone MarrowAllogeneicNo DataHematology2020Standard TherapyPoland10
3423Bone MarrowAllogeneicOsteopetrosisHematology2020Standard TherapyPoland1
3424Bone MarrowAllogeneicPrimary Immunodeficiency With Severe Mds AssociatedHematology2020Standard TherapyPoland14
3425Bone MarrowAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3426Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland5
3427Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland57
3428Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland27
3429Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland43
3430Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland10
3431Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland34
3432Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland11
3433Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland12
3434Bone MarrowAllogeneicX-Linked Chronic Granulomatous DiseaseHematology2020Standard TherapyPoland5
3435Bone MarrowAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland13
3436Bone MarrowAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland17
3437Bone MarrowAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland6
3438ApheresisAllogeneicAcute Biphenotypic LeukemiaHematology2020Standard TherapyPoland71
3439ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland54
3440ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland72
3441ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland41
3442ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland14
3443ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland59
3444ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland60
3445ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland9
3446ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland23
3447ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland40
3448ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland51
3449ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland71
3450ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland34
3451ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland67
3452ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland50
3453ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland18
3454ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland69
3455ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland12
3456ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland13
3457ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland12
3458ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland44
3459ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland34
3460ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland36
3461ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland54
3462ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland56
3463ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland44
3464ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland36
3465ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland25
3466ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland44
3467ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyGermany52
3468ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2020Standard TherapyGermany48
3469ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3470ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3471ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3472ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3473ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3474ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3475ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3476ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland37
3477ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3478ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland70
3479ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland46
3480ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3481ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3482ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland73
3483ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland27
3484ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland29
3485ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland52
3486ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3487ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland43
3488ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3489ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3490ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3491ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3492ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland60
3493ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland32
3494ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3495ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland44
3496ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland40
3497ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3498ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3499ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland38
3500ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland49
3501ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3502ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3503ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3504ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3505ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland73
3506ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3507ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3508ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland70
3509ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3510ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland68
3511ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3512ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland60
3513ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland55
3514ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3515ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland56
3516ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland54
3517ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland44
3518ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland55
3519ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland67
3520ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland53
3521ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3522ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland30
3523ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland34
3524ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3525ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3526ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland35
3527ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland5
3528ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland65
3529ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3530ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland49
3531ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3532ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3533ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland39
3534ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland45
3535ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3536ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3537ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3538ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland59
3539ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland1
3540ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland53
3541ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland14
3542ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland15
3543ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3544ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland66
3545ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland61
3546ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3547ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland51
3548ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland53
3549ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland39
3550ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland42
3551ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland52
3552ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland55
3553ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland69
3554ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland63
3555ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland64
3556ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland58
3557ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland37
3558ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyPoland72
3559ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany64
3560ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany45
3561ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany67
3562ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany67
3563ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany61
3564ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany36
3565ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany34
3566ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany48
3567ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany60
3568ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany48
3569ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany35
3570ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany42
3571ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany59
3572ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany20
3573ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany58
3574ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany44
3575ApheresisAllogeneicAcute Myeloid LeukemiaHematology2020Standard TherapyGermany30
3576ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2020Standard TherapyPoland64
3577ApheresisAllogeneicAcute Undifferentiated LeukemiaHematology2020Standard TherapyPoland31
3578ApheresisAutologousAmyloid Light-Chain AmyloidosisHematology2020Standard TherapyGermany62
3579ApheresisAutologousAmyloidosisHematology2020Standard TherapyGermany58
3580ApheresisAllogeneicAnaplastic Large Cell LymphomaHematology2020Standard TherapyPoland8
3581ApheresisAllogeneicAplastic AnemiaHematology2020Standard TherapyPoland12
3582ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland29
3583ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyGermany58
3584ApheresisAutologousB-Cell LymphomaHematology2020Standard TherapyGermany68
3585ApheresisAutologousB-Cell LymphomaHematology2020Standard TherapyGermany70
3586ApheresisAutologousB-Cell Lymphoma - Second Primary Central Nervous System LymphomaHematology2020Standard TherapyGermany70
3587ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany57
3588ApheresisAutologousBone TumorHematology2020Standard TherapyGermany28
3589ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland49
3590ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland74
3591ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland67
3592ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2020Standard TherapyPoland58
3593ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland61
3594ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland56
3595ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland47
3596ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland73
3597ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland62
3598ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland57
3599ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland44
3600ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2020Standard TherapyPoland62
3601ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2020Standard TherapyPoland66
3602ApheresisAllogeneicChronic Neutrophilic LeukemiaHematology2020Standard TherapyGermany31
3603ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2020Standard TherapyPoland63
3604ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany68
3605ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany51
3606ApheresisAllogeneicDyskeratosis CongenitaHematology2020Standard TherapyPoland19
3607ApheresisAllogeneicErdheim-Chester DiseaseHematology2020Standard TherapyPoland4
3608ApheresisAutologousEwing SarcomaHematology2020Standard TherapyGermany30
3609ApheresisAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland1
3610ApheresisAllogeneicFanconi AnemiaHematology2020Standard TherapyPoland29
3611ApheresisAutologousGerm Cell TumorHematology2020Standard TherapyGermany30
3612ApheresisAutologousHodgkin LymphomaHematology2020Standard TherapyGermany48
3613ApheresisAutologousHodgkin LymphomaHematology2020Standard TherapyGermany22
3614ApheresisAutologousHodgkin Lymphoma-RelapseHematology2020Standard TherapyGermany66
3615ApheresisAllogeneicLymphoblastic LymphomaHematology2020Standard TherapyPoland24
3616ApheresisAllogeneicMantle Cell LymphomaHematology2020Standard TherapyPoland56
3617ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany56
3618ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany48
3619ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany53
3620ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany59
3621ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany65
3622ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany58
3623ApheresisAutologousMantle Cell LymphomaHematology2020Standard TherapyGermany49
3624ApheresisAllogeneicMast Cell LeukemiaHematology2020Standard TherapyGermany55
3625ApheresisAutologousMorbus HodgkinHematology2020Standard TherapyGermany68
3626ApheresisAutologousMorbus HodgkinHematology2020Standard TherapyGermany53
3627ApheresisAutologousMorbus Hodgkin-RelapseHematology2020Standard TherapyGermany18
3628ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany54
3629ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3630ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany56
3631ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3632ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany70
3633ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany41
3634ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany56
3635ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany61
3636ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3637ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany67
3638ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany52
3639ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany69
3640ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany64
3641ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany46
3642ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3643ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany60
3644ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3645ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany51
3646ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3647ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany63
3648ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3649ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany55
3650ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3651ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3652ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3653ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany42
3654ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany59
3655ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3656ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3657ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany67
3658ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3659ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany60
3660ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3661ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany63
3662ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3663ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany63
3664ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany62
3665ApheresisAllogeneicMultiple MyelomaHematology2020Standard TherapyGermany49
3666ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany45
3667ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany65
3668ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany45
3669ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3670ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany40
3671ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany53
3672ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany54
3673ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany44
3674ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3675ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany48
3676ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3677ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany66
3678ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany68
3679ApheresisAutologousMultiple MyelomaHematology2020Standard TherapyGermany54
3680ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland67
3681ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland59
3682ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland60
3683ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland62
3684ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland55
3685ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3686ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland66
3687ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland51
3688ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland56
3689ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland64
3690ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3691ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland73
3692ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3693ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland37
3694ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland59
3695ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3696ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland74
3697ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland66
3698ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland22
3699ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland64
3700ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3701ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland70
3702ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland67
3703ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland60
3704ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland68
3705ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland58
3706ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland67
3707ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland47
3708ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland56
3709ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland55
3710ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland64
3711ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland66
3712ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland65
3713ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3714ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland69
3715ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyPoland63
3716ApheresisAllogeneicMyelodysplastic SyndromeHematology2020Standard TherapyGermany73
3717ApheresisAllogeneicMyelofibrosisHematology2020Standard TherapyPoland63
3718ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland69
3719ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland70
3720ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland63
3721ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland62
3722ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2020Standard TherapyPoland43
3723ApheresisAllogeneicMyeloma MultiplexHematology2020Standard TherapyPoland63
3724ApheresisAllogeneicMyeloma MultiplexHematology2020Standard TherapyPoland52
3725ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2020Standard TherapyPoland68
3726ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2020Standard TherapyPoland40
3727ApheresisAllogeneicNo DataHematology2020Standard TherapyPoland71
3728ApheresisAllogeneicNo DataHematology2020Standard TherapyPoland64
3729ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland65
3730ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland58
3731ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland63
3732ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland58
3733ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland62
3734ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland53
3735ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland57
3736ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland69
3737ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland62
3738ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyPoland34
3739ApheresisAutologousNon-Hodgkin LymphomaHematology2020Standard TherapyGermany42
3740ApheresisAllogeneicNon-Hodgkin LymphomaHematology2020Standard TherapyGermany62
3741ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2020Standard TherapyGermany56
3742ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2020Standard TherapyGermany67
3743ApheresisAllogeneicOsteomyelofibrosisHematology2020Standard TherapyPoland68
3744ApheresisAllogeneicOsteomyelofibrosisHematology2020Standard TherapyPoland52
3745ApheresisAllogeneicOsteomyelofibrosisHematology2020Standard TherapyPoland64
3746ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2020Standard TherapyPoland57
3747ApheresisAllogeneicPerforin DeficiencyHematology2020Standard TherapyPoland2
3748ApheresisAutologousPrimary Central Nervous System LymphomaHematology2020Standard TherapyGermany59
3749ApheresisAutologousPrimary Cerebral Diffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany66
3750ApheresisAutologousPrimary Cerebral Diffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany59
3751ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland63
3752ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland61
3753ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland51
3754ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland66
3755ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyPoland61
3756ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyGermany54
3757ApheresisAllogeneicPrimary MyelofibrosisHematology2020Standard TherapyGermany58
3758ApheresisAllogeneicPurine Nucleoside Phosphorylase DeficiencyHematology2020Standard TherapyPoland1
3759ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland43
3760ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland76
3761ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyPoland57
3762ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyGermany66
3763ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2020Standard TherapyGermany56
3764ApheresisAutologousSecondary B-Cell Non-Hodgkin-LymphomaHematology2020Standard TherapyGermany73
3765ApheresisAutologousSecondary Diffuse Large B-Cell LymphomaHematology2020Standard TherapyGermany54
3766ApheresisAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland9
3767ApheresisAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland53
3768ApheresisAllogeneicSevere Aplastic AnemiaHematology2020Standard TherapyPoland52
3769ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2020Standard TherapyPoland2
3770ApheresisAllogeneicSezary SyndromeHematology2020Standard TherapyPoland44
3771ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2020Standard TherapyPoland14
3772ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany57
3773ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany29
3774ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany64
3775ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2020Standard TherapyGermany63
3776ApheresisAllogeneicT-Cell-LymphomaHematology2020Standard TherapyPoland29
3777ApheresisAutologousT-Cell-LymphomaHematology2020Standard TherapyGermany51
3778ApheresisAutologousT-Cell-LymphomaHematology2020Standard TherapyGermany60
3779ApheresisAllogeneicT-Cell-Prolymphocytic LeukemiaHematology2020Standard TherapyPoland55
3780ApheresisAllogeneicT-Cell-Prolymphocytic LeukemiaHematology2020Standard TherapyPoland74
3781ApheresisAllogeneicΒ - ThalassemiaHematology2020Standard TherapyPoland6
3782ApheresisAllogeneicΒ - Thalassemia MajorHematology2020Standard TherapyPoland17
3783Adipose TissueAutologousAlopeciaDermatology2020Experimental TherapyPoland68,5
3784Adipose TissueAutologousChondromalaciaOrthopedy2020Experimental TherapyPoland45,9
3785Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland52,8
3786Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland63,4
3787Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland41,1
3788Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland34,8
3789Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland48,1
3790Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland57,11
3791Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland59,8
3792Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland35,1
3793Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland61,8
3794Adipose TissueAutologousGonarthrosisOrthopedy2020Experimental TherapyPoland56,5
3795Adipose TissueAutologousGonarthrosis; Shoulder OsteoarthritisOrthopedy2020Experimental TherapyPoland42,5
3796Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2020Experimental TherapyPoland53,6
3797Adipose TissueAutologousInternal Damage To The Knee JointOrthopedy2020Experimental TherapyPoland49,2
3798Adipose TissueAutologousOmarthrosisOrthopedy2020Experimental TherapyPoland70,1
3799Adipose TissueAutologousOther Acquired Deformities Of The Ankle And FootOrthopedy2020Experimental TherapyPoland41,6
3800Adipose TissueAutologousScarDermatology2020Clinical TrialPolandno data
3801Adipose TissueAutologousSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2020Experimental TherapyPoland61,1
3802Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2019Experimental TherapyPoland5,3
3803Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland1,9
3804Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland6,1
3805Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland2,2
3806Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland10,1
3807Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland18,2
3808Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2019Experimental TherapyPoland10,2
3809Cord TissueAllogeneic - UnrelatedAgenesis Of Corpus Callosum; Atrophy Of The Optic NervesNeurology2019Experimental TherapyPoland7,3
3810Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2019Experimental TherapyPoland47,11
3811Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2019Experimental TherapyPoland57,9
3812Cord TissueAllogeneic - UnrelatedAlopecia AreataDermatology2019Experimental TherapyPoland43,3
3813Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland54,9
3814Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland58,7
3815Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65,5
3816Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland60,11
3817Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland38,2
3818Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland61,9
3819Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland70,11
3820Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland73,1
3821Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland58,1
3822Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65,1
3823Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland39,8
3824Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland46,1
3825Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland59,1
3826Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland61
3827Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland66,2
3828Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland44,1
3829Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65,1
3830Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland65
3831Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland41,5
3832Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland59,8
3833Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland32,2
3834Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland56,1
3835Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland61,5
3836Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland49,7
3837Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland67,11
3838Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland59,3
3839Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPolandno data
3840Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland57,7
3841Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland62,4
3842Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2019Experimental TherapyPoland67,8
3843Cord TissueAllogeneic - UnrelatedAngelman Syndrome; Cerebral PalsyNeurology2019Experimental TherapyPoland13,5
3844Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex Congenita; MyopathyNeurology2019Experimental TherapyPoland3,11
3845Cord TissueAllogeneic - UnrelatedArthrosis Of The Knee Joint - ChondromalaciaOrthopedy2019Experimental TherapyPoland51,4
3846Cord TissueAllogeneic - UnrelatedAsperger SyndromeNeurology2019Experimental TherapyPoland10,8
3847Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2019Experimental TherapyPoland38,7
3848Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,6
3849Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland2,6
3850Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland11,6
3851Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,7
3852Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,9
3853Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,2
3854Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,8
3855Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,2
3856Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland9
3857Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland11,1
3858Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland4,8
3859Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland13,4
3860Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,11
3861Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland2,7
3862Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,1
3863Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,2
3864Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,9
3865Cord TissueAllogeneic - RelatedAutismNeurology2019Experimental TherapyPoland4
3866Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,3
3867Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,5
3868Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,3
3869Cord TissueAllogeneic - RelatedAutismNeurology2019Experimental TherapyPoland7
3870Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland4,2
3871Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,3
3872Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland4,6
3873Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,8
3874Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland9,5
3875Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland6,11
3876Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,8
3877Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland3,8
3878Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPolandno data
3879Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland5,2
3880Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,6
3881Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,1
3882Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland7,7
3883Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland8,7
3884Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland9,11
3885Cord TissueAllogeneic - UnrelatedAutismNeurology2019Experimental TherapyPoland12,4
3886Cord TissueAllogeneic - UnrelatedAutism; Diabetes Mellitus Type 1Neurology2019Experimental TherapyPoland8,1
3887Cord TissueAllogeneic - UnrelatedAutism; MicrocephalyNeurology2019Experimental TherapyPoland7,8
3888Cord TissueAllogeneic - UnrelatedBest DiseaseOphthalmology2019Experimental TherapyPoland56,4
3889Cord TissueAllogeneic - UnrelatedBirth AsphyxiaNeurology2019Experimental TherapyPoland5,4
3890Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2019Experimental TherapyPoland50,1
3891Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2019Experimental TherapyPoland37,7
3892Cord TissueAllogeneic - UnrelatedCerebellar Syndrome; Multiple System AtrophyNeurology2019Experimental TherapyPoland57,2
3893Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6
3894Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,11
3895Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland11 months
3896Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,5
3897Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,4
3898Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland11,1
3899Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,2
3900Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,3
3901Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,5
3902Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,6
3903Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,1
3904Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland4
3905Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,2
3906Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,3
3907Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,9
3908Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland2
3909Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland1,6
3910Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland15,5
3911Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,7
3912Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,9
3913Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,11
3914Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,1
3915Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,6
3916Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,6
3917Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland1,1
3918Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,3
3919Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland22,8
3920Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland28,2
3921Cord TissueAllogeneic - Unrelated & RelatedCerebral PalsyNeurology2019Experimental TherapyPoland/Romania7,5
3922Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland9,7
3923Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland10
3924Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,8
3925Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,3
3926Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland10,8
3927Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland7,1
3928Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,8
3929Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland14,9
3930Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,9
3931Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland52,7
3932Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,7
3933Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland2,9
3934Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland6,11
3935Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland16,1
3936Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,1
3937Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland5,7
3938Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland3
3939Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland3
3940Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3
3941Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland11,6
3942Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2019Experimental TherapyPoland3,8
3943Cord TissueAllogeneic - UnrelatedCerebral Palsy; AutismNeurology2019Experimental TherapyPoland5,5
3944Cord TissueAllogeneic - UnrelatedCerebral Palsy; Dandy-Walker MalformationNeurology2019Experimental TherapyPoland7,3
3945Cord TissueAllogeneic - UnrelatedCerebral Palsy; Developmental DelayNeurology2019Experimental TherapyPoland18,9
3946Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland3,7
3947Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland3
3948Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,5
3949Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,11
3950Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland10,1
3951Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland7,11
3952Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,3
3953Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland8,5
3954Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland6,3
3955Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland5,6
3956Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland15,7
3957Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2019Experimental TherapyPoland6
3958Cord TissueAllogeneic - UnrelatedCerebral Palsy; Epilepsy; Developmental DelayNeurology2019Experimental TherapyPoland1,11
3959Cord TissueAllogeneic - UnrelatedCerebral Palsy; Epilepsy; MicrocephaliaNeurology2019Experimental TherapyPoland9,3
3960Cord TissueAllogeneic - UnrelatedCerebral Palsy; HydrocephalusNeurology2019Experimental TherapyPoland2,2
3961Cord TissueAllogeneic - UnrelatedCerebral Palsy; HydrocephalusNeurology2019Experimental TherapyPoland4,2
3962Cord TissueAllogeneic - UnrelatedCerebral Palsy; Hydrocephalus; EpilepsyNeurology2019Experimental TherapyPoland3,7
3963Cord TissueAllogeneic - UnrelatedCerebral Palsy; Wolf-Hirschhorn SyndromeNeurology2019Experimental TherapyPoland10,1
3964Cord TissueAllogeneic - UnrelatedChondrocalcinosis; Moderate GonarthrosisOrthopedy2019Experimental TherapyPoland79,1
3965Cord TissueAllogeneic - UnrelatedChondromalaciaOrthopedy2019Experimental TherapyPoland60,9
3966Cord TissueAllogeneic - UnrelatedChoroideremiaOphthalmology2019Experimental TherapyPoland24,5
3967Cord TissueAllogeneic - UnrelatedChoroideremiaOphthalmology2019Experimental TherapyPoland30,1
3968Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2019Experimental TherapyPoland10,5
3969Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Aplastic AnemiaHematology2019Experimental TherapyPoland9
3970Cord TissueAllogeneic - UnrelatedCondition After Bilateral Optic Nerve InflammationOphthalmology2019Experimental TherapyPoland46,11
3971Cord TissueAllogeneic - UnrelatedCondition After Sympathetic Inflammation Of The Left EyeOphthalmology2019Experimental TherapyPoland23,1
3972Cord TissueAllogeneic - RelatedCoxarthrosisOrthopedy2019Experimental TherapyPoland57
3973Cord TissueAllogeneic - UnrelatedDandy-Walker Malformation; Trisomy 9Neurology2019Experimental TherapyPoland10,8
3974Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2019Experimental TherapyPoland44,7
3975Cord TissueAllogeneic - UnrelatedDegenerative Disease Of The SpineOrthopedy2019Experimental TherapyPoland86,11
3976Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; Chiari MalformationNeurology2019Experimental TherapyPoland4,6
3977Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; Congenital CytomegalovirusNeurology2019Experimental TherapyPoland8,3
3978Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; EpilepsyNeurology2019Experimental TherapyPoland2,1
3979Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3980Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3981Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3982Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3983Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3984Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3985Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3986Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3987Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3988Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Clinical TrialPolandno data
3989Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Experimental TherapyPoland2,11
3990Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2019Experimental TherapyPoland37,5
3991Cord TissueAllogeneic - UnrelatedDravet's SyndromeNeurology2019Experimental TherapyPoland19,7
3992Cord TissueAllogeneic - RelatedDuchenne Muscular Dystrophy (Dmd)Neurology2019Experimental TherapyPoland15
3993Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2019Experimental TherapyPoland7,8
3994Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2019Experimental TherapyPoland7,7
3995Cord TissueAllogeneic - RelatedEncephalopathy; Cerebral PalsyNeurology2019Experimental TherapyPoland6
3996Cord TissueAllogeneic - UnrelatedEncephalopathy; EpilepsyNeurology2019Experimental TherapyPoland17,1
3997Cord TissueAllogeneic - UnrelatedEncephalopathy; EpilepsyNeurology2019Experimental TherapyPoland3,6
3998Cord TissueAllogeneic - UnrelatedEncephalopathy; Epilepsy; Delayed Psychomotor DevelopmentNeurology2019Experimental TherapyPoland13,1
3999Cord TissueAllogeneic - UnrelatedEncephalopathy; Epilepsy; Delayed Psychomotor DevelopmentNeurology2019Experimental TherapyPoland2,5
4000Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland4,4
4001Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland5,8
4002Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland7,4
4003Cord TissueAllogeneic - UnrelatedEncephalopathy; Global Developmental DelayNeurology2019Experimental TherapyPoland7,4
4004Cord TissueAllogeneic - UnrelatedEpidermolysis BullosaDermatology2019Experimental TherapyPoland51,1
4005Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2019Experimental TherapyPoland8,1
4006Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2019Experimental TherapyPoland13,9
4007Cord TissueAllogeneic - UnrelatedEpilepsy; Developmental DelayNeurology2019Experimental TherapyPoland9,4
4008Cord TissueAllogeneic - UnrelatedEpilepsy; Developmental DelayNeurology2019Experimental TherapyPoland3,2
4009Cord TissueAllogeneic - UnrelatedEpilepsy; EncephalopathyNeurology2019Experimental TherapyPoland8,1
4010Cord TissueAllogeneic - UnrelatedEpileptic Encephalopathy; EpilepsyNeurology2019Experimental TherapyPoland16,2
4011Cord TissueAllogeneic - UnrelatedEpileptic Encephalopathy; EpilepsyNeurology2019Experimental TherapyPoland2,11
4012Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2019Experimental TherapyPoland39,1
4013Cord TissueAllogeneic - UnrelatedFragile X Syndrome; Pervasive Developmental DisorderNeurology2019Experimental TherapyPoland4
4014Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2019Experimental TherapyPoland59,6
4015Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2019Experimental TherapyPoland2,1
4016Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2019Experimental TherapyPoland6,7
4017Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland70,8
4018Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland78,7
4019Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland84,1
4020Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland48,7
4021Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland34,2
4022Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland63,7
4023Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2019Experimental TherapyPoland64,8
4024Cord TissueAllogeneic - UnrelatedHyperacute Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Congenital NeutropeniaHematology2019Experimental TherapyPoland8 months
4025Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2019Experimental TherapyPoland2,2
4026Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2019Experimental TherapyPoland2,5
4027Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2019Experimental TherapyPoland4,8
4028Cord TissueAllogeneic - UnrelatedIschemic StrokeNeurology2019Experimental TherapyPoland40,7
4029Cord TissueAllogeneic - UnrelatedIschemic StrokeNeurology2019Experimental TherapyPolandno data
4030Cord TissueAllogeneic - UnrelatedKrabbe DiseaseNeurology2019Experimental TherapyPoland3,3
4031Cord TissueAllogeneic - UnrelatedMacular DegenerationOphthalmology2019Experimental TherapyPoland15,2
4032Cord TissueAllogeneic - UnrelatedMicrocephalia; Cerebellar Syndrome; Delayed Psychomotor DevelopmentNeurology2019Experimental TherapyPoland7,7
4033Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2019Experimental TherapyPoland54,1
4034Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2019Experimental TherapyPoland71,11
4035Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2019Experimental TherapyPoland46,1
4036Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2019Experimental TherapyPoland17,3
4037Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2019Experimental TherapyPoland13,1
4038Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland2,2
4039Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland19,11
4040Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland2,1
4041Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland1,11
4042Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2019Experimental TherapyPoland4,11
4043Cord TissueAllogeneic - UnrelatedNon-Adhesion Left Tibia Shank Fracture; Neurofibromatosis T. IOrthopedy2019Experimental TherapyPoland18,4
4044Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland43,9
4045Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland68,4
4046Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland72,5
4047Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland33,3
4048Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland26
4049Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland23,9
4050Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland35,1
4051Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland38,3
4052Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland24,5
4053Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland12,1
4054Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland9,8
4055Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland41,3
4056Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland34,7
4057Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland59,4
4058Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland53,2
4059Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2019Experimental TherapyPoland12,3
4060Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2019Experimental TherapyPoland26,8
4061Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2019Experimental TherapyPoland71,3
4062Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2019Experimental TherapyPoland49,8
4063Cord TissueAllogeneic - UnrelatedOther Disorders Of The Central Nervous System; Genetic Defect; Suspected AutismNeurology2019Experimental TherapyPoland6,7
4064Cord TissueAllogeneic - UnrelatedOther Disorders Of The Central Nervous System; Genetic Defect; Suspected AutismNeurology2019Experimental TherapyPoland6,7
4065Cord TissueAllogeneic - UnrelatedOther Disorders Of The Optic DiscNeurology2019Experimental TherapyPoland3
4066Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland1,7
4067Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland4,1
4068Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland11 months
4069Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland3,1
4070Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2019Experimental TherapyPoland3,6
4071Cord TissueAllogeneic - UnrelatedOther Vascular And Retinal DisordersOphthalmology2019Experimental TherapyPoland34,2
4072Cord TissueAllogeneic - UnrelatedParkinson SyndromeNeurology2019Experimental TherapyPoland51,2
4073Cord TissueAllogeneic - UnrelatedParoxysmal DystoniaNeurology2019Experimental TherapyPoland3,7
4074Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2019Experimental TherapyPoland60,8
4075Cord TissueAllogeneic - UnrelatedProgressive Supranuclear AtrophyNeurology2019Experimental TherapyPoland62,4
4076Cord TissueAllogeneic - UnrelatedPropionic AciduriaNeurology2019Experimental TherapyPoland10,7
4077Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland19,1
4078Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland35
4079Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland21,6
4080Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland67,2
4081Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland63,4
4082Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2019Experimental TherapyPoland69
4083Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland62,7
4084Cord TissueAllogeneic - RelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland61
4085Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland61,6
4086Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2019Experimental TherapyPoland59,7
4087Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland22,9
4088Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland64
4089Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland54,6
4090Cord TissueAllogeneic - UnrelatedSecondary Progressive Multiple SclerosisNeurology2019Experimental TherapyPoland59,5
4091Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland5,11
4092Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland10 months
4093Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland10 months
4094Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2019Experimental TherapyPoland5,11
4095Cord TissueAllogeneic - UnrelatedSpina Bifida; EpilepsyNeurology2019Experimental TherapyPoland2,2
4096Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2019Experimental TherapyPoland33
4097Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPolandno data
4098Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2019Experimental TherapyPoland27,5
4099Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryNeurology2019Experimental TherapyPoland26,9
4100Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPoland38,6
4101Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPoland27,8
4102Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2019Experimental TherapyPoland41,1
4103Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2019Experimental TherapyPoland11
4104Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland40
4105Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland26,1
4106Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland54,11
4107Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2019Experimental TherapyPoland37
4108Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2019Experimental TherapyPoland30,5
4109Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2019Experimental TherapyPoland40
4110Cord TissueAllogeneic - UnrelatedStatus After Meningitis And Encephalitis; EncephalopathyNeurology2019Experimental TherapyPoland4
4111Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2019Standard TherapyTurkey2
4112Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany6
4113Cord BloodAutologousAutismNeurology2019Experimental TherapyPoland3,6
4114Cord BloodAutologousAutismNeurology2019Experimental TherapyPoland10,5
4115Cord BloodAutologousAutismNeurology2019Experimental TherapyGermany4
4116Cord BloodAutologousBrain DamageNeurology2019Experimental TherapyGermany11 months
4117Cord BloodAutologousBrain DamageNeurology2019Experimental TherapyGermany1,5
4118Cord BloodAllogeneic - RelatedBrain DamageNeurology2019Experimental TherapyGermany7
4119Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyUK3
4120Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland4,5
4121Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2019Experimental TherapyPoland8,8
4122Cord BloodAllogeneic - RelatedFanconi AnemiaHematology2019Standard TherapyTurkey12,4
4123Cord BloodAutologousSevere Aplastic AnemiaHematology2019Standard TherapyPortugal4
4124Cord BloodAllogeneic - RelatedSevere Chronic NeutropeniaHematology2019Standard TherapyGermany6
4125Cord BloodAllogeneic - RelatedThalassemiaHematology2019Standard TherapyTurkey5,5
4126Cord BloodAllogeneic - RelatedThalassemiaHematology2019Standard TherapyTurkey5,11
4127Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey5,1
4128Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey3,5
4129Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey12
4130Cord BloodAllogeneic - RelatedThalassemia MajorHematology2019Standard TherapyTurkey16
4131Bone Marrow FamilyAllogeneicActivated Pi3k Delta Syndrome (Apds)Hematology2019Standard TherapyPoland20
4132Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4133Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4134Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland73
4135Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4136Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4137Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4138Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4139Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4140Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4141Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4142Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland23
4143Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4144Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4145Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland23
4146Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4147Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland5
4148Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4149Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland14
4150Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland42
4151Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4152Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2019Standard TherapyGermany61
4153Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia - RelapseHematology2019Standard TherapyGermany22
4154Bone Marrow FamilyAllogeneicGlanzmann ThrombastheniaHematology2019Standard TherapyPoland11
4155Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland58
4156Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland78
4157Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4158Bone Marrow FamilyAllogeneicMyelofibrosisHematology2019Standard TherapyPoland60
4159Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland48
4160Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland56
4161Bone Marrow FamilyAllogeneicNo DataHematology2019Standard TherapyPoland66
4162Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland58
4163Bone Marrow FamilyAllogeneicRefractory Anemia With Blast Excess RelapseHematology2019Standard TherapyGermany53
4164Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyPoland27
4165Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland52
4166Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland5
4167Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland21
4168Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland17
4169Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland42
4170Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland15
4171Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland64
4172Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland2
4173Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland17
4174Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland11
4175Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland51
4176Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland8
4177Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland20
4178Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland3
4179Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland10
4180Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland13
4181Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland15
4182Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland5
4183Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland3
4184Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland66
4185Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland14
4186Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4187Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland10
4188Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland4
4189Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland47
4190Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4191Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland5
4192Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4193Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland47
4194Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4195Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4196Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland12
4197Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland20
4198Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland48
4199Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland30
4200Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland3
4201Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland32
4202Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland14
4203Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland47
4204Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland1
4205Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland3
4206Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland16
4207Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland42
4208Bone MarrowAllogeneicAdrenoleukodystrophyMetabolic2019Standard TherapyPoland3
4209Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland18
4210Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland8
4211Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland10
4212Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland25
4213Bone MarrowAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland30
4214Bone MarrowAllogeneicC-Hhyp Cartilage-Hair HypoplasiaHematology2019Standard TherapyPoland2
4215Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland7
4216Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland9
4217Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland35
4218Bone MarrowAllogeneicCongenital Amegakaryocytic Thrombocytopenia (Camt)Hematology2019Standard TherapyPoland1
4219Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2019Standard TherapyPoland2
4220Bone MarrowAllogeneicFanconi AnemiaHematology2019Standard TherapyPoland6
4221Bone MarrowAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland62
4222Bone MarrowAllogeneicHurler SyndromeHematology2019Standard TherapyPoland2
4223Bone MarrowAllogeneicHurler SyndromeHematology2019Standard TherapyPoland3
4224Bone MarrowAllogeneicImmunodeficiencyHematology2019Standard TherapyPoland1
4225Bone MarrowAllogeneicMucopolysaccharidosis Type IMetabolic2019Standard TherapyPoland2
4226Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland75
4227Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland57
4228Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland63
4229Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland8
4230Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland14
4231Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland75
4232Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4233Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland27
4234Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland67
4235Bone MarrowAllogeneicMyeloproliferative SyndromeHematology2019Standard TherapyPoland2
4236Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2019Standard TherapyPoland6
4237Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2019Standard TherapyPoland16
4238Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland59
4239Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland3
4240Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland1
4241Bone MarrowAllogeneicNo DataHematology2019Standard TherapyPoland64
4242Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland43
4243Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland55
4244Bone MarrowAllogeneicOhis - Other Histiocytic DisordersHematology2019Standard TherapyPoland5
4245Bone MarrowAllogeneicOsteopetrosisMetabolic2019Standard TherapyPoland1
4246Bone MarrowAllogeneicOsteopetrosisMetabolic2019Standard TherapyPoland5 months
4247Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2019Standard TherapyPoland14
4248Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland2
4249Bone MarrowAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland22
4250Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland11
4251Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland12
4252Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland5
4253Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland17
4254Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland4
4255Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland22
4256Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland11
4257Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland14
4258Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland3
4259Bone MarrowAllogeneicShwachman Diamond AnemiaHematology2019Standard TherapyPoland20
4260Bone MarrowAllogeneicThalassemia MajorHematology2019Standard TherapyPoland13
4261Bone MarrowAllogeneicThalassemia MajorHematology2019Standard TherapyPoland5
4262Bone MarrowAllogeneicThalassemia MajorHematology2019Standard TherapyPoland10
4263Bone MarrowAllogeneicVery Severe Aplastic AnemiaHematology2019Standard TherapyPoland13
4264ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland4
4265ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland27
4266ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland47
4267ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland67
4268ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland65
4269ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland63
4270ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland18
4271ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland20
4272ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland15
4273ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland43
4274ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland51
4275ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland7
4276ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland59
4277ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland46
4278ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland48
4279ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland63
4280ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland28
4281ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland36
4282ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland36
4283ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland63
4284ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland43
4285ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany32
4286ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany44
4287ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland63
4288ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4289ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland39
4290ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland53
4291ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland66
4292ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4293ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland37
4294ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland54
4295ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland36
4296ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland53
4297ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4298ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland38
4299ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4300ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4301ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4302ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland70
4303ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4304ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4305ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4306ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4307ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4308ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4309ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4310ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4311ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4312ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland37
4313ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland56
4314ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4315ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4316ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4317ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4318ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland54
4319ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4320ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4321ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4322ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland42
4323ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4324ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4325ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4326ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4327ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4328ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4329ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland53
4330ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland68
4331ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4332ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4333ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland70
4334ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland54
4335ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4336ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland70
4337ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4338ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4339ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland55
4340ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4341ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland48
4342ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland38
4343ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4344ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland51
4345ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland68
4346ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4347ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4348ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland65
4349ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4350ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland11
4351ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4352ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4353ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland40
4354ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland25
4355ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland63
4356ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland44
4357ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland60
4358ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland38
4359ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4360ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland27
4361ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland69
4362ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4363ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4364ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland52
4365ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4366ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland61
4367ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland67
4368ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4369ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4370ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4371ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4372ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland62
4373ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland68
4374ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland15
4375ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4376ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4377ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4378ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland49
4379ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland23
4380ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland39
4381ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland25
4382ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland71
4383ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland25
4384ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland48
4385ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland45
4386ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland58
4387ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland64
4388ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland31
4389ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland57
4390ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland3
4391ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland29
4392ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland72
4393ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyPoland46
4394ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany57
4395ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany58
4396ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany31
4397ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany47
4398ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany64
4399ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany46
4400ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany40
4401ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany60
4402ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany65
4403ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany68
4404ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany65
4405ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany26
4406ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany52
4407ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany38
4408ApheresisAllogeneicAcute Myeloid LeukemiaHematology2019Standard TherapyGermany56
4409ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2019Standard TherapyGermany51
4410ApheresisAutologousAmyloidosisHematology2019Standard TherapyGermany60
4411ApheresisAllogeneicAplasiaHematology2019Standard TherapyPoland51
4412ApheresisAllogeneicAplastic AnemiaHematology2019Standard TherapyPoland16
4413ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland8
4414ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany46
4415ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany21
4416ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyGermany28
4417ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2019Standard TherapyPoland66
4418ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany66
4419ApheresisAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland2
4420ApheresisAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland16
4421ApheresisAllogeneicChronic Granulomatous DiseaseHematology2019Standard TherapyPoland3
4422ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland58
4423ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland65
4424ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland69
4425ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland65
4426ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland60
4427ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2019Standard TherapyPoland69
4428ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland23
4429ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland34
4430ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland37
4431ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland56
4432ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland58
4433ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland56
4434ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland31
4435ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland54
4436ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2019Standard TherapyPoland46
4437ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland54
4438ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland65
4439ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland73
4440ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2019Standard TherapyPoland62
4441ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2019Standard TherapyGermany66
4442ApheresisAutologousEmbryonal Cell Carcinoma Of The TesticleHematology2019Standard TherapyGermany29
4443ApheresisAllogeneicExtracranial Malignant Germ Cell TumorsHematology2019Standard TherapyPoland53
4444ApheresisAllogeneicGlanzmann ThrombastheniaHematology2019Standard TherapyPoland11
4445ApheresisAllogeneicHigh-Risk Myelodysplastic SyndromeHematology2019Standard TherapyPoland61
4446ApheresisAllogeneicHistiocytosis XHematology2019Standard TherapyPoland14
4447ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland65
4448ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland58
4449ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland28
4450ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland44
4451ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland1
4452ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland32
4453ApheresisAllogeneicHodgkin LymphomaHematology2019Standard TherapyPoland34
4454ApheresisAllogeneicMantle Cell LymphomaHematology2019Standard TherapyPoland62
4455ApheresisAllogeneicMantle Cell LymphomaHematology2019Standard TherapyPoland69
4456ApheresisAllogeneicMantle Cell LymphomaHematology2019Standard TherapyPoland65
4457ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany66
4458ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany63
4459ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany59
4460ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany68
4461ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany65
4462ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany54
4463ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany64
4464ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany59
4465ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany59
4466ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany71
4467ApheresisAutologousMantle Cell LymphomaHematology2019Standard TherapyGermany63
4468ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2019Standard TherapyPoland59
4469ApheresisAllogeneicMixed Phenotype Acute LeukemiaHematology2019Standard TherapyPoland49
4470ApheresisAutologousMonoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline MyopathyHematology2019Standard TherapyGermany36
4471ApheresisAutologousMorbus HodgkinHematology2019Standard TherapyGermany66
4472ApheresisAllogeneicMucopolysaccharidosis Type IMetabolic2019Standard TherapyPoland1
4473ApheresisAllogeneicMucopolysaccharidosis Type IiMetabolic2019Standard TherapyPoland2
4474ApheresisAllogeneicMucopolysaccharidosis Type IiMetabolic2019Standard TherapyPoland2
4475ApheresisAllogeneicMultiple MyelomaHematology2019Standard TherapyPoland52
4476ApheresisAllogeneicMultiple MyelomaHematology2019Standard TherapyPoland55
4477ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4478ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4479ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4480ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany69
4481ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4482ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4483ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany52
4484ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany56
4485ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany54
4486ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany51
4487ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany57
4488ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany52
4489ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany61
4490ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4491ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany59
4492ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4493ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany39
4494ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany52
4495ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany59
4496ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany63
4497ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany40
4498ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany57
4499ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany53
4500ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4501ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany70
4502ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4503ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany56
4504ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany63
4505ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany35
4506ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany70
4507ApheresisAllogeneicMultiple MyelomaHematology2019Standard TherapyGermany57
4508ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany41
4509ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany60
4510ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4511ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4512ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany63
4513ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4514ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany66
4515ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany57
4516ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4517ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany67
4518ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4519ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany70
4520ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany64
4521ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany66
4522ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany68
4523ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany58
4524ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany59
4525ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany72
4526ApheresisAutologousMultiple MyelomaHematology2019Standard TherapyGermany65
4527ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4528ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland55
4529ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4530ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland14
4531ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4532ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4533ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland75
4534ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland45
4535ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland70
4536ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland72
4537ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland69
4538ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland45
4539ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland40
4540ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4541ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland72
4542ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland50
4543ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland59
4544ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4545ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4546ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland42
4547ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland68
4548ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4549ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland56
4550ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland63
4551ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4552ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland64
4553ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland42
4554ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland68
4555ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4556ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland68
4557ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4558ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4559ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4560ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland67
4561ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland4
4562ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland56
4563ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4564ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland62
4565ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4566ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland61
4567ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland63
4568ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland44
4569ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland45
4570ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland33
4571ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland66
4572ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4573ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland49
4574ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland69
4575ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland71
4576ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland25
4577ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland42
4578ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland46
4579ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyPoland65
4580ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany49
4581ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany66
4582ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany64
4583ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany67
4584ApheresisAllogeneicMyelodysplastic SyndromeHematology2019Standard TherapyGermany66
4585ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2019Standard TherapyPoland21
4586ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2019Standard TherapyPoland16
4587ApheresisAllogeneicMyelodysplastic Syndrome; Myeloproliferative Neoplasms OverlapHematology2019Standard TherapyGermany64
4588ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland46
4589ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland62
4590ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland47
4591ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland33
4592ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland45
4593ApheresisAllogeneicMyelofibrosisHematology2019Standard TherapyPoland43
4594ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland66
4595ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland69
4596ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland63
4597ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland61
4598ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2019Standard TherapyPoland61
4599ApheresisAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland45
4600ApheresisAllogeneicMyeloma MultiplexHematology2019Standard TherapyPoland62
4601ApheresisAutologousMyeloma; AmyloidosisHematology2019Standard TherapyGermany47
4602ApheresisAutologousNatural Killer / T-Cell-Non-Hodgkin-LymphomaHematology2019Standard TherapyGermany32
4603ApheresisAllogeneicNo DataHematology2019Standard TherapyPoland43
4604ApheresisAllogeneicNo DataHematology2019Standard TherapyPoland20
4605ApheresisAllogeneicNo DataHematology2019Standard TherapyPoland58
4606ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland68
4607ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland28
4608ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland58
4609ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland67
4610ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland51
4611ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland65
4612ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland42
4613ApheresisAllogeneicNon-Hodgkin LymphomaHematology2019Standard TherapyPoland55
4614ApheresisAutologousNon-Hodgkin LymphomaHematology2019Standard TherapyGermany56
4615ApheresisAutologousNon-Hodgkin LymphomaHematology2019Standard TherapyGermany59
4616ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2019Standard TherapyGermany63
4617ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2019Standard TherapyGermany69
4618ApheresisAllogeneicOsteomyelofibrosis - OtherHematology2019Standard TherapyPoland63
4619ApheresisAllogeneicOther MyelofibrosisHematology2019Standard TherapyPoland70
4620ApheresisAllogeneicOther MyelofibrosisHematology2019Standard TherapyPoland61
4621ApheresisAllogeneicOther MyelofibrosisHematology2019Standard TherapyPoland50
4622ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2019Standard TherapyPoland24
4623ApheresisAllogeneicPlasma Cell LeukemiaHematology2019Standard TherapyPoland35
4624ApheresisAllogeneicPolycythemia Vera-MyelofibrosisHematology2019Standard TherapyGermany58
4625ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2019Standard TherapyGermany70
4626ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany65
4627ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany63
4628ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany69
4629ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany64
4630ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany56
4631ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany57
4632ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany63
4633ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany67
4634ApheresisAutologousPrimary Central Nervous System LymphomaHematology2019Standard TherapyGermany78
4635ApheresisAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland21
4636ApheresisAllogeneicPrimary ImmunodeficiencyHematology2019Standard TherapyPoland19
4637ApheresisAllogeneicPrimary MediastinalHematology2019Standard TherapyPoland33
4638ApheresisAllogeneicPrimary MyelofibrosisHematology2019Standard TherapyPoland46
4639ApheresisAllogeneicPrimary MyelofibrosisHematology2019Standard TherapyPoland45
4640ApheresisAllogeneicPrimary MyelofibrosisHematology2019Standard TherapyGermany55
4641ApheresisAllogeneicRelapsed Peripheral T Cell LymphomaHematology2019Standard TherapyPoland65
4642ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyPoland59
4643ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyGermany64
4644ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2019Standard TherapyGermany60
4645ApheresisAllogeneicSecondary Acute Myeloid Leukemia At Myeloproliferative NeoplasmsHematology2019Standard TherapyGermany56
4646ApheresisAutologousSecondary Primary Central Nervous System LymphomaHematology2019Standard TherapyGermany66
4647ApheresisAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland12
4648ApheresisAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland11
4649ApheresisAllogeneicSevere Aplastic AnemiaHematology2019Standard TherapyPoland55
4650ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2019Standard TherapyPoland1
4651ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2019Standard TherapyPoland44
4652ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany55
4653ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany59
4654ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany67
4655ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany45
4656ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany72
4657ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany61
4658ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2019Standard TherapyGermany61
4659ApheresisAutologousTesticular Cancer RelapseHematology2019Standard TherapyGermany29
4660ApheresisAllogeneicThalassemia MajorHematology2019Standard TherapyPoland20
4661ApheresisAllogeneicWiskott-Aldrich SyndromeHematology2019Standard TherapyPoland1
4662ApheresisAllogeneicΒ - ThalassemiaHematology2019Standard TherapyPoland13
4663Adipose TissueAutologousChondromalaciaOrthopedy2019Experimental TherapyPoland48,8
4664Adipose TissueAutologousChondromalaciaOrthopedy2019Experimental TherapyPoland38,6
4665Adipose TissueAutologousCoxarthrosisOrthopedy2019Experimental TherapyPoland34
4666Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4667Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4668Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4669Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4670Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4671Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4672Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4673Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4674Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4675Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4676Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4677Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4678Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4679Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4680Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4681Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4682Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4683Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4684Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4685Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4686Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4687Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4688Adipose TissueAutologousCutis LaxaDermatology2019Clinical TrialPolandno data
4689Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland44,11
4690Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland65,3
4691Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland68,6
4692Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland36,1
4693Adipose TissueAutologousGonarthrosisOrthopedy2019Experimental TherapyPoland54,3
4694Adipose TissueAutologousMild ArthritisOrthopedy2019Experimental TherapyPoland21,2
4695Adipose TissueAutologousMild ArthritisOrthopedy2019Experimental TherapyPoland68,5
4696Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland52,8
4697Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland44,8
4698Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland52,5
4699Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland54,5
4700Adipose TissueAutologousOsteoarthritisOrthopedy2019Experimental TherapyPoland55,11
4701Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4702Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4703Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4704Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4705Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4706Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4707Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4708Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4709Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4710Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4711Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4712Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4713Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4714Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4715Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4716Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4717Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4718Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4719Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4720Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4721Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4722Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4723Adipose TissueAutologousScarDermatology2019Clinical TrialPolandno data
4724Adipose TissueAutologousShoulder OsteoarthritisOrthopedy2019Experimental TherapyPoland47,1
4725Adipose TissueAutologousSoft Tissue Diseases Related To Use, Overload And PressureOrthopedy2019Experimental TherapyPoland45,3
4726Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2018Experimental TherapyPoland7
4727Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2018Experimental TherapyPolandno data
4728Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2018Experimental TherapyPoland4,7
4729Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2018Experimental TherapyPoland46,7
4730Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2018Experimental TherapyPoland20,6
4731Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2018Experimental TherapyPoland82,11
4732Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland61,11
4733Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland67,1
4734Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland41,8
4735Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland52,3
4736Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland66,3
4737Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland46,2
4738Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland65,2
4739Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland47,3
4740Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland52,11
4741Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland40
4742Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland54,2
4743Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland67,11
4744Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland41,9
4745Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland80,3
4746Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland65,7
4747Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland65,2
4748Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland60,2
4749Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland67,9
4750Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland49,2
4751Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland64,5
4752Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland63,7
4753Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland62,1
4754Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland55,6
4755Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland38,8
4756Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland69,5
4757Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland37,11
4758Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland56,8
4759Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland71,1
4760Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland64,3
4761Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland68,5
4762Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland78,2
4763Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland70,9
4764Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland62,4
4765Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland61,8
4766Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland41,7
4767Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland38,1
4768Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland62,7
4769Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland44,3
4770Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2018Experimental TherapyPoland55,11
4771Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex Congenita; EpilepsiaNeurology2018Experimental TherapyPoland6,3
4772Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2018Experimental TherapyPoland18,11
4773Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,5
4774Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9
4775Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,3
4776Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,1
4777Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9,5
4778Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,11
4779Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,3
4780Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,1
4781Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland11,11
4782Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,7
4783Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,5
4784Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5
4785Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,3
4786Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,3
4787Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,4
4788Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,9
4789Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5,1
4790Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland11,4
4791Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,11
4792Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,1
4793Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6
4794Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9,2
4795Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland9,6
4796Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,5
4797Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,11
4798Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland5
4799Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland7,9
4800Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,7
4801Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland15
4802Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland6,3
4803Cord TissueAllogeneic - UnrelatedAutismNeurology2018Experimental TherapyPoland8,3
4804Cord TissueAllogeneic - RelatedAutismNeurology2018Experimental TherapyPoland4
4805Cord TissueAllogeneic - UnrelatedAutism - Delayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland6
4806Cord TissueAllogeneic - RelatedAutism; Congenital CytomegalovirusNeurology2018Experimental TherapyPoland6
4807Cord TissueAllogeneic - UnrelatedBilateral Edema Of The Optic NervesOphthalmology2018Experimental TherapyPoland12,4
4808Cord TissueAllogeneic - UnrelatedBrain Disorder, UnspecifiedNeurology2018Experimental TherapyPoland10,1
4809Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2018Experimental TherapyPoland56
4810Cord TissueAllogeneic - UnrelatedCerebellar Syndrome; Delayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland3,7
4811Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland16,7
4812Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,8
4813Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,11
4814Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,11
4815Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland9,4
4816Cord TissueAllogeneic - Unrelated & RelatedCerebral PalsyNeurology2018Experimental TherapyPoland13,1
4817Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,4
4818Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,1
4819Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,5
4820Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,11
4821Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,6
4822Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland11,6
4823Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,9
4824Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,2
4825Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,1
4826Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,3
4827Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,6
4828Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,2
4829Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland16,5
4830Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,1
4831Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,6
4832Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,9
4833Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,5
4834Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,4
4835Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,3
4836Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,11
4837Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,1
4838Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,8
4839Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,1
4840Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,4
4841Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland8,5
4842Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland12,4
4843Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,7
4844Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland10 months
4845Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland8,9
4846Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,2
4847Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland15,7
4848Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,2
4849Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland13,5
4850Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,1
4851Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,4
4852Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,6
4853Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,1
4854Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland4,2
4855Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,9
4856Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,1
4857Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,9
4858Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,5
4859Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,1
4860Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2,3
4861Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,11
4862Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland13,2
4863Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland7,3
4864Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland1,2
4865Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland16
4866Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,4
4867Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland12,2
4868Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland3,9
4869Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2018Experimental TherapyPoland10
4870Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland2
4871Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland5,2
4872Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland6,6
4873Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2018Experimental TherapyPoland9,5
4874Cord TissueAllogeneic - UnrelatedCerebral Palsy; EncephalopathyNeurology2018Experimental TherapyPoland1,11
4875Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland3,7
4876Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland9,2
4877Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2,4
4878Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland10,9
4879Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland7,4
4880Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland3,6
4881Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland3,1
4882Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2
4883Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2,4
4884Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland8,3
4885Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland10,11
4886Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2018Experimental TherapyPoland2,3
4887Cord TissueAllogeneic - UnrelatedCerebral Palsy; Epilepsy; Developmental DelayNeurology2018Experimental TherapyPoland8,11
4888Cord TissueAllogeneic - UnrelatedCongenital MyastheniaNeurology2018Experimental TherapyPoland6,4
4889Cord TissueAllogeneic - UnrelatedCongenital MyastheniaNeurology2018Experimental TherapyPoland3,3
4890Cord TissueAllogeneic - UnrelatedDamage To The Intercondylar Fissure Of The Right KneeOrthopedy2018Experimental TherapyPoland40
4891Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2018Experimental TherapyPoland34
4892Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2018Experimental TherapyPoland57
4893Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland6,2
4894Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland5,4
4895Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland4,8
4896Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland7,11
4897Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland4,7
4898Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2018Experimental TherapyPoland4,2
4899Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; Atrophy Of The Optic NervesNeurology2018Experimental TherapyPoland2
4900Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; EpilepsyNeurology2018Experimental TherapyPoland4,5
4901Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2018Experimental TherapyPoland14
4902Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2018Experimental TherapyPoland7,11
4903Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2018Experimental TherapyPoland5,2
4904Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4905Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4906Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4907Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4908Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4909Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4910Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4911Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4912Cord TissueAllogeneic - UnrelatedDiabetes Mellitus T. 1Endocrinology2018Clinical TrialPolandno data
4913Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2018Experimental TherapyPoland8,8
4914Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2018Experimental TherapyPoland54,8
4915Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2018Experimental TherapyPoland11,4
4916Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2018Experimental TherapyPoland24,5
4917Cord TissueAllogeneic - UnrelatedEncephalopathy; Cerebral PalsyNeurology2018Experimental TherapyPoland22,1
4918Cord TissueAllogeneic - UnrelatedEncephalopathy; EpilepsyNeurology2018Experimental TherapyPoland21,2
4919Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland20,9
4920Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland13,3
4921Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland7,6
4922Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland4
4923Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2018Experimental TherapyPoland3,9
4924Cord TissueAllogeneic - UnrelatedEpilepsy; Agenesis Of Corpus CallosumNeurology2018Experimental TherapyPoland2
4925Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2018Experimental TherapyPoland27,6
4926Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2018Experimental TherapyPoland31,5
4927Cord TissueAllogeneic - UnrelatedFriedreich's AtaxiaNeurology2018Experimental TherapyPoland22,4
4928Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2018Experimental TherapyPoland2,5
4929Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2018Experimental TherapyPoland9,11
4930Cord TissueAllogeneic - UnrelatedGeneral HypotoniaNeurology2018Experimental TherapyPoland7,3
4931Cord TissueAllogeneic - UnrelatedGeneral Hypotonia; AutismNeurology2018Experimental TherapyPoland8,4
4932Cord TissueAllogeneic - UnrelatedGenetic Syndrome - Deletion Of Part Of Chromosome 3Neurology2018Experimental TherapyPoland8,1
4933Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland44,11
4934Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland46,1
4935Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland28,11
4936Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland66
4937Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland48
4938Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland43
4939Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2018Experimental TherapyPoland48
4940Cord TissueAllogeneic - UnrelatedHoloprosencephalyNeurology2018Experimental TherapyPoland12,2
4941Cord TissueAllogeneic - UnrelatedLack Of Expected Normal Physical Development, UnspecifiedNeurology2018Experimental TherapyPoland10,2
4942Cord TissueAllogeneic - UnrelatedLeber's Hereditary Optic NeuropathyOphthalmology2018Experimental TherapyPoland18,11
4943Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2018Experimental TherapyPoland5,2
4944Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2018Experimental TherapyPoland7,5
4945Cord TissueAllogeneic - UnrelatedMicrocephaliaNeurology2018Experimental TherapyPoland12,1
4946Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2018Experimental TherapyPoland47,8
4947Cord TissueAllogeneic - UnrelatedMultiple System AtrophyNeurology2018Experimental TherapyPoland61,8
4948Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland28,1
4949Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland21,7
4950Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland22,6
4951Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland29,9
4952Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland21,8
4953Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2018Experimental TherapyPoland66,2
4954Cord TissueAllogeneic - UnrelatedMyelomeningoceleNeurology2018Experimental TherapyPoland1
4955Cord TissueAllogeneic - UnrelatedMyelomeningocele; HydrocephalusNeurology2018Experimental TherapyPoland2,9
4956Cord TissueAllogeneic - UnrelatedMyopathyNeurology2018Experimental TherapyPoland57,3
4957Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2018Experimental TherapyPoland27,4
4958Cord TissueAllogeneic - UnrelatedNeuropathyNeurology2018Experimental TherapyPoland47,6
4959Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland68,5
4960Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland31,11
4961Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland55,4
4962Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland36,6
4963Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland34,11
4964Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland27,2
4965Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland59,3
4966Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland50,8
4967Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland38,6
4968Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland55,8
4969Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland62,5
4970Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland35
4971Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland57,8
4972Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland75,5
4973Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland54,4
4974Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland80,5
4975Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland40,9
4976Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland70,11
4977Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland47,1
4978Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland38,2
4979Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland67,1
4980Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland64,7
4981Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland55,8
4982Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland27,5
4983Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland38,7
4984Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland23,7
4985Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland50,1
4986Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland70,5
4987Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland66,7
4988Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland22
4989Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland69,8
4990Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland78
4991Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland30
4992Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland73,8
4993Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland30,7
4994Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland49,7
4995Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland34,9
4996Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland46,5
4997Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland53,7
4998Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland56,7
4999Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland54,9
5000Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland42,4
5001Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland44,6
5002Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland60,3
5003Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland42,2
5004Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2018Experimental TherapyPoland52
5005Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2018Experimental TherapyPoland15,8
5006Cord TissueAllogeneic - UnrelatedOther Reduction Deformities Of Brain; SchizencephalyNeurology2018Experimental TherapyPoland5,7
5007Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland1,11
5008Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland1,9
5009Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland16,1
5010Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland5
5011Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland6
5012Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland11 months
5013Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland4,5
5014Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland1,2
5015Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2018Experimental TherapyPoland2,1
5016Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System - Syndrome Pierre-RobinNeurology2018Experimental TherapyPoland2,7
5017Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous System- Pitt Hopkins SyndromeNeurology2018Experimental TherapyPoland10,1
5018Cord TissueAllogeneic - UnrelatedParalysisNeurology2018Experimental TherapyPoland14,11
5019Cord TissueAllogeneic - UnrelatedPhelan-Mcdermid SyndromeNeurology2018Experimental TherapyPoland17,1
5020Cord TissueAllogeneic - UnrelatedProgressive Supranuclear AtrophyNeurology2018Experimental TherapyPoland62
5021Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland25,5
5022Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland36,3
5023Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland48,11
5024Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland44,3
5025Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland52,8
5026Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland32,3
5027Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland46,7
5028Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland47,8
5029Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland51,9
5030Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland38,1
5031Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland30,4
5032Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland34,2
5033Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland28,6
5034Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland83,5
5035Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland57,5
5036Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland45,11
5037Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland28,6
5038Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland61,3
5039Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland20,8
5040Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland76,1
5041Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland35,1
5042Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland31,2
5043Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland64,4
5044Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland66,2
5045Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland75,7
5046Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland62
5047Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland44
5048Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland48,1
5049Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland47,11
5050Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland44,2
5051Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland42,6
5052Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland64,9
5053Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland85,1
5054Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland61,9
5055Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland64,3
5056Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland51,6
5057Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland40,11
5058Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland50,4
5059Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland49,2
5060Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland33,5
5061Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland54,7
5062Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2018Experimental TherapyPoland36,7
5063Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland59,1
5064Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland66,8
5065Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland39,5
5066Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland44,2
5067Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland39,1
5068Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland47,3
5069Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland58,2
5070Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2018Experimental TherapyPoland42
5071Cord TissueAllogeneic - UnrelatedSpastic TetraparesisNeurology2018Experimental TherapyPoland12
5072Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2,6
5073Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland3,1
5074Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland4,11
5075Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland4,4
5076Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1
5077Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2
5078Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,5
5079Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,1
5080Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,4
5081Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2,8
5082Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland2,6
5083Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland3,2
5084Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2018Experimental TherapyPoland1,6
5085Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland33,11
5086Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland30,9
5087Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland25,9
5088Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland25,9
5089Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland34,3
5090Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland18,5
5091Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland26,6
5092Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland18,2
5093Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2018Experimental TherapyPoland38
5094Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2018Experimental TherapyPoland64,1
5095Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland34,1
5096Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland22,4
5097Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland34
5098Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2018Experimental TherapyPoland39,2
5099Cord TissueAllogeneic - UnrelatedState After Encephalitis; EpilepsyNeurology2018Experimental TherapyPoland44,11
5100Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland70,1
5101Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland53,4
5102Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland67,3
5103Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland42,3
5104Cord TissueAllogeneic - UnrelatedStrokeNeurology2018Experimental TherapyPoland60,9
5105Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2018Experimental TherapyPoland32,2
5106Cord TissueAllogeneic - UnrelatedVisual Pathway DysfunctionOphthalmology2018Experimental TherapyPoland48,9
5107Cord TissueAllogeneic - UnrelatedWolf-Hirschhorn SyndromeNeurology2018Experimental TherapyPoland1,8
5108Cord BloodAllogeneic - RelatedAlpha-MannosidosisNeurology2018Experimental TherapyGermany8
5109Cord BloodAutologousAplastic AnemiaHematology2018Standard TherapyPoland3,5
5110Cord BloodAutologousAutismNeurology2018Experimental TherapyPortugal6
5111Cord BloodAutologousAutismNeurology2018Experimental TherapyPortugal8
5112Cord BloodAllogeneic - RelatedAutismNeurology2018Experimental TherapyPoland3,9
5113Cord BloodAutologousAutismNeurology2018Experimental TherapyUK5,4
5114Cord BloodAutologousBrain DamageNeurology2018Experimental TherapyGermany3
5115Cord BloodAutologousCerebral PalsyNeurology2018Experimental TherapyPoland1,7
5116Cord BloodAutologousCerebral PalsyNeurology2018Experimental TherapyUK3,4
5117Cord BloodAllogeneicImmunodeficiencyHematology2018Standard TherapyGermany3 months
5118Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2018Standard TherapyTurkey10,1
5119Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2018Standard TherapyTurkey6
5120Cord BloodAllogeneicSphingolipidosisNeurology2018Experimental TherapyGermany4
5121Cord BloodAutologousStrokeNeurology2018Experimental TherapyGermany8 months
5122Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey8,6
5123Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey4,3
5124Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey3,1
5125Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey5
5126Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey10,9
5127Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyTurkey3
5128Cord BloodAllogeneic - RelatedThalassemia MajorHematology2018Standard TherapyGermany5
5129Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5130Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland3
5131Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5132Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland32
5133Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland27
5134Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland63
5135Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland28
5136Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland33
5137Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5138Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5139Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland64
5140Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5141Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland25
5142Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland42
5143Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5144Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland52
5145Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland20
5146Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland34
5147Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland63
5148Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany34
5149Bone Marrow FamilyAllogeneicAcute Myeloid Leukemia In First Complete RemissionHematology2018Standard TherapyPoland61
5150Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland62
5151Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland66
5152Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland23
5153Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland45
5154Bone Marrow FamilyAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland57
5155Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland70
5156Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland64
5157Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland3
5158Bone Marrow FamilyAllogeneicNo DataHematology2018Standard TherapyPoland58
5159Bone Marrow FamilyAllogeneicRelapsed Peripheral T Cell LymphomaHematology2018Standard TherapyPoland44
5160Bone Marrow FamilyAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland9
5161Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland3
5162Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland9 months
5163Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland12
5164Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5165Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland11
5166Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland14
5167Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5168Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland7
5169Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5170Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland14
5171Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland6
5172Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland59
5173Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland12
5174Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland6
5175Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland18
5176Bone MarrowAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2018Standard TherapyPoland14
5177Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5178Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland49
5179Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5180Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland36
5181Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland20
5182Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland1
5183Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland8
5184Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland3
5185Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5186Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland41
5187Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland32
5188Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland17
5189Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland25
5190Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5191Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland70
5192Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland8
5193Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5194Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland40
5195Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland22
5196Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5197Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland53
5198Bone MarrowAllogeneicAplastic AnemiaHematology2018Standard TherapyPoland24
5199Bone MarrowAllogeneicBilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid LeukemiaHematology2018Standard TherapyPoland2
5200Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland1
5201Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland3
5202Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland2
5203Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland2
5204Bone MarrowAllogeneicCongenital Hypoplastic AnemiaHematology2018Standard TherapyPoland2
5205Bone MarrowAllogeneicDiffuse Large B-Cell LymphomaHematology2018Standard TherapyPoland68
5206Bone MarrowAllogeneicFanconi AnemiaHematology2018Standard TherapyPoland3
5207Bone MarrowAllogeneicFanconi AnemiaHematology2018Standard TherapyPoland3
5208Bone MarrowAllogeneicHodgkin LymphomaHematology2018Standard TherapyPoland31
5209Bone MarrowAllogeneicHurler SyndromeHematology2018Standard TherapyPoland2
5210Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2018Standard TherapyPoland11
5211Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
5212Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland12
5213Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland2
5214Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland70
5215Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
5216Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
5217Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland31
5218Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland37
5219Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland16
5220Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland48
5221Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland52
5222Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland1
5223Bone MarrowAllogeneicNo DataHematology2018Standard TherapyPoland1
5224Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland62
5225Bone MarrowAllogeneicOther Non-Malignant DiseaseHematology2018Standard TherapyPoland29
5226Bone MarrowAllogeneicPrimary Myelofibrosis Grade IiiHematology2018Standard TherapyGermany73
5227Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland19
5228Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland14
5229Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland27
5230Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland18
5231Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland2
5232Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland20
5233Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland6
5234Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyGermany54
5235Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland2
5236Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland1
5237Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland7 months
5238Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland21
5239Bone MarrowAllogeneicT-Cell Leukemia/LymphomaHematology2018Standard TherapyPoland10
5240Bone MarrowAllogeneicThalassemia MajorHematology2018Standard TherapyPoland14
5241Bone MarrowAllogeneicThalassemia MajorHematology2018Standard TherapyPoland12
5242ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland29
5243ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland63
5244ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland65
5245ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland48
5246ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5247ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland33
5248ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland61
5249ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland42
5250ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland47
5251ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland62
5252ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5253ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5254ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland49
5255ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland59
5256ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland20
5257ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland27
5258ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland1
5259ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland61
5260ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland33
5261ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland33
5262ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland21
5263ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland39
5264ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5265ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland7 months
5266ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland25
5267ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland64
5268ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland36
5269ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland49
5270ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland20
5271ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland44
5272ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland59
5273ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland55
5274ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland30
5275ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland34
5276ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland48
5277ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland40
5278ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland45
5279ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland9
5280ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland8
5281ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland47
5282ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland24
5283ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany52
5284ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany43
5285ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany52
5286ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany59
5287ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany24
5288ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland26
5289ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland35
5290ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5291ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland42
5292ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5293ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5294ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5295ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland34
5296ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5297ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5298ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5299ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5300ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland30
5301ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5302ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland56
5303ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5304ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland51
5305ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland64
5306ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5307ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland64
5308ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5309ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5310ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland76
5311ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland38
5312ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5313ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5314ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5315ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5316ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland68
5317ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland37
5318ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland65
5319ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5320ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland33
5321ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5322ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland73
5323ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5324ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland52
5325ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5326ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland57
5327ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland35
5328ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5329ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland42
5330ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5331ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5332ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5333ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland70
5334ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland40
5335ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5336ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5337ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland39
5338ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland53
5339ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5340ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5341ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5342ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland31
5343ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5344ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5345ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland38
5346ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5347ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland32
5348ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5349ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland69
5350ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5351ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland28
5352ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland52
5353ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5354ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5355ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5356ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland47
5357ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland29
5358ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland37
5359ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland57
5360ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland6
5361ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland56
5362ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland71
5363ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland31
5364ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5365ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland45
5366ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5367ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland32
5368ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland60
5369ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland68
5370ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland54
5371ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5372ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland57
5373ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland59
5374ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland25
5375ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland75
5376ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland43
5377ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland72
5378ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland37
5379ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5380ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland46
5381ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland55
5382ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland56
5383ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland62
5384ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland61
5385ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland41
5386ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland14
5387ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland62
5388ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland66
5389ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland67
5390ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyPoland38
5391ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany20
5392ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany47
5393ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany58
5394ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany31
5395ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany68
5396ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany60
5397ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany59
5398ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany67
5399ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany62
5400ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany58
5401ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany69
5402ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany62
5403ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany60
5404ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany65
5405ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany19
5406ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany68
5407ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany62
5408ApheresisAllogeneicAcute Myeloid LeukemiaHematology2018Standard TherapyGermany67
5409ApheresisAllogeneicAcute Myeloid Leukemia; Myeloproliferative SyndromeHematology2018Standard TherapyGermany62
5410ApheresisAutologousAmyloidosisHematology2018Standard TherapyGermany72
5411ApheresisAutologousAmyloidosisHematology2018Standard TherapyGermany75
5412ApheresisAllogeneicAplastic AnemiaHematology2018Standard TherapyGermany61
5413ApheresisAutologousApoplexyHematology2018Standard TherapyGermany3
5414ApheresisAllogeneicAtypical Chronic Myeloid Leukemia Hematology2018Standard TherapyPoland58
5415ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland41
5416ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland50
5417ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland34
5418ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland34
5419ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland52
5420ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland46
5421ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2018Standard TherapyPoland65
5422ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany69
5423ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany43
5424ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany66
5425ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany32
5426ApheresisAllogeneicBlastic Nk Cell LymphomaHematology2018Standard TherapyPoland65
5427ApheresisAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland15
5428ApheresisAllogeneicChronic Granulomatous DiseaseHematology2018Standard TherapyPoland2
5429ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2018Standard TherapyPoland49
5430ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2018Standard TherapyPoland38
5431ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland63
5432ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland48
5433ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland25
5434ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyPoland41
5435ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyGermany44
5436ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2018Standard TherapyGermany54
5437ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland39
5438ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland63
5439ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland56
5440ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland71
5441ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland51
5442ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland67
5443ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland67
5444ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland49
5445ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2018Standard TherapyPoland60
5446ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2018Standard TherapyPoland54
5447ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2018Standard TherapyGermany71
5448ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2018Standard TherapyGermany71
5449ApheresisAllogeneicFanconi AnemiaHematology2018Standard TherapyPoland9
5450ApheresisAllogeneicFollicular LymphomaHematology2018Standard TherapyPoland44
5451ApheresisAutologousFollicular LymphomaHematology2018Standard TherapyGermany65
5452ApheresisAllogeneicFollicular Lymphoma (Non-Hodgkin Lymphoma)Hematology2018Standard TherapyPoland56
5453ApheresisAutologousGerm Cell TumorHematology2018Standard TherapyGermany23
5454ApheresisAutologousGerm Cell TumorHematology2018Standard TherapyGermany31
5455ApheresisAllogeneicHodgkin LymphomaHematology2018Standard TherapyPoland38
5456ApheresisAllogeneicHodgkin LymphomaHematology2018Standard TherapyPoland27
5457ApheresisAllogeneicHypoplastic Mds-Eb2 With Incipient SamlHematology2018Standard TherapyPoland63
5458ApheresisAutologousLarge B-Cell Non-Hodgkin-LymphomaHematology2018Standard TherapyGermany66
5459ApheresisAllogeneicLeukemiaHematology2018Standard TherapyPoland34
5460ApheresisAllogeneicLymphomatoid GranulomatosisHematology2018Standard TherapyGermany36
5461ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany66
5462ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany64
5463ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany44
5464ApheresisAutologousMantle Cell LymphomaHematology2018Standard TherapyGermany66
5465ApheresisAutologousMorbus HodgkinHematology2018Standard TherapyGermany65
5466ApheresisAutologousMorbus HodgkinHematology2018Standard TherapyGermany31
5467ApheresisAllogeneicMorbus Hodgkin-RelapseHematology2018Standard TherapyGermany35
5468ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany67
5469ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5470ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5471ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5472ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany57
5473ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany53
5474ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany57
5475ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5476ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany47
5477ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany60
5478ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5479ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5480ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany67
5481ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5482ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany54
5483ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany58
5484ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany51
5485ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany69
5486ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany52
5487ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5488ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5489ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5490ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5491ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5492ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany63
5493ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany55
5494ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany60
5495ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5496ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany62
5497ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5498ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany55
5499ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5500ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5501ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany52
5502ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany61
5503ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany69
5504ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany73
5505ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany42
5506ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany60
5507ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5508ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5509ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany66
5510ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany65
5511ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany51
5512ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany69
5513ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany50
5514ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany67
5515ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany50
5516ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany64
5517ApheresisAutologousMultiple MyelomaHematology2018Standard TherapyGermany56
5518ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland74
5519ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5520ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland72
5521ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland59
5522ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland50
5523ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland62
5524ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland68
5525ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland54
5526ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5527ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland22
5528ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland64
5529ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland77
5530ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland66
5531ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland60
5532ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland68
5533ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland39
5534ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland62
5535ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland56
5536ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5537ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5538ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland27
5539ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland70
5540ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland39
5541ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland71
5542ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland32
5543ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland59
5544ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland59
5545ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5546ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5547ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland65
5548ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland66
5549ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland48
5550ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland60
5551ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland57
5552ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland46
5553ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland49
5554ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland4
5555ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5556ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland69
5557ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland63
5558ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland8
5559ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland58
5560ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland61
5561ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyPoland67
5562ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany61
5563ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany65
5564ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany57
5565ApheresisAllogeneicMyelodysplastic SyndromeHematology2018Standard TherapyGermany27
5566ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2018Standard TherapyPoland61
5567ApheresisAllogeneicMyelodysplastic Syndrome Refractory Anemia With Blast Proliferation IiHematology2018Standard TherapyGermany57
5568ApheresisAllogeneicMyelodysplastic Syndrome; Acute Lymphoblastic LeukemiaHematology2018Standard TherapyGermany65
5569ApheresisAllogeneicMyelodysplastic Syndrome; Acute Myelogenous LeukemiaHematology2018Standard TherapyPoland74
5570ApheresisAllogeneicMyelodysplastic Syndrome; Myeloproliferative NeoplasmsHematology2018Standard TherapyGermany62
5571ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland49
5572ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland60
5573ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland56
5574ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland58
5575ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland64
5576ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland68
5577ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland72
5578ApheresisAllogeneicMyelofibrosisHematology2018Standard TherapyPoland53
5579ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland56
5580ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland57
5581ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland55
5582ApheresisAllogeneicMyeloma MultiplexHematology2018Standard TherapyPoland52
5583ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2018Standard TherapyPoland61
5584ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland69
5585ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland70
5586ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland38
5587ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland22
5588ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland60
5589ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland19
5590ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland65
5591ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland22
5592ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland67
5593ApheresisAllogeneicNo DataHematology2018Standard TherapyPoland46
5594ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland23
5595ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland69
5596ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland70
5597ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland17
5598ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland31
5599ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland66
5600ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland17
5601ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland58
5602ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland11
5603ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland64
5604ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland30
5605ApheresisAllogeneicNon-Hodgkin LymphomaHematology2018Standard TherapyPoland54
5606ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany72
5607ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany54
5608ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany58
5609ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany63
5610ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany48
5611ApheresisAutologousNon-Hodgkin LymphomaHematology2018Standard TherapyGermany62
5612ApheresisAllogeneicNon-Hodgkin Lymphoma; Diffuse Large B-Cell LymphomaHematology2018Standard TherapyPoland62
5613ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2018Standard TherapyGermany51
5614ApheresisAllogeneicOther MalignancyHematology2018Standard TherapyPoland59
5615ApheresisAllogeneicOther Myelodysplastic SyndromesHematology2018Standard TherapyPoland67
5616ApheresisAllogeneicOther MyelofibrosisHematology2018Standard TherapyPoland57
5617ApheresisAllogeneicPeripheral T-Cell LymphomaHematology2018Standard TherapyPoland50
5618ApheresisAllogeneicPlasma Cell DisorderHematology2018Standard TherapyPoland64
5619ApheresisAllogeneicPlasma Cell DisorderHematology2018Standard TherapyPoland57
5620ApheresisAutologousPlasma Cell LeukemiaHematology2018Standard TherapyGermany52
5621ApheresisAllogeneicPost-Essential Thrombocythemia-MyelofibrosisHematology2018Standard TherapyGermany53
5622ApheresisAutologousPrimary Central Nervous System LymphomaHematology2018Standard TherapyGermany67
5623ApheresisAutologousPrimary Central Nervous System LymphomaHematology2018Standard TherapyGermany69
5624ApheresisAutologousPrimary Central Nervous System LymphomaHematology2018Standard TherapyGermany66
5625ApheresisAutologousPrimary Central Nervous System Lymphoma RelapseHematology2018Standard TherapyGermany63
5626ApheresisAllogeneicPrimary ImmunodeficiencyHematology2018Standard TherapyPoland3
5627ApheresisAllogeneicPrimary Myelofibrosis; Secondary Acute Myelogenous LeukemiaHematology2018Standard TherapyPoland53
5628ApheresisAllogeneicProlymphocytic LeukemiaHematology2018Standard TherapyPoland62
5629ApheresisAutologousRefractory Diffuse Large B-Cell LymphomaHematology2018Standard TherapyGermany36
5630ApheresisAllogeneicRefractory Diffuse Large B-Cell LymphomaHematology2018Standard TherapyGermany50
5631ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2018Standard TherapyPoland58
5632ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2018Standard TherapyGermany68
5633ApheresisAllogeneicSecondary Acute Myeloid Leukemia At Primary MyelofibrosisHematology2018Standard TherapyGermany56
5634ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland18
5635ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland74
5636ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland24
5637ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland70
5638ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland6
5639ApheresisAllogeneicSevere Aplastic AnemiaHematology2018Standard TherapyPoland13
5640ApheresisAllogeneicSevere Combined ImmunodeficiencyHematology2018Standard TherapyPoland2
5641ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland7
5642ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland13
5643ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland45
5644ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2018Standard TherapyPoland40
5645ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2018Standard TherapyGermany67
5646ApheresisAutologousT-Cell-LymphomaHematology2018Standard TherapyGermany67
5647ApheresisAllogeneicT-Cell-LymphomaHematology2018Standard TherapyGermany23
5648ApheresisAllogeneicThalassemia MajorHematology2018Standard TherapyPoland5
5649ApheresisAllogeneicTherapy-Related Myelodysplastic SyndromesHematology2018Standard TherapyPoland65
5650Adipose TissueAutologousCondition After Injury Of The Left Knee JointOrthopedy2018Experimental TherapyPoland33
5651Adipose TissueAutologousCoxarthrosisOrthopedy2018Experimental TherapyPoland53
5652Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5653Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5654Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5655Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5656Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5657Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5658Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5659Adipose TissueAutologousCutis LaxaDermatology2018Clinical TrialPolandno data
5660Adipose TissueAutologousGonarthrosisOrthopedy2018Experimental TherapyPoland69
5661Adipose TissueAutologousGonarthrosisOrthopedy2018Experimental TherapyPoland42
5662Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5663Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5664Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5665Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5666Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5667Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5668Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5669Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5670Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5671Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5672Adipose TissueAutologousScarDermatology2018Clinical TrialPolandno data
5673Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland44,2
5674Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland25,8
5675Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland38,5
5676Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland26,1
5677Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland37,11
5678Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland62,5
5679Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland35,4
5680Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2017Experimental TherapyPoland31,3
5681Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland13
5682Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland11,1
5683Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland2,4
5684Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland8,1
5685Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2017Experimental TherapyPoland7,6
5686Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2017Experimental TherapyPoland33,4
5687Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland67,11
5688Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland37,9
5689Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland71,7
5690Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPolandno data
5691Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland47,6
5692Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland56,7
5693Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland48,11
5694Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland46,3
5695Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland45,9
5696Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland75,9
5697Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,3
5698Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland59,8
5699Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland64,9
5700Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland56,7
5701Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland40,11
5702Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland69,1
5703Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland52
5704Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland35,1
5705Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland77,2
5706Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland35,6
5707Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland33,5
5708Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,6
5709Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland46
5710Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland54,1
5711Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland63,2
5712Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland43,8
5713Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland64,7
5714Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,6
5715Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland70,11
5716Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland65,1
5717Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland51,3
5718Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland68,1
5719Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland59,3
5720Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland49,1
5721Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland60,1
5722Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland56,7
5723Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland58,7
5724Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland63
5725Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland62,9
5726Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland57,9
5727Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland59,11
5728Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland46,5
5729Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland53,9
5730Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland55,2
5731Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland54,6
5732Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland78,6
5733Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland44
5734Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland78,7
5735Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland60,1
5736Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland28,7
5737Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland78,5
5738Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland54,2
5739Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland45,3
5740Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland48,2
5741Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2017Experimental TherapyPoland71,8
5742Cord TissueAllogeneic - UnrelatedAnterior Ischemic Optic NeuropathyOphthalmology2017Experimental TherapyPoland67,7
5743Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex CongenitaNeurology2017Experimental TherapyPoland1,7
5744Cord TissueAllogeneic - UnrelatedArthrogryposis Multiplex CongenitaNeurology2017Experimental TherapyPoland3,5
5745Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2017Experimental TherapyPoland23,9
5746Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2017Experimental TherapyPoland35,5
5747Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7,11
5748Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland13,4
5749Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland11,11
5750Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland9,1
5751Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland6,3
5752Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7,11
5753Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland10,2
5754Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,8
5755Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland6,8
5756Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7
5757Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,8
5758Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland10,8
5759Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland13,1
5760Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,11
5761Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland4,8
5762Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland12,2
5763Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland5,1
5764Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland6,5
5765Cord TissueAllogeneic - UnrelatedAutismNeurology2017Experimental TherapyPoland7,8
5766Cord TissueAllogeneic - UnrelatedAutism; EncephalopathyNeurology2017Experimental TherapyPoland7,11
5767Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2017Experimental TherapyPoland61
5768Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2017Experimental TherapyPoland46
5769Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2017Experimental TherapyPoland33
5770Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland11,5
5771Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland60,5
5772Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland52,6
5773Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland60,11
5774Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2017Experimental TherapyPoland46,5
5775Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland18,7
5776Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland15,4
5777Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,11
5778Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland31,9
5779Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,7
5780Cord TissueAllogeneic - RelatedCerebral PalsyNeurology2017Experimental TherapyPoland12
5781Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,9
5782Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,3
5783Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,1
5784Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland13,6
5785Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,2
5786Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,7
5787Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,4
5788Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland15,1
5789Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland18,4
5790Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland7,9
5791Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,5
5792Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,7
5793Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,5
5794Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,1
5795Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,4
5796Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,3
5797Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,7
5798Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,2
5799Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,7
5800Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,11
5801Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland15,3
5802Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland13,6
5803Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,4
5804Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3,3
5805Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,3
5806Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,2
5807Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland3
5808Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,9
5809Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland7,8
5810Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,2
5811Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland10
5812Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,6
5813Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland1,11
5814Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland4,2
5815Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland24,8
5816Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,1
5817Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland1,6
5818Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,8
5819Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland10,9
5820Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland17
5821Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,6
5822Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland5,9
5823Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,8
5824Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland8,6
5825Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,2
5826Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland1,6
5827Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland2,5
5828Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2017Experimental TherapyPoland6,2
5829Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2017Experimental TherapyPoland5,8
5830Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2017Experimental TherapyPoland3,6
5831Cord TissueAllogeneic - UnrelatedCerebral Palsy; EpilepsyNeurology2017Experimental TherapyPoland2,1
5832Cord TissueAllogeneic - UnrelatedCerebral Palsy; Neonatal Cerebral LeukomalaciaNeurology2017Experimental TherapyPoland1,9
5833Cord TissueAllogeneic - UnrelatedChronic Myelogenous LeukemiaHematology2017Experimental TherapyPoland5,11
5834Cord TissueAllogeneic - UnrelatedCondition After EncephalitisNeurology2017Experimental TherapyPoland19,7
5835Cord TissueAllogeneic - UnrelatedCondition After MyelitisNeurology2017Experimental TherapyPoland34,11
5836Cord TissueAllogeneic - UnrelatedCongenital Fiber-Type Disproportion MyopathyNeurology2017Experimental TherapyPoland1,1
5837Cord TissueAllogeneic - UnrelatedCongenital Malformations Of The Nervous System, UnspecifiedNeurology2017Experimental TherapyPoland8,2
5838Cord TissueAllogeneic - UnrelatedCranium BifidumNeurology2017Experimental TherapyPoland5,2
5839Cord TissueAllogeneic - UnrelatedCri Du Chat SyndromeNeurology2017Experimental TherapyPoland8,6
5840Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland3,5
5841Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland6,3
5842Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland5
5843Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland7,9
5844Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2017Experimental TherapyPoland8,3
5845Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development; EpilepsyNeurology2017Experimental TherapyPoland11,8
5846Cord TissueAllogeneic - UnrelatedDevic’s DiseaseNeurology2017Experimental TherapyPoland45,2
5847Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland28,6
5848Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland28,11
5849Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland23,9
5850Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland9,1
5851Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2017Experimental TherapyPoland14,5
5852Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland21,1
5853Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland5
5854Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland5,5
5855Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2017Experimental TherapyPoland1,6
5856Cord TissueAllogeneic - UnrelatedEncephalopathy; Cerebral PalsyNeurology2017Experimental TherapyPoland4,4
5857Cord TissueAllogeneic - UnrelatedEncephalopathy; Cerebral PalsyNeurology2017Experimental TherapyPoland1,5
5858Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland3,1
5859Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland16,4
5860Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland9,11
5861Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland12,11
5862Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2017Experimental TherapyPoland15,9
5863Cord TissueAllogeneic - UnrelatedEpilepsy; AutismNeurology2017Experimental TherapyPoland6
5864Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland22,1
5865Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland31,6
5866Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland32,3
5867Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland33,4
5868Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland42,1
5869Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2017Experimental TherapyPoland22,4
5870Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2017Experimental TherapyPoland4,7
5871Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2017Experimental TherapyPoland7,11
5872Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2017Experimental TherapyPoland58
5873Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2017Experimental TherapyPoland65,6
5874Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2017Experimental TherapyPoland66
5875Cord TissueAllogeneic - UnrelatedHydrocephalus; Neonatal Cerebral LeukomalaciaNeurology2017Experimental TherapyPoland2,3
5876Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2017Experimental TherapyPoland1,9
5877Cord TissueAllogeneic - UnrelatedHypoxia-Ischemic Encephalopathy (Hie)Neurology2017Experimental TherapyPoland1,1
5878Cord TissueAllogeneic - UnrelatedIschemia Within The Optic NerveOphthalmology2017Experimental TherapyPoland37,11
5879Cord TissueAllogeneic - UnrelatedKrabbe DiseaseNeurology2017Experimental TherapyPoland6,3
5880Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2017Experimental TherapyPoland7,1
5881Cord TissueAllogeneic - UnrelatedMoyamoya DiseaseNeurology2017Experimental TherapyPoland17,7
5882Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland26,11
5883Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland34,1
5884Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland6,7
5885Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland12,1
5886Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland10,8
5887Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland8
5888Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland29,8
5889Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2017Experimental TherapyPoland7,4
5890Cord TissueAllogeneic - UnrelatedMyopathy Of Congenital Fiber Type Disproportion; Damage To The Central Nervous SystemNeurology2017Experimental TherapyPoland2,2
5891Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2017Experimental TherapyPoland37,7
5892Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2017Experimental TherapyPoland41,11
5893Cord TissueAllogeneic - UnrelatedMyotonic DystrophyNeurology2017Experimental TherapyPoland3,2
5894Cord TissueAllogeneic - UnrelatedNo Bone AdhesionOrthopedy2017Experimental TherapyPoland14,1
5895Cord TissueAllogeneic - UnrelatedNo Bone AdhesionOrthopedy2017Experimental TherapyPoland17,11
5896Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland39
5897Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland30,9
5898Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland37,7
5899Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland66,11
5900Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland31,5
5901Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland39,7
5902Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland76,1
5903Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland77,5
5904Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland30,6
5905Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland85,7
5906Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland52,8
5907Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland37,1
5908Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland59
5909Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2017Experimental TherapyPoland66,1
5910Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland56,4
5911Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland30,11
5912Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland74,5
5913Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2017Experimental TherapyPoland7,11
5914Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2017Experimental TherapyPoland2,1
5915Cord TissueAllogeneic - UnrelatedOther Specific Disorders Of The Central Nervous SystemNeurology2017Experimental TherapyPoland2,4
5916Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland58,1
5917Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland49
5918Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland56,8
5919Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland65,2
5920Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland43,4
5921Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland42,11
5922Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland41
5923Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland52,1
5924Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland61,5
5925Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland48,1
5926Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland31,1
5927Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland52,11
5928Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland36,11
5929Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland63,11
5930Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland31,9
5931Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland45,5
5932Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland49,1
5933Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland26,9
5934Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland65,4
5935Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland43,11
5936Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland22,1
5937Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland61,3
5938Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland61,7
5939Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland65,1
5940Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland43,1
5941Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland36,9
5942Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2017Experimental TherapyPoland48,8
5943Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland52,9
5944Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland47,2
5945Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland46,9
5946Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland38
5947Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland25,2
5948Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland53,1
5949Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland47,6
5950Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland32,9
5951Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland69,2
5952Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2017Experimental TherapyPoland64,3
5953Cord TissueAllogeneic - UnrelatedSpastic TetraparesisNeurology2017Experimental TherapyPoland29,4
5954Cord TissueAllogeneic - UnrelatedSpastic Tetraparesis; EpilepsyNeurology2017Experimental TherapyPoland2,8
5955Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland1,11
5956Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland6,4
5957Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland6,3
5958Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland1,1
5959Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland4,1
5960Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland3,6
5961Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland3,4
5962Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland2,11
5963Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland5,8
5964Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland6,1
5965Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland2,8
5966Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland2,3
5967Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland18,5
5968Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland5,1
5969Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland11,1
5970Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland10,3
5971Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2017Experimental TherapyPoland9 months
5972Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland34,11
5973Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland34,1
5974Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland24,9
5975Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland39
5976Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland6,4
5977Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPolandno data
5978Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPolandno data
5979Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland27,3
5980Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland33,8
5981Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland3,4
5982Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland38,4
5983Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland14,4
5984Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2017Experimental TherapyPoland57,1
5985Cord TissueAllogeneic - UnrelatedSpinal Cord Injury; TetraparesisOrthopedy2017Experimental TherapyPoland42,9
5986Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland10,6
5987Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland41,4
5988Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland12,11
5989Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland8,5
5990Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2017Experimental TherapyPoland24,9
5991Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland44,1
5992Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland24,6
5993Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland35,9
5994Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2017Experimental TherapyPoland24,6
5995Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland37,4
5996Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland31,6
5997Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland30
5998Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland23,7
5999Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland27,11
6000Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland45,4
6001Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland48,1
6002Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2017Experimental TherapyPoland37,8
6003Cord TissueAllogeneic - UnrelatedSyndrome IfapHematology2017Experimental TherapyPoland3,5
6004Cord TissueAllogeneic - UnrelatedSyringomyeliaNeurology2017Experimental TherapyPoland42,6
6005Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2017Experimental TherapyPoland27,11
6006Cord TissueAllogeneic - UnrelatedTransverse MyelitisNeurology2017Experimental TherapyPoland8,3
6007Cord TissueAllogeneic - UnrelatedTraumatic Brain InjuryNeurology2017Experimental TherapyPoland9,4
6008Cord BloodAutologousAutismNeurology2017Experimental TherapyPoland4,11
6009Cord BloodAutologousAutismNeurology2017Experimental TherapyPoland6,2
6010Cord BloodAutologousAutismNeurology2017Experimental TherapyPoland7,3
6011Cord BloodAutologousAutismNeurology2017Experimental TherapyRomania5,4
6012Cord BloodAutologousAutismNeurology2017Experimental TherapyRomania4,1
6013Cord BloodAutologousAutismNeurology2017Experimental TherapyRomania4,1
6014Cord BloodAllogeneic - RelatedCd40 Ligand DeficiencyHematology2017Standard TherapyTurkey9,7
6015Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapySpain 7
6016Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland2,2
6017Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland5,4
6018Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland10,3
6019Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyPoland6,8
6020Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyUK7
6021Cord BloodAutologousCerebral PalsyNeurology2017Experimental TherapyUK3,4
6022Cord BloodAllogeneic - RelatedChronic Granulomatous DiseaseHematology2017Standard TherapyTurkey3,9
6023Cord Bloodno dataLymphoblastic LeukemiaHematology2017Standard TherapyUK3
6024Cord BloodAllogeneic - RelatedRelapse Of Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7,3
6025Cord BloodAllogeneic - RelatedThalassemia MajorHematology2017Standard TherapyTurkey4,1
6026Cord BloodAllogeneic - RelatedThalassemia MajorHematology2017Standard TherapyTurkey4,1
6027Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland51
6028Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland47
6029Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
6030Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
6031Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland52
6032Bone Marrow FamilyAllogeneicChronic Granulomatous DiseaseHematology2017Standard TherapyPoland4
6033Bone Marrow FamilyAllogeneicHurler SyndromeHematology2017Standard TherapyPoland2
6034Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland68
6035Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6036Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland50
6037Bone Marrow FamilyAllogeneicMyelofibrosisHematology2017Standard TherapyPoland29
6038Bone Marrow FamilyAllogeneicMyeloproliferative NeoplasmsHematology2017Standard TherapyPoland7
6039Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland68
6040Bone Marrow FamilyAllogeneicNo Datano data2017Standard TherapyPoland39
6041Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland39
6042Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland65
6043Bone Marrow FamilyAllogeneicNo DataHematology2017Standard TherapyPoland32
6044Bone Marrow FamilyAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland56
6045Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
6046Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland6
6047Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland30
6048Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland10
6049Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland14
6050Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland16
6051Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland38
6052Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland9
6053Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland21
6054Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland3
6055Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland8
6056Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland14
6057Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland4
6058Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
6059Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland2
6060Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
6061Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland18
6062Bone MarrowAllogeneicAcute Megakaryocytic LeukemiaHematology2017Standard TherapyPoland2
6063Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
6064Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland19
6065Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland76
6066Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland22
6067Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
6068Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
6069Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
6070Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland13
6071Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
6072Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland1
6073Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
6074Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
6075Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland10
6076Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
6077Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
6078Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland10
6079Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland17
6080Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
6081Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland56
6082Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland24
6083Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland9
6084Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland12
6085Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland2
6086Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany70
6087Bone MarrowAllogeneicAcute Myeloid Leukemia (High Risk)Hematology2017Standard TherapyGermany31
6088Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2017Standard TherapyPoland2
6089Bone MarrowAllogeneicChronic Granulomatous DiseaseHematology2017Standard TherapyPoland4
6090Bone MarrowAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland51
6091Bone MarrowAllogeneicFanconi AnemiaHematology2017Standard TherapyPoland10
6092Bone MarrowAllogeneicFanconi AnemiaHematology2017Standard TherapyPoland10
6093Bone MarrowAllogeneicHyper-Igm SyndromeHematology2017Standard TherapyPoland2
6094Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2017Standard TherapyPoland1
6095Bone MarrowAllogeneicLeukemiaHematology2017Standard TherapyPoland40
6096Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland60
6097Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland61
6098Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland2
6099Bone MarrowAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland50
6100Bone MarrowAllogeneicNijmegen Breakage SyndromeHematology2017Standard TherapyPoland8
6101Bone MarrowAllogeneicNo DataHematology2017Standard TherapyPoland32
6102Bone MarrowAllogeneicOther Combined ImmunodeficiencyHematology2017Standard TherapyPoland11
6103Bone MarrowAllogeneicPrimary Immunodeficiency; Nijmegen Breakage SyndromeHematology2017Standard TherapyPoland6
6104Bone MarrowAllogeneicPure Red Cell AplasiaHematology2017Standard TherapyPoland5
6105Bone MarrowAllogeneicSecondary Acute Myelogenous Leukemia After Ewing SarcomaHematology2017Standard TherapyPoland16
6106Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland6
6107Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland1
6108Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland1
6109Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland2
6110Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland1
6111Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2017Standard TherapyPoland8
6112Bone MarrowAllogeneicT-Cell Leukemia/LymphomaHematology2017Standard TherapyPoland18
6113Bone MarrowAllogeneicThalassemia MajorHematology2017Standard TherapyPoland11
6114Bone MarrowAllogeneicWiskott-Aldrich SyndromeHematology2017Standard TherapyPoland2
6115ApheresisAllogeneicAccrued Hemophagocytic LymphohistiocytosisHematology2017Standard TherapyGermany43
6116ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland24
6117ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland43
6118ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland17
6119ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland53
6120ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland43
6121ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland3
6122ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland12
6123ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland19
6124ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland60
6125ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland33
6126ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland56
6127ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland59
6128ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland35
6129ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland23
6130ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland12
6131ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland38
6132ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland62
6133ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland51
6134ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland19
6135ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland11
6136ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland4
6137ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland41
6138ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland64
6139ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland30
6140ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland57
6141ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland56
6142ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland17
6143ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland36
6144ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland43
6145ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland21
6146ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland53
6147ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland67
6148ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland6
6149ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland64
6150ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland24
6151ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland10
6152ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland26
6153ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland8
6154ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland13
6155ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyGermany26
6156ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2017Standard TherapyGermany39
6157ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
6158ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
6159ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland48
6160ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
6161ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland32
6162ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland47
6163ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland48
6164ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland20
6165ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland44
6166ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland66
6167ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland75
6168ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland61
6169ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
6170ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
6171ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
6172ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland45
6173ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
6174ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
6175ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
6176ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
6177ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland32
6178ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland75
6179ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
6180ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
6181ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
6182ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland56
6183ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
6184ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland75
6185ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland69
6186ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
6187ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland70
6188ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland34
6189ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland52
6190ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
6191ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
6192ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
6193ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland48
6194ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
6195ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
6196ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
6197ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
6198ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland39
6199ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
6200ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland35
6201ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland29
6202ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
6203ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
6204ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland38
6205ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland32
6206ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
6207ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
6208ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland67
6209ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
6210ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland43
6211ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland42
6212ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
6213ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
6214ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland52
6215ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland49
6216ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
6217ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland65
6218ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland51
6219ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland35
6220ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
6221ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland31
6222ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland64
6223ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland60
6224ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland49
6225ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
6226ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland22
6227ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland54
6228ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland61
6229ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland40
6230ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
6231ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
6232ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
6233ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
6234ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
6235ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
6236ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
6237ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland16
6238ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland57
6239ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland71
6240ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland24
6241ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland62
6242ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland66
6243ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland69
6244ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland55
6245ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland59
6246ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland63
6247ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland37
6248ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland23
6249ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland26
6250ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland46
6251ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland68
6252ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland71
6253ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland53
6254ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland58
6255ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland27
6256ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland72
6257ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland72
6258ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland37
6259ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyPoland71
6260ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany58
6261ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany38
6262ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany64
6263ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany57
6264ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany56
6265ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany52
6266ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany63
6267ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany44
6268ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany62
6269ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany54
6270ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany25
6271ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany71
6272ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany34
6273ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany49
6274ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany68
6275ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany39
6276ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany30
6277ApheresisAllogeneicAcute Myeloid LeukemiaHematology2017Standard TherapyGermany57
6278ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2017Standard TherapyPoland64
6279ApheresisAutologousAngioimmunoblastic Lymphadenopathy With DysproteinemiaHematology2017Standard TherapyGermany36
6280ApheresisAllogeneicAplastic AnemiaHematology2017Standard TherapyPoland23
6281ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland44
6282ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland28
6283ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland64
6284ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2017Standard TherapyPoland48
6285ApheresisAutologousB-Cell LymphomaHematology2017Standard TherapyGermany65
6286ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2017Standard TherapyGermany57
6287ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2017Standard TherapyGermany50
6288ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2017Standard TherapyGermany68
6289ApheresisAllogeneicBlastic Plasmacytoid Dendritic Cell NeoplasmHematology2017Standard TherapyPoland56
6290ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland57
6291ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland45
6292ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland47
6293ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland67
6294ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland65
6295ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland51
6296ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyPoland7
6297ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2017Standard TherapyGermany31
6298ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland29
6299ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland74
6300ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2017Standard TherapyPoland57
6301ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland54
6302ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland58
6303ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland51
6304ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland61
6305ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland72
6306ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2017Standard TherapyPoland60
6307ApheresisAllogeneicChronic Myeloproliferative Neoplasm Blast CrisisHematology2017Standard TherapyPoland29
6308ApheresisAllogeneicCommon Variable Immunodeficiency, Relapsed Hemophagocytic SyndromeHematology2017Standard TherapyPoland44
6309ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2017Standard TherapyPoland61
6310ApheresisAllogeneicDiffuse Large B-Cell LymphomaHematology2017Standard TherapyGermany41
6311ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2017Standard TherapyGermany67
6312ApheresisAutologousFollicular B-Cell Non-Hodgkin-Lymphoma Grade I-Ii RelapseHematology2017Standard TherapyGermany59
6313ApheresisAllogeneicFollicular CaHematology2017Standard TherapyPoland42
6314ApheresisAutologousFollicular LymphomaHematology2017Standard TherapyGermany47
6315ApheresisAllogeneicHemophagocytosisHematology2017Standard TherapyPoland52
6316ApheresisAllogeneicHodgkin LymphomaHematology2017Standard TherapyPoland25
6317ApheresisAllogeneicLangerhans LymphohistiocytosisHematology2017Standard TherapyPoland2
6318ApheresisAutologousLight-Chain MyelomaHematology2017Standard TherapyGermany62
6319ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany58
6320ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany63
6321ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany61
6322ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany64
6323ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany59
6324ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany68
6325ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany50
6326ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany56
6327ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany62
6328ApheresisAutologousMantle Cell LymphomaHematology2017Standard TherapyGermany53
6329ApheresisAllogeneicMorbus HodgkinHematology2017Standard TherapyGermany38
6330ApheresisAutologousMorbus HodgkinHematology2017Standard TherapyGermany60
6331ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany61
6332ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany65
6333ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6334ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany61
6335ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany60
6336ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany58
6337ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany61
6338ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany63
6339ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany58
6340ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany72
6341ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany63
6342ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany50
6343ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany52
6344ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany72
6345ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany57
6346ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany56
6347ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany59
6348ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6349ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany72
6350ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany69
6351ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany52
6352ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany67
6353ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6354ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6355ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany50
6356ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany67
6357ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany53
6358ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany62
6359ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany44
6360ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany62
6361ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany56
6362ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany60
6363ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6364ApheresisAutologousMultiple MyelomaHematology2017Standard TherapyGermany64
6365ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland60
6366ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland3
6367ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland56
6368ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland54
6369ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland75
6370ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland64
6371ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland64
6372ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland46
6373ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland53
6374ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland71
6375ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland50
6376ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6377ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland67
6378ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland65
6379ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland68
6380ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland59
6381ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6382ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6383ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland54
6384ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland65
6385ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6386ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland54
6387ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland49
6388ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland39
6389ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland67
6390ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6391ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland76
6392ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland70
6393ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland53
6394ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland69
6395ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6396ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland66
6397ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland68
6398ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6399ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland61
6400ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland61
6401ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland22
6402ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland40
6403ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland57
6404ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland63
6405ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyPoland70
6406ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyGermany51
6407ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyGermany53
6408ApheresisAllogeneicMyelodysplastic SyndromeHematology2017Standard TherapyGermany68
6409ApheresisAllogeneicMyelodysplastic Syndrome In Fanconi AnemiaHematology2017Standard TherapyPoland23
6410ApheresisAllogeneicMyelodysplastic Syndrome With Excess Of BlastsHematology2017Standard TherapyGermany62
6411ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland63
6412ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland63
6413ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland66
6414ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland62
6415ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland55
6416ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland62
6417ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland62
6418ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyPoland72
6419ApheresisAllogeneicMyelofibrosisHematology2017Standard TherapyGermany70
6420ApheresisAllogeneicMyelofibrosis With Myeloid MetaplasiaHematology2017Standard TherapyPoland47
6421ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland44
6422ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland56
6423ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland57
6424ApheresisAllogeneicMyeloma MultiplexHematology2017Standard TherapyPoland38
6425ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2017Standard TherapyPoland7
6426ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2017Standard TherapyGermany37
6427ApheresisAllogeneicNiemann–Pick DiseaseHematology2017Standard TherapyPoland2
6428ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland36
6429ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland58
6430ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland53
6431ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland1
6432ApheresisAllogeneicNo DataHematology2017Standard TherapyPoland55
6433ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland63
6434ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland56
6435ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland47
6436ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland57
6437ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland65
6438ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland58
6439ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland42
6440ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland36
6441ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland63
6442ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland68
6443ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland52
6444ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland53
6445ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland56
6446ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland65
6447ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland55
6448ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland69
6449ApheresisAllogeneicNon-Hodgkin LymphomaHematology2017Standard TherapyPoland69
6450ApheresisAutologousNon-Hodgkin LymphomaHematology2017Standard TherapyGermany72
6451ApheresisAutologousNon-Hodgkin LymphomaHematology2017Standard TherapyGermany51
6452ApheresisAutologousNon-Hodgkin LymphomaHematology2017Standard TherapyGermany57
6453ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2017Standard TherapyGermany52
6454ApheresisAllogeneicOsteopetrosisMetabolic2017Standard TherapyPoland3
6455ApheresisAllogeneicOther MalignancyHematology2017Standard TherapyPoland59
6456ApheresisAllogeneicOther MyelofibrosisHematology2017Standard TherapyPoland71
6457ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2017Standard TherapyGermany61
6458ApheresisAutologousPrimary Central Nervous System LymphomaHematology2017Standard TherapyGermany51
6459ApheresisAutologousPrimary Central Nervous System LymphomaHematology2017Standard TherapyGermany66
6460ApheresisAutologousPrimary Central Nervous System LymphomaHematology2017Standard TherapyGermany50
6461ApheresisAllogeneicPrimary ImmunodeficiencyHematology2017Standard TherapyPoland4
6462ApheresisAllogeneicPrimary ImmunodeficiencyHematology2017Standard TherapyPoland2
6463ApheresisAllogeneicPrimary MyelofibrosisHematology2017Standard TherapyPoland29
6464ApheresisAllogeneicPrimary MyelofibrosisHematology2017Standard TherapyPoland32
6465ApheresisAllogeneicProlymphocytic LeukemiaHematology2017Standard TherapyPoland38
6466ApheresisAllogeneicProlymphocytic LeukemiaHematology2017Standard TherapyPoland63
6467ApheresisAllogeneicRichter's Transformation At Chronic Lymphocytic LeukemiaHematology2017Standard TherapyGermany60
6468ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2017Standard TherapyPoland24
6469ApheresisAllogeneicSecondary Myelodysplastic SyndromeHematology2017Standard TherapyGermany61
6470ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland14
6471ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland27
6472ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland32
6473ApheresisAllogeneicSevere Aplastic AnemiaHematology2017Standard TherapyPoland16
6474ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland30
6475ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland7
6476ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland25
6477ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2017Standard TherapyPoland28
6478ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2017Standard TherapyGermany24
6479ApheresisAllogeneicT-Cell Lymphoblastic LymphomaHematology2017Standard TherapyGermany19
6480ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2017Standard TherapyGermany56
6481ApheresisAutologousT-Cell-LymphomaHematology2017Standard TherapyGermany63
6482ApheresisAllogeneicΒ - Thalassemia MajorHematology2017Standard TherapyPoland4
6483Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2016Experimental TherapyPoland22
6484Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2016Experimental TherapyPoland32,3
6485Cord TissueAllogeneic - Unrelated Limb-Girdle Muscular DystrophyNeurology2016Experimental TherapyPoland44,7
6486Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland14
6487Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland6
6488Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland60,5
6489Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2016Experimental TherapyPoland3,11
6490Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2016Experimental TherapyPoland11,11
6491Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2016Experimental TherapyPoland6,11
6492Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophyNeurology2016Experimental TherapyPoland9,7
6493Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophy; EncephalopathyNeurology2016Experimental TherapyPoland8,4
6494Cord TissueAllogeneic - UnrelatedAge-Related Macular DegenerationOphthalmology2016Experimental TherapyPoland86,5
6495Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland44,5
6496Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,8
6497Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland32,2
6498Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,7
6499Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59,4
6500Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland33,4
6501Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland37,4
6502Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland39,3
6503Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland63,2
6504Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland54,11
6505Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,9
6506Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland46,9
6507Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland58
6508Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55
6509Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland58,1
6510Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,7
6511Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland52,6
6512Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59,11
6513Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,9
6514Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59
6515Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,9
6516Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland42,7
6517Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland45,1
6518Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,4
6519Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland36,1
6520Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland59,1
6521Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,2
6522Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,7
6523Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,1
6524Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland46,1
6525Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland72,4
6526Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland54,3
6527Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,1
6528Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,8
6529Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland64,7
6530Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland64,2
6531Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland62,8
6532Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,5
6533Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland51,3
6534Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland33,1
6535Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,4
6536Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland73,7
6537Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,6
6538Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,4
6539Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland79,2
6540Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland72,6
6541Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland48,4
6542Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland54,2
6543Cord TissueAllogeneic - Unrelated & RelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland50,9
6544Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,9
6545Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland62,6
6546Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,2
6547Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,9
6548Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,4
6549Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,7
6550Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland58,1
6551Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,8
6552Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland39,6
6553Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland47,11
6554Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,3
6555Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,2
6556Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland31,9
6557Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland53,4
6558Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland65,9
6559Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland52,7
6560Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland71,5
6561Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland68,5
6562Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland44,5
6563Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,7
6564Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland51,9
6565Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland49,3
6566Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland68,2
6567Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,4
6568Cord TissueAllogeneic - Unrelated & RelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland41,2
6569Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland72,1
6570Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,8
6571Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland48,1
6572Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland56,3
6573Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland66,1
6574Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPolandno data
6575Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland61,2
6576Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland60,8
6577Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2016Experimental TherapyPoland55,5
6578Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2016Experimental TherapyPoland20,3
6579Cord TissueAllogeneic - UnrelatedAtrophy Of The Optic NervesOphthalmology2016Experimental TherapyPoland20,11
6580Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland18,4
6581Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6
6582Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland12,11
6583Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland8,5
6584Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland7,11
6585Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland8,5
6586Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6,9
6587Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland10,1
6588Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6,2
6589Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland11,3
6590Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6,1
6591Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland13,2
6592Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland8,4
6593Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland5
6594Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland12,3
6595Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland24,5
6596Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland10,3
6597Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland6
6598Cord TissueAllogeneic - UnrelatedAutismNeurology2016Experimental TherapyPoland20,9
6599Cord TissueAllogeneic - UnrelatedCartilage DamageOrthopedy2016Experimental TherapyPoland57
6600Cord TissueAllogeneic - UnrelatedCerebellar SyndromeNeurology2016Experimental TherapyPoland28,6
6601Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland7,1
6602Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland5,1
6603Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,11
6604Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,3
6605Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland12,2
6606Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,11
6607Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland9,7
6608Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,3
6609Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,9
6610Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland9,11
6611Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,1
6612Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland4,2
6613Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland12,6
6614Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland3
6615Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland9,9
6616Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland3
6617Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland13,7
6618Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland2,2
6619Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland12,11
6620Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland10,8
6621Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland1,1
6622Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland7,6
6623Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland6,8
6624Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland16,4
6625Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland13,1
6626Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland4,1
6627Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland3,7
6628Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2016Experimental TherapyPoland4,4
6629Cord TissueAllogeneic - UnrelatedChondronecrosis Femoral CondyleOrthopedy2016Experimental TherapyPoland54
6630Cord TissueAllogeneic - UnrelatedChoroideremiaOphthalmology2016Experimental TherapyPoland50,8
6631Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2016Experimental TherapyPoland19,2
6632Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2016Experimental TherapyPoland8 months
6633Cord TissueAllogeneic - UnrelatedDegeneration Of The Cartilage Of The Knee JointOrthopedy2016Experimental TherapyPoland54
6634Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2016Experimental TherapyPoland3,1
6635Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2016Experimental TherapyPoland7,4
6636Cord TissueAllogeneic - UnrelatedDevelopmental DelayNeurology2016Experimental TherapyPoland2,7
6637Cord TissueAllogeneic - UnrelatedDiffuse Cartilage Damage Left Medial Compartment Of The KneeOrthopedy2016Experimental TherapyPoland50
6638Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland48,8
6639Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland14,4
6640Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland34,7
6641Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland9,2
6642Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland4,8
6643Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland10
6644Cord TissueAllogeneic - UnrelatedDuchenne Muscular Dystrophy (Dmd)Neurology2016Experimental TherapyPoland19,2
6645Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2016Experimental TherapyPoland2,11
6646Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2016Experimental TherapyPoland3
6647Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2016Experimental TherapyPoland4,3
6648Cord TissueAllogeneic - UnrelatedEndometrial AtrophyGynecology2016Experimental TherapyPoland37,3
6649Cord TissueAllogeneic - UnrelatedEndometrial AtrophyGynecology2016Experimental TherapyPoland39,1
6650Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland19,5
6651Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland14,9
6652Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland13,11
6653Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland14,7
6654Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland14,9
6655Cord TissueAllogeneic - UnrelatedEpilepsyNeurology2016Experimental TherapyPoland16,2
6656Cord TissueAllogeneic - UnrelatedEpileptic EncephalopathyNeurology2016Experimental TherapyPoland3,6
6657Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland35,3
6658Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland39,1
6659Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland25,4
6660Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland59,6
6661Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland30,3
6662Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland15
6663Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland31,11
6664Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2016Experimental TherapyPoland33,4
6665Cord TissueAllogeneic - UnrelatedFetal Alcohol Spectrum DisordersNeurology2016Experimental TherapyPoland5,2
6666Cord TissueAllogeneic - UnrelatedGangliosidosis T. 1Neurology2016Experimental TherapyPoland1,4
6667Cord TissueAllogeneic - UnrelatedGlobal Developmental DelayNeurology2016Experimental TherapyPoland6,9
6668Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland65,8
6669Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland69,6
6670Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland69,3
6671Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2016Experimental TherapyPoland49
6672Cord TissueAllogeneic - UnrelatedHereditary AtaxiaNeurology2016Experimental TherapyPoland69
6673Cord TissueAllogeneic - UnrelatedInjuries To The Spinal NervesNeurology2016Experimental TherapyPoland5 months
6674Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2016Experimental TherapyPoland2,9
6675Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2016Experimental TherapyPoland2,11
6676Cord TissueAllogeneic - UnrelatedMalformation SyndromeNeurology2016Experimental TherapyPoland3,5
6677Cord TissueAllogeneic - UnrelatedMeniscus DamageOrthopedy2016Experimental TherapyPoland35,5
6678Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2016Experimental TherapyPoland31,9
6679Cord TissueAllogeneic - UnrelatedMyopia; Hyperopia; Astigmatism; Abnormal Refraction And Accommodation; Optic AtrophyOphthalmology2016Experimental TherapyPoland37,1
6680Cord TissueAllogeneic - UnrelatedNeurodevelopmental DisordersNeurology2016Experimental TherapyPoland4,5
6681Cord TissueAllogeneic - UnrelatedNo DataOphthalmology2016Experimental TherapyPoland66,1
6682Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2016Experimental TherapyPoland69,9
6683Cord TissueAllogeneic - UnrelatedOptic AtrophyOphthalmology2016Experimental TherapyPoland69,1
6684Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2016Experimental TherapyPoland66
6685Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2016Experimental TherapyPoland79,8
6686Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2016Experimental TherapyPoland33,5
6687Cord TissueAllogeneic - UnrelatedPatella Cartilage DamageOrthopedy2016Experimental TherapyPoland60
6688Cord TissueAllogeneic - UnrelatedPatella Cartilage DamageOrthopedy2016Experimental TherapyPoland60
6689Cord TissueAllogeneic - UnrelatedPatella Cartilage DamageOrthopedy2016Experimental TherapyPoland53
6690Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2016Experimental TherapyPoland70,8
6691Cord TissueAllogeneic - UnrelatedPremature Ovarian FailureGynecology2016Experimental TherapyPoland23,4
6692Cord TissueAllogeneic - UnrelatedPremature Ovarian FailureGynecology2016Experimental TherapyPoland34,9
6693Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland38
6694Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland63,1
6695Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland32,7
6696Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland23,6
6697Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland54,6
6698Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPolandno data
6699Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland59,4
6700Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland60,7
6701Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2016Experimental TherapyPoland44,8
6702Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland29,11
6703Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland44,8
6704Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland55,4
6705Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland54,8
6706Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland41,4
6707Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland49,3
6708Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland61,11
6709Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland45,8
6710Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland38,1
6711Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland68,5
6712Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2016Experimental TherapyPoland38,4
6713Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland28,8
6714Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland47,9
6715Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland58,4
6716Cord TissueAllogeneic - UnrelatedSpastic TetraparesisOrthopedy2016Experimental TherapyPoland18
6717Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland2,4
6718Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland4,8
6719Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland1,5
6720Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland7,4
6721Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland1,3
6722Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland2,11
6723Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland15,9
6724Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland2,11
6725Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2016Experimental TherapyPoland4,9
6726Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland33,5
6727Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland22,2
6728Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland28
6729Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland33,11
6730Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland20,7
6731Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland24,5
6732Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland25,6
6733Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland18,8
6734Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland7,4
6735Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland48,3
6736Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland58,1
6737Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland37,11
6738Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland29,7
6739Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland17,9
6740Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2016Experimental TherapyPoland44,5
6741Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland34,9
6742Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland3,3
6743Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland34,2
6744Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland17,1
6745Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2016Experimental TherapyPoland1,1
6746Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland64
6747Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland62,5
6748Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland54,3
6749Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2016Experimental TherapyPoland41,8
6750Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2016Experimental TherapyPoland53
6751Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2016Experimental TherapyPoland24,5
6752Cord TissueAllogeneic - UnrelatedStargardt's DiseaseOphthalmology2016Experimental TherapyPoland37,7
6753Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2016Experimental TherapyPoland27,9
6754Cord TissueAllogeneic - UnrelatedTetraparesisOrthopedy2016Experimental TherapyPoland27,2
6755Cord TissueAllogeneic - UnrelatedTraumatic Brain InjuryNeurology2016Experimental TherapyPoland54,9
6756Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2016Standard TherapyHungary7
6757Cord BloodAllogeneic - UnrelatedAcute Myeloid LeukemiaHematology2016Standard TherapyPoland6
6758Cord BloodAutologousAutismNeurology2016Experimental TherapyPoland6
6759Cord BloodAutologousBrain DamageNeurology2016Experimental TherapyGermany1
6760Cord BloodAllogeneic - RelatedCerebral PalsyNeurology2016Experimental TherapyUK6
6761Cord BloodAllogeneic - RelatedHermansky-Pudlak Syndrome Type 2Hematology2016Standard TherapyTurkey6
6762Cord BloodAllogeneic - RelatedThalassemia MajorHematology2016Standard TherapyGermany4,3
6763Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland38
6764Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland38
6765Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6766Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland32
6767Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland62
6768Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland72
6769Bone Marrow FamilyAllogeneicChronic Myelomonocytic Leukemia, Minimal Residual DiseaseHematology2016Standard TherapyPoland50
6770Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland18
6771Bone Marrow FamilyAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland32
6772Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland59
6773Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland67
6774Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland62
6775Bone Marrow FamilyAllogeneicNo Datano data2016Standard TherapyPoland59
6776Bone Marrow FamilyAllogeneicNo Datano data2016Standard TherapyPoland4
6777Bone Marrow FamilyAllogeneicPlasma Cell DisorderHematology2016Standard TherapyPoland54
6778Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland9
6779Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland6
6780Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland14
6781Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland7
6782Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland11
6783Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland18
6784Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland5
6785Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland25
6786Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland1
6787Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland5
6788Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland15
6789Bone MarrowAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland6
6790Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6791Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland55
6792Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6793Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland12
6794Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland67
6795Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland29
6796Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland33
6797Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland39
6798Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland9
6799Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland45
6800Bone MarrowAllogeneicAnemiaHematology2016Standard TherapyPoland16
6801Bone MarrowAllogeneicAnemiaHematology2016Standard TherapyPoland5
6802Bone MarrowAllogeneicAplastic AnemiaHematology2016Standard TherapyPoland20
6803Bone MarrowAllogeneicBilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid LeukemiaHematology2016Standard TherapyPoland27
6804Bone MarrowAllogeneicDiamond Blackfan AnemiaHematology2016Standard TherapyPoland2
6805Bone MarrowAllogeneicDigeorge SyndromeHematology2016Standard TherapyPoland24
6806Bone MarrowAllogeneicFanconi AnemiaHematology2016Standard TherapyPoland7
6807Bone MarrowAllogeneicFanconi AnemiaHematology2016Standard TherapyPoland41
6808Bone MarrowAllogeneicHigh-Risk Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland18
6809Bone MarrowAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland17
6810Bone MarrowAllogeneicHurler SyndromeMetabolic2016Standard TherapyPoland2
6811Bone MarrowAllogeneicJuvenile Myelomonocytic LeukemiaHematology2016Standard TherapyPoland3
6812Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland1
6813Bone MarrowAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland56
6814Bone MarrowAllogeneicMyelofibrosisHematology2016Standard TherapyPoland31
6815Bone MarrowAllogeneicMyeloproliferative SyndromeHematology2016Standard TherapyPoland22
6816Bone MarrowAllogeneicNo Datano data2016Standard TherapyPoland3
6817Bone MarrowAllogeneicNo Datano data2016Standard TherapyPoland7
6818Bone MarrowAllogeneicNo DataHematology2016Standard TherapyPoland33
6819Bone MarrowAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland46
6820Bone MarrowAllogeneicOsteopetrosisMetabolic2016Standard TherapyPoland6
6821Bone MarrowAllogeneicOsteopetrosisMetabolic2016Standard TherapyPoland1
6822Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2016Standard TherapyPoland9
6823Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2016Standard TherapyPoland9
6824Bone MarrowAllogeneicSevere Aplastic Anemia; Paroxysmal Nocturnal HemoglobinuriaHematology2016Standard TherapyPoland17
6825Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland2
6826Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland4
6827Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland7 months
6828Bone MarrowAllogeneicSevere Combined ImmunodeficiencyHematology2016Standard TherapyPoland12
6829Bone MarrowAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland4
6830Bone MarrowAllogeneicThalassemia MajorHematology2016Standard TherapyGermany18
6831ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland56
6832ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland43
6833ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland61
6834ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland24
6835ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland13
6836ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland58
6837ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland20
6838ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland23
6839ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland27
6840ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland30
6841ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland37
6842ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland38
6843ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland28
6844ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland30
6845ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland39
6846ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland66
6847ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland20
6848ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland56
6849ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland9
6850ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland33
6851ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland21
6852ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland35
6853ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany57
6854ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany29
6855ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany1
6856ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany42
6857ApheresisAllogeneicAcute Lymphoblastic Leukemia - RelapseHematology2016Standard TherapyGermany27
6858ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland58
6859ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland62
6860ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland40
6861ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland18
6862ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6863ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6864ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland54
6865ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland54
6866ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland18
6867ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland31
6868ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland35
6869ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6870ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland29
6871ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland32
6872ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland49
6873ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland64
6874ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland42
6875ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland13
6876ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland8
6877ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6878ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland40
6879ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland32
6880ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6881ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland43
6882ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6883ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland47
6884ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland15
6885ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland37
6886ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland57
6887ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland56
6888ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland52
6889ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland35
6890ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland72
6891ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6892ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland51
6893ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland62
6894ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland69
6895ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland51
6896ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland55
6897ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland63
6898ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland65
6899ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland46
6900ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland18
6901ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland48
6902ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland67
6903ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland59
6904ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland9 months
6905ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland36
6906ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland66
6907ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland68
6908ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland63
6909ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland60
6910ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland37
6911ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland61
6912ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland51
6913ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland65
6914ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland53
6915ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland59
6916ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland65
6917ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland41
6918ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland50
6919ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland68
6920ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland54
6921ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland24
6922ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland44
6923ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland55
6924ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland30
6925ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland50
6926ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland47
6927ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland47
6928ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland63
6929ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyPoland19
6930ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany62
6931ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany29
6932ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany39
6933ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany48
6934ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany69
6935ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany38
6936ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany66
6937ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany50
6938ApheresisAutologousAcute Myeloid LeukemiaHematology2016Standard TherapyGermany74
6939ApheresisAutologousAcute Myeloid LeukemiaHematology2016Standard TherapyGermany18
6940ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany54
6941ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany62
6942ApheresisAutologousAcute Myeloid LeukemiaHematology2016Standard TherapyGermany55
6943ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany54
6944ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany41
6945ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany53
6946ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany68
6947ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany71
6948ApheresisAllogeneicAcute Myeloid LeukemiaHematology2016Standard TherapyGermany68
6949ApheresisAllogeneicAcute Myeloid Leukemia M2/M4Hematology2016Standard TherapyPoland59
6950ApheresisAllogeneicAdrenoleukodystrophyMetabolic2016Standard TherapyPoland1
6951ApheresisAutologousAmyloid Light-Chain AmyloidosisHematology2016Standard TherapyGermany45
6952ApheresisAutologousAmyloidosisHematology2016Standard TherapyGermany71
6953ApheresisAutologousAnaplastic LymphomaHematology2016Standard TherapyGermany57
6954ApheresisAllogeneicAplastic AnemiaHematology2016Standard TherapyPoland23
6955ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland44
6956ApheresisAutologousB-Cell LymphomaHematology2016Standard TherapyGermany55
6957ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany57
6958ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany42
6959ApheresisAutologousBurkitt LymphomaHematology2016Standard TherapyGermany40
6960ApheresisAllogeneicC-Acute Lymphoblastic LeukemiaHematology2016Standard TherapyGermany60
6961ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2016Standard TherapyPoland52
6962ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2016Standard TherapyPoland61
6963ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2016Standard TherapyPoland62
6964ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2016Standard TherapyPoland62
6965ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2016Standard TherapyPoland46
6966ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2016Standard TherapyPoland40
6967ApheresisAllogeneicChronic Myelomonocytic LeukemiaHematology2016Standard TherapyPoland53
6968ApheresisAllogeneicComposite LymphomaHematology2016Standard TherapyPoland51
6969ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2016Standard TherapyGermany39
6970ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2016Standard TherapyGermany51
6971ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2016Standard TherapyGermany64
6972ApheresisAutologousDiffuse Large B-Cell Lymphoma - RelapseHematology2016Standard TherapyGermany69
6973ApheresisAllogeneicFanconi AnemiaHematology2016Standard TherapyPoland7
6974ApheresisAutologousFollicular LymphomaHematology2016Standard TherapyGermany38
6975ApheresisAutologousFollicular LymphomaHematology2016Standard TherapyGermany63
6976ApheresisAutologousFollicular LymphomaHematology2016Standard TherapyGermany63
6977ApheresisAllogeneicHigh-Risk Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland5
6978ApheresisAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland31
6979ApheresisAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland32
6980ApheresisAllogeneicHodgkin LymphomaHematology2016Standard TherapyPoland38
6981ApheresisAutologousHodgkin Lymphoma-RelapseHematology2016Standard TherapyGermany44
6982ApheresisAllogeneicLeukemiaHematology2016Standard TherapyPoland53
6983ApheresisAllogeneicLymphoblastic LymphomaHematology2016Standard TherapyPoland33
6984ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany56
6985ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany63
6986ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany53
6987ApheresisAutologousMantle Cell LymphomaHematology2016Standard TherapyGermany60
6988ApheresisAllogeneicMorbus HodgkinHematology2016Standard TherapyGermany32
6989ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany59
6990ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany59
6991ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany44
6992ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
6993ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany70
6994ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany67
6995ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany62
6996ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany63
6997ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
6998ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany73
6999ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany65
7000ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany55
7001ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany67
7002ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany59
7003ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany66
7004ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
7005ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany68
7006ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany63
7007ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany57
7008ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany68
7009ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany56
7010ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany61
7011ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany55
7012ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany64
7013ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany64
7014ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany52
7015ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany55
7016ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany67
7017ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany49
7018ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany56
7019ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany47
7020ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany53
7021ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany58
7022ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany49
7023ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany69
7024ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany61
7025ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany54
7026ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany65
7027ApheresisAutologousMultiple MyelomaHematology2016Standard TherapyGermany48
7028ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland60
7029ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland56
7030ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland50
7031ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland73
7032ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland47
7033ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland67
7034ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland62
7035ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland61
7036ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland68
7037ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland65
7038ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland15
7039ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland52
7040ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland20
7041ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland60
7042ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland9
7043ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland61
7044ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland63
7045ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland15
7046ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland37
7047ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland59
7048ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland62
7049ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland58
7050ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland69
7051ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyPoland66
7052ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyGermany67
7053ApheresisAllogeneicMyelodysplastic SyndromeHematology2016Standard TherapyGermany57
7054ApheresisAllogeneicMyelodysplastic Syndrome - RcmdHematology2016Standard TherapyPoland32
7055ApheresisAllogeneicMyelodysplastic Syndrome - RaebHematology2016Standard TherapyPoland56
7056ApheresisAllogeneicMyelofibrosisHematology2016Standard TherapyPoland72
7057ApheresisAllogeneicMyelofibrosisHematology2016Standard TherapyPoland66
7058ApheresisAllogeneicMyelofibrosisHematology2016Standard TherapyPoland67
7059ApheresisAllogeneicMyeloma MultiplexHematology2016Standard TherapyPoland63
7060ApheresisAllogeneicMyeloma MultiplexHematology2016Standard TherapyPoland51
7061ApheresisAllogeneicMyeloma MultiplexHematology2016Standard TherapyPoland38
7062ApheresisAllogeneicMyeloproliferative SyndromeHematology2016Standard TherapyPoland52
7063ApheresisAllogeneicMyeloproliferative SyndromeHematology2016Standard TherapyGermany63
7064ApheresisAutologousNeuroblastomaHematology2016Standard TherapyGermany5
7065ApheresisAllogeneicNo Datano data2016Standard TherapyPoland45
7066ApheresisAllogeneicNo Datano data2016Standard TherapyPoland70
7067ApheresisAllogeneicNo Datano data2016Standard TherapyPoland43
7068ApheresisAllogeneicNo Datano data2016Standard TherapyPoland69
7069ApheresisAllogeneicNo Datano data2016Standard TherapyPoland28
7070ApheresisAllogeneicNo Datano data2016Standard TherapyPoland1
7071ApheresisAllogeneicNo Datano data2016Standard TherapyPoland30
7072ApheresisAllogeneicNo Datano data2016Standard TherapyPoland71
7073ApheresisAllogeneicNo Datano data2016Standard TherapyPoland58
7074ApheresisAllogeneicNo Datano data2016Standard TherapyPoland17
7075ApheresisAllogeneicNo Datano data2016Standard TherapyPoland59
7076ApheresisAllogeneicNo Datano data2016Standard TherapyPoland58
7077ApheresisAllogeneicNo Datano data2016Standard TherapyPoland55
7078ApheresisAllogeneicNo Datano data2016Standard TherapyPoland44
7079ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland38
7080ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland58
7081ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland32
7082ApheresisAllogeneicNon-Hodgkin LymphomaHematology2016Standard TherapyPoland39
7083ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany61
7084ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany73
7085ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany27
7086ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany65
7087ApheresisAutologousNon-Hodgkin LymphomaHematology2016Standard TherapyGermany61
7088ApheresisAllogeneicPlasma Cell DisorderHematology2016Standard TherapyPoland47
7089ApheresisAutologousPlasmacytomaHematology2016Standard TherapyGermany58
7090ApheresisAutologousPlasmacytomaHematology2016Standard TherapyGermany68
7091ApheresisAutologousPlasmacytomaHematology2016Standard TherapyGermany48
7092ApheresisAutologousPrimary Central Nervous System LymphomaHematology2016Standard TherapyGermany62
7093ApheresisAutologousPrimary Central Nervous System LymphomaHematology2016Standard TherapyGermany51
7094ApheresisAutologousPrimary Central Nervous System LymphomaHematology2016Standard TherapyGermany62
7095ApheresisAllogeneicPrimary ImmunodeficiencyHematology2016Standard TherapyPoland5
7096ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyPoland50
7097ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyPoland67
7098ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyPoland67
7099ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyGermany56
7100ApheresisAllogeneicPrimary MyelofibrosisHematology2016Standard TherapyGermany58
7101ApheresisAllogeneicRefractory Anemia With Excess BlastsHematology2016Standard TherapyPoland62
7102ApheresisAllogeneicSevere Aplastic Anemia / AmyloidosisHematology2016Standard TherapyPoland45
7103ApheresisAllogeneicSecondary Acute Myeloid Leukemia At Myeloproliferative SyndromeHematology2016Standard TherapyGermany28
7104ApheresisAllogeneicSevere Aplastic AnemiaHematology2016Standard TherapyPoland18
7105ApheresisAutologousSmall Cell Ovarian CarcinomaHematology2016Standard TherapyGermany18
7106ApheresisAllogeneicT Cell Lymphoma/ Nos - Not Otherwise SpecifiedHematology2016Standard TherapyPoland55
7107ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland19
7108ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland21
7109ApheresisAllogeneicT-Cell Acute Lymphoblastic LeukemiaHematology2016Standard TherapyPoland41
7110ApheresisAllogeneicT-Cell Leukemia/LymphomaHematology2016Standard TherapyPoland31
7111ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany48
7112ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2016Standard TherapyGermany24
7113ApheresisAutologousT-Cell-LymphomaHematology2016Standard TherapyGermany55
7114ApheresisAutologousT-Cell-LymphomaHematology2016Standard TherapyGermany33
7115ApheresisAllogeneicT-Cell-Prolymphocytic LeukemiaHematology2016Standard TherapyPoland61
7116ApheresisAllogeneicWiskott-Aldrich SyndromeHematology2016Standard TherapyPoland1
7117ApheresisAllogeneicX-Linked Lymphoproliferative DiseaseHematology2016Standard TherapyPoland12
7118Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland1,4
7119Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland11 months
7120Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland51,5
7121Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland6,6
7122Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2015Experimental TherapyPoland13,4
7123Cord TissueAllogeneic - UnrelatedAdrenoleukodystrophy; EncephalopathyNeurology2015Experimental TherapyPoland23
7124Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,6
7125Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61
7126Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland56
7127Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland51
7128Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland65
7129Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland60
7130Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland52
7131Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland59,4
7132Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,5
7133Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland58
7134Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,6
7135Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland62
7136Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland26,5
7137Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland27
7138Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland63,11
7139Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland67,6
7140Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland37,6
7141Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland58,1
7142Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland46,2
7143Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland48,7
7144Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland61,3
7145Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2015Experimental TherapyPoland54
7146Cord TissueAllogeneic - UnrelatedAnterior Ischemic Optic NeuropathyOphthalmology2015Experimental TherapyPoland54,1
7147Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland5,4
7148Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland3
7149Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland12,5
7150Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland6,1
7151Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland4,6
7152Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland5,6
7153Cord TissueAllogeneic - UnrelatedAutismNeurology2015Experimental TherapyPoland8,7
7154Cord TissueAllogeneic - UnrelatedBilateral BlindnessOphthalmology2015Experimental TherapyPoland36,1
7155Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2015Experimental TherapyPoland18,7
7156Cord TissueAllogeneic - UnrelatedCerebellar AtaxiaNeurology2015Experimental TherapyPoland26,1
7157Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland3,8
7158Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland15,8
7159Cord TissueAllogeneic - Unrelated & RelatedCerebral PalsyNeurology2015Experimental TherapyPoland7,1
7160Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland13,1
7161Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland8,11
7162Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland2,7
7163Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland12,1
7164Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland4,1
7165Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland22
7166Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland9,9
7167Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland1,6
7168Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland14,1
7169Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2015Experimental TherapyPoland16,9
7170Cord TissueAllogeneic - UnrelatedCeroid LipofuscinosisNeurology2015Experimental TherapyPoland5,1
7171Cord TissueAllogeneic - UnrelatedCeroid LipofuscinosisNeurology2015Experimental TherapyPoland7,1
7172Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2015Experimental TherapyPoland10
7173Cord TissueAllogeneic - UnrelatedDecerebration RigidityNeurology2015Experimental TherapyPoland9,6
7174Cord TissueAllogeneic - UnrelatedDelayed Psychomotor DevelopmentNeurology2015Experimental TherapyPoland3,6
7175Cord TissueAllogeneic - UnrelatedDelayed Psychomotor Development, DeafnessNeurology2015Experimental TherapyPoland3,3
7176Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2015Experimental TherapyPoland14,5
7177Cord TissueAllogeneic - UnrelatedEncephalopathyNeurology2015Experimental TherapyPoland8 months
7178Cord TissueAllogeneic - Unrelated & RelatedEncephalopathyNeurology2015Experimental TherapyPoland11,2
7179Cord TissueAllogeneic - UnrelatedFacioscapulohumeral Muscular DystrophyNeurology2015Experimental TherapyPoland30,1
7180Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2015Experimental TherapyPoland66
7181Cord TissueAllogeneic - UnrelatedGonarthrosisOrthopedy2015Experimental TherapyPoland65
7182Cord TissueAllogeneic - UnrelatedIatrogenic Spinal Cord InjuryNeurology2015Experimental TherapyPoland17,2
7183Cord TissueAllogeneic - UnrelatedIntracranial InjuryNeurology2015Experimental TherapyPoland24,3
7184Cord TissueAllogeneic - UnrelatedLeukodystrophyNeurology2015Experimental TherapyPoland18,8
7185Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2015Experimental TherapyPoland15,8
7186Cord TissueAllogeneic - UnrelatedOptic NeuropathyOphthalmology2015Experimental TherapyPoland45,1
7187Cord TissueAllogeneic - UnrelatedPolyneuropathyNeurology2015Experimental TherapyPoland74,2
7188Cord TissueAllogeneic - UnrelatedRetinitis PigmentosaOphthalmology2015Experimental TherapyPoland34,5
7189Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2015Experimental TherapyPoland23,2
7190Cord TissueAllogeneic - UnrelatedSclerosis MultiplexNeurology2015Experimental TherapyPoland33,3
7191Cord TissueAllogeneic - UnrelatedSevere Developmental DelayNeurology2015Experimental TherapyPoland1,1
7192Cord TissueAllogeneic - UnrelatedSpina BifidaNeurology2015Experimental TherapyPoland2
7193Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland31,2
7194Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland18,8
7195Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland40
7196Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland26,1
7197Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland37,1
7198Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland32,1
7199Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland21,4
7200Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland24,7
7201Cord TissueAllogeneic - UnrelatedSpinal Cord InjuryOrthopedy2015Experimental TherapyPoland34,4
7202Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2015Experimental TherapyPoland11 months
7203Cord TissueAllogeneic - UnrelatedSpinal Muscular AtrophyNeurology2015Experimental TherapyPoland26,2
7204Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2015Experimental TherapyPoland35,6
7205Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2015Experimental TherapyPoland44,6
7206Cord TissueAllogeneic - UnrelatedSpinocerebellar AtaxiaNeurology2015Experimental TherapyPoland24,3
7207Cord TissueAllogeneic - UnrelatedStrokeNeurology2015Experimental TherapyPoland62,8
7208Cord TissueAllogeneic - UnrelatedStrokeNeurology2015Experimental TherapyPoland54,9
7209Cord TissueAllogeneic - UnrelatedTraumatic EncephalopathyNeurology2015Experimental TherapyPoland20,11
7210Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2015Standard TherapyPoland4
7211Cord BloodAutologousBrain DamageNeurology2015Experimental TherapyGermany5
7212Cord BloodAutologousHypoxia-Ischemic Encephalopathy (Hie)Neurology2015Experimental TherapyUK6 months
7213Cord BloodAutologousNeuroblastomaHematology2015Standard TherapyGermany5
7214Cord BloodAllogeneic - RelatedScid (Severe Combined Immunodeficiency)Hematology2015Standard TherapyUK3 months
7215Cord BloodAllogeneic - RelatedSickle Cell AnemiaHematology2015Standard TherapyUK2,6
7216Cord BloodAllogeneic - RelatedThalassemiaHematology2015Standard TherapyUK12
7217Cord BloodAllogeneic - RelatedThalassemia MajorHematology2015Standard TherapyTurkey3
7218Cord BloodAllogeneic - RelatedThalassemia MajorHematology2015Standard TherapyTurkey2
7219Bone Marrow FamilyAllogeneicChronic Lymphocytic LeukemiaHematology2015Standard TherapyGermany74
7220Bone Marrow FamilyAllogeneicSecondary Acute Myeloid LeukemiaHematology2015Standard TherapyGermany64
7221ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2015Standard TherapyGermany23
7222ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany72
7223ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany43
7224ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany63
7225ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany73
7226ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany61
7227ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany33
7228ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany42
7229ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany57
7230ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany37
7231ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany72
7232ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany63
7233ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany66
7234ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany45
7235ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany48
7236ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany59
7237ApheresisAllogeneicAcute Myeloid LeukemiaHematology2015Standard TherapyGermany58
7238ApheresisAutologousAnaplastic Large Cell LymphomaHematology2015Standard TherapyGermany57
7239ApheresisAutologousAnaplastic T-Cell Lymphoma - RelapseHematology2015Standard TherapyGermany26
7240ApheresisAllogeneicAplastic Anemia - RelapseHematology2015Standard TherapyGermany53
7241ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany59
7242ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany48
7243ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany23
7244ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany62
7245ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2015Standard TherapyGermany51
7246ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2015Standard TherapyGermany50
7247ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2015Standard TherapyGermany31
7248ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2015Standard TherapyGermany57
7249ApheresisAutologousEwing SarcomaHematology2015Standard TherapyGermany24
7250ApheresisAutologousGerm Cell TumorHematology2015Standard TherapyGermany17
7251ApheresisAutologousGray Zone LymphomaHematology2015Standard TherapyGermany26
7252ApheresisAutologousHodgkin RelapseHematology2015Standard TherapyGermany29
7253ApheresisAutologousLymphomaHematology2015Standard TherapyGermany53
7254ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany56
7255ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany66
7256ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany53
7257ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany63
7258ApheresisAutologousMantle Cell LymphomaHematology2015Standard TherapyGermany58
7259ApheresisAutologousMantle Cell Lymphoma-RelapseHematology2015Standard TherapyGermany66
7260ApheresisAllogeneicMorbus HodgkinHematology2015Standard TherapyGermany25
7261ApheresisAllogeneicMorbus HodgkinHematology2015Standard TherapyGermany22
7262ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany58
7263ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany54
7264ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany62
7265ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany70
7266ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany69
7267ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany56
7268ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany75
7269ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany70
7270ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany60
7271ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany72
7272ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany56
7273ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany65
7274ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany37
7275ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany54
7276ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany29
7277ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany68
7278ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany50
7279ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7280ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany69
7281ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany60
7282ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany72
7283ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany43
7284ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany53
7285ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany73
7286ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany66
7287ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7288ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany70
7289ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany71
7290ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany62
7291ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany56
7292ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany74
7293ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany50
7294ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany51
7295ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany63
7296ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany53
7297ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany72
7298ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany48
7299ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany63
7300ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany60
7301ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany65
7302ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany71
7303ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7304ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7305ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany61
7306ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany64
7307ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany48
7308ApheresisAutologousMultiple MyelomaHematology2015Standard TherapyGermany49
7309ApheresisAllogeneicMultiple Myeloma, Second Acute Myeloid LeukemiaHematology2015Standard TherapyGermany64
7310ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany57
7311ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany60
7312ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany29
7313ApheresisAllogeneicMyelodysplastic SyndromeHematology2015Standard TherapyGermany73
7314ApheresisAllogeneicNon-Hodgkin LymphomaHematology2015Standard TherapyGermany62
7315ApheresisAllogeneicNon-Hodgkin LymphomaHematology2015Standard TherapyGermany22
7316ApheresisAutologousNon-Hodgkin LymphomaHematology2015Standard TherapyGermany61
7317ApheresisAllogeneicPost–Polycythemia Vera MyelofibrosisHematology2015Standard TherapyGermany54
7318ApheresisAutologousPrimary Central Nervous System LymphomaHematology2015Standard TherapyGermany61
7319ApheresisAutologousPrimary Central Nervous System LymphomaHematology2015Standard TherapyGermany41
7320ApheresisAutologousPrimary Central Nervous System LymphomaHematology2015Standard TherapyGermany70
7321ApheresisAllogeneicPrimary MyelofibrosisHematology2015Standard TherapyGermany70
7322ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2015Standard TherapyGermany44
7323Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2014Experimental TherapyPoland6
7324Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2014Experimental TherapyPoland60,1
7325Cord TissueAllogeneic - UnrelatedAmyotrophic Lateral SclerosisNeurology2014Experimental TherapyPoland24,1
7326Cord TissueAllogeneic - UnrelatedAutismNeurology2014Experimental TherapyPoland12,6
7327Cord TissueAllogeneic - UnrelatedAutismNeurology2014Experimental TherapyPoland8,3
7328Cord TissueAllogeneic - UnrelatedBirth Asphyxia; RetinopathyNeurology2014Experimental TherapyPoland11 months
7329Cord TissueAllogeneic - UnrelatedCentral Motor Coordination Impairment After Hypoxic Ischemic Lesion At BirthNeurology2014Experimental TherapyPoland2,1
7330Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2014Experimental TherapyPoland4,1
7331Cord TissueAllogeneic - UnrelatedCerebral PalsyNeurology2014Experimental TherapyPoland15,1
7332Cord TissueAllogeneic - UnrelatedMuscular DystrophyNeurology2014Experimental TherapyPoland6
7333Cord TissueAllogeneic - UnrelatedNeuropathyNeurology2014Experimental TherapyPoland23,6
7334Cord BloodAllogeneic - UnrelatedAcute Lymphoblastic LeukemiaHematology2014Standard TherapySpain 15
7335Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2014Standard TherapyTurkey8,8
7336Cord BloodAllogeneicAcute Lymphoblastic LeukemiaHematology2014Standard TherapyGermany45
7337Cord BloodAutologousAcute Myeloid LeukemiaHematology2014Standard TherapyPortugal6
7338Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2014Standard TherapyGermany6
7339Cord BloodAutologousCerebral PalsyNeurology2014Experimental TherapyPortugal4
7340Cord BloodAutologousCerebral PalsyNeurology2014Experimental TherapyUK1
7341Cord BloodAutologousHsv Encephalitis And Nmda Receptor Antibody EncephalitisNeurology2014Experimental TherapyUK2
7342Cord BloodAutologousHypoxia-Ischemic Encephalopathy (Hie)Neurology2014Experimental TherapyUK3 months
7343Cord BloodAllogeneic - RelatedLeukemiaHematology2014Standard TherapyUK4
7344Cord BloodAutologousSevere Aplastic AnemiaHematology2014Standard TherapyGermany11
7345Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany35
7346Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany73
7347Bone MarrowAllogeneicNon-Hodgkin-Lymphoma-RelapseHematology2014Standard TherapyGermany44
7348Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2014Standard TherapyGermany60
7349ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany52
7350ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany69
7351ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany51
7352ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany69
7353ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany52
7354ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany29
7355ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany76
7356ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany48
7357ApheresisAllogeneicAcute Myeloid LeukemiaHematology2014Standard TherapyGermany53
7358ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2014Standard TherapyGermany45
7359ApheresisAllogeneicAplastic AnemiaHematology2014Standard TherapyGermany27
7360ApheresisAllogeneicAplastic AnemiaHematology2014Standard TherapyGermany44
7361ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany46
7362ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2014Standard TherapyGermany67
7363ApheresisAutologousBing–Neel Syndrome; LymphomaHematology2014Standard TherapyGermany64
7364ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2014Standard TherapyGermany42
7365ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2014Standard TherapyGermany57
7366ApheresisAllogeneicComposite LymphomaHematology2014Standard TherapyGermany59
7367ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2014Standard TherapyGermany53
7368ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2014Standard TherapyGermany50
7369ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2014Standard TherapyGermany63
7370ApheresisAutologousGerm Cell TumorHematology2014Standard TherapyGermany24
7371ApheresisAutologousLymphoma-RelapseHematology2014Standard TherapyGermany56
7372ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany51
7373ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany62
7374ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany58
7375ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany62
7376ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany51
7377ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany59
7378ApheresisAutologousMantle Cell LymphomaHematology2014Standard TherapyGermany68
7379ApheresisAllogeneicMantle Cell LymphomaHematology2014Standard TherapyGermany60
7380ApheresisAutologousMarginal Zone LymphomaHematology2014Standard TherapyGermany52
7381ApheresisAllogeneicMorbus HodgkinHematology2014Standard TherapyGermany31
7382ApheresisAutologousMorbus Hodgkin-RelapseHematology2014Standard TherapyGermany44
7383ApheresisAutologousMorbus Hodgkin-RelapseHematology2014Standard TherapyGermany37
7384ApheresisAutologousMorbus Hodgkin-RelapseHematology2014Standard TherapyGermany19
7385ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany70
7386ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany71
7387ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7388ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany71
7389ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany66
7390ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7391ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany53
7392ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany59
7393ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7394ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany30
7395ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany64
7396ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany70
7397ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany77
7398ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany52
7399ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany60
7400ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany69
7401ApheresisAutologousMultiple MyelomaHematology2014Standard TherapyGermany63
7402ApheresisAllogeneicMultiple MyelomaHematology2014Standard TherapyGermany63
7403ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany68
7404ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany49
7405ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany55
7406ApheresisAllogeneicMyelodysplastic SyndromeHematology2014Standard TherapyGermany57
7407ApheresisAllogeneicMyeloproliferative NeoplasmsHematology2014Standard TherapyGermany56
7408ApheresisAllogeneicMyeloproliferative SyndromeHematology2014Standard TherapyGermany60
7409ApheresisAutologousNeuroblastomaHematology2014Standard TherapyGermany7
7410ApheresisAutologousNon-Hodgkin LymphomaHematology2014Standard TherapyGermany60
7411ApheresisAllogeneicNon-Hodgkin LymphomaHematology2014Standard TherapyGermany43
7412ApheresisAutologousPost-Transplant Lymphoproliferative DisorderHematology2014Standard TherapyGermany60
7413ApheresisAutologousPrimary Central Nervous System LymphomaHematology2014Standard TherapyGermany69
7414ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany64
7415ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany42
7416ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany51
7417ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany56
7418ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2014Standard TherapyGermany75
7419ApheresisAutologousSecondary LymphomaHematology2014Standard TherapyGermany59
7420ApheresisAutologousT-Cell Lymphoblastic LymphomaHematology2014Standard TherapyGermany54
7421ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany46
7422ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany48
7423ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2014Standard TherapyGermany43
7424ApheresisAllogeneicT-Cell Non-Hodgkin Lymphoma RelapseHematology2014Standard TherapyGermany56
7425Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2013Experimental TherapyPoland18,9
7426Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2013Experimental TherapyPoland2,11
7427Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2013Experimental TherapyPoland3,5
7428Cord TissueAllogeneic - UnrelatedAcute Myeloid LeukemiaHematology2013Experimental TherapyPoland3,5
7429Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2013Experimental TherapyPoland18,8
7430Cord TissueAllogeneic - UnrelatedChronic Graft Versus Host DiseaseHematology2013Experimental TherapyPoland17,5
7431Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2013Standard TherapyGermany8
7432Cord BloodAllogeneic - RelatedAcute Myeloid LeukemiaHematology2013Standard TherapyPoland3
7433Cord BloodAllogeneic - RelatedAplastic AnemiaHematology2013Standard TherapyPoland3
7434Cord BloodAllogeneic - RelatedLeukemiaHematology2013Standard TherapyTurkey7
7435Cord BloodAllogeneic - RelatedThalassemiaHematology2013Standard TherapyUK5
7436Cord BloodAllogeneic - RelatedThalassemia MajorHematology2013Standard TherapyTurkey7,12
7437Cord BloodAllogeneic - RelatedThalassemia MajorHematology2013Standard TherapyTurkey3
7438Cord BloodAllogeneic - RelatedThalassemia MajorHematology2013Standard TherapyTurkey?
7439Cord BloodAllogeneic - RelatedWiskott-Aldrich SyndromeHematology2013Standard TherapyGermany3
7440Cord BloodAllogeneic - RelatedX-Linked Lymphoproliferative SyndromeHematology2013Standard TherapyPoland10 months
7441Bone Marrow FamilyAllogeneicFollicular Lymphoma + Non-Hodgkin-HodgkinHematology2013Standard TherapyGermany38
7442Bone Marrow FamilyAllogeneicMultiple MyelomaHematology2013Standard TherapyGermany58
7443Bone Marrow FamilyAllogeneicMyelodysplastic SyndromeHematology2013Standard TherapyGermany73
7444Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2013Standard TherapyGermany71
7445ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2013Standard TherapyGermany44
7446ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany17
7447ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany55
7448ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany51
7449ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany21
7450ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany18
7451ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany59
7452ApheresisAllogeneicAcute Myeloid LeukemiaHematology2013Standard TherapyGermany55
7453ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2013Standard TherapyGermany62
7454ApheresisAutologousAngioimmunoblastic Lymphadenopathy With Dysproteinemia - RelapseHematology2013Standard TherapyGermany51
7455ApheresisAutologousAngioimmunoblastic Lymphadenopathy With Dysproteinemia - RelapseHematology2013Standard TherapyGermany54
7456ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2013Standard TherapyGermany55
7457ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2013Standard TherapyGermany62
7458ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2013Standard TherapyGermany52
7459ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2013Standard TherapyGermany32
7460ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2013Standard TherapyGermany51
7461ApheresisAutologousBurkitt LymphomaHematology2013Standard TherapyGermany49
7462ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany48
7463ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany48
7464ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany64
7465ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany61
7466ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2013Standard TherapyGermany54
7467ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2013Standard TherapyGermany62
7468ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2013Standard TherapyGermany54
7469ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2013Standard TherapyGermany39
7470ApheresisAutologousDiffuse Large B-Cell LymphomaHematology2013Standard TherapyGermany43
7471ApheresisAllogeneicHypoplastic Myelodysplastic SyndromeHematology2013Standard TherapyGermany32
7472ApheresisAutologousMantle Cell LymphomaHematology2013Standard TherapyGermany47
7473ApheresisAutologousMorbus Hodgkin-RelapseHematology2013Standard TherapyGermany50
7474ApheresisAutologousMorbus Hodgkin-RelapseHematology2013Standard TherapyGermany62
7475ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany70
7476ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany52
7477ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany48
7478ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7479ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany62
7480ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany73
7481ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany55
7482ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany53
7483ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany56
7484ApheresisAllogeneicMultiple MyelomaHematology2013Standard TherapyGermany61
7485ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany54
7486ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany60
7487ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany64
7488ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany66
7489ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany59
7490ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7491ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany59
7492ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7493ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany45
7494ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany50
7495ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany78
7496ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany46
7497ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany53
7498ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany65
7499ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany61
7500ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany40
7501ApheresisAutologousMultiple MyelomaHematology2013Standard TherapyGermany58
7502ApheresisAllogeneicMycosis FungoidesHematology2013Standard TherapyGermany62
7503ApheresisAllogeneicMyelodysplastic SyndromeHematology2013Standard TherapyGermany62
7504ApheresisAutologousNeuroblastomaHematology2013Standard TherapyGermany3
7505ApheresisAutologousNeuroblastomaHematology2013Standard TherapyGermany1
7506ApheresisAllogeneicNo DataHematology2013Standard TherapyGermany51
7507ApheresisAutologousNon-Hodgkin LymphomaHematology2013Standard TherapyGermany60
7508ApheresisAutologousNon-Hodgkin LymphomaHematology2013Standard TherapyGermany60
7509ApheresisAutologousNon-Hodgkin LymphomaHematology2013Standard TherapyGermany60
7510ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2013Standard TherapyGermany68
7511ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2013Standard TherapyGermany73
7512ApheresisAutologousPlasmacytomaHematology2013Standard TherapyGermany62
7513ApheresisAllogeneicPrimary Central Nervous System LymphomaHematology2013Standard TherapyGermany52
7514ApheresisAllogeneicPrimary MyelofibrosisHematology2013Standard TherapyGermany43
7515ApheresisAllogeneicPrimary Myelofibrosis, Second Acute Myeloid LeukemiaHematology2013Standard TherapyGermany60
7516ApheresisAllogeneicPrimary OsteomyelofibrosisHematology2013Standard TherapyGermany59
7517ApheresisAllogeneicT-Cell Acute Myeloid LeukemiaHematology2013Standard TherapyGermany61
7518ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2013Standard TherapyGermany45
7519ApheresisAutologousTeratocarcinomaHematology2013Standard TherapyGermany49
7520ApheresisAutologousTesticular Cancer RelapseHematology2013Standard TherapyGermany27
7521Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2012Experimental TherapyPoland19,7
7522Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2012Experimental TherapyPoland7,1
7523Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2012Experimental TherapyPoland4,3
7524Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany2
7525Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2012Standard TherapyGermany14
7526Cord BloodAutologousBrain DamageNeurology2012Experimental TherapyGermany3
7527Cord BloodAutologousCerebral PalsyNeurology2012Experimental TherapyPortugal3
7528Cord BloodAllogeneic - RelatedMyelodysplastic SyndromeHematology2012Standard TherapyHungary3
7529Cord BloodAllogeneic - RelatedT-Cell Acute Lymphoblastic LeukemiaHematology2012Standard TherapyTurkey4,1
7530Cord BloodAllogeneic - RelatedThalassemia MajorHematology2012Standard TherapyTurkey6,7
7531Cord BloodAllogeneic - RelatedThalassemia Major, Acute Lymphoblastic LeukemiaHematology2012Standard TherapyTurkey3,6
7532Cord BloodAutologousTyp-1-DiabetesEndocrinology2012Experimental TherapyGermany5
7533Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany64
7534Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany75
7535Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany55
7536Bone MarrowAutologousIschemic MyopathyHematology2012Standard TherapyGermany56
7537Bone MarrowAllogeneicMyelodysplastic Syndrome Refractory Anemia With Blast ExcessHematology2012Standard TherapyGermany70
7538ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany18
7539ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany42
7540ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany43
7541ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany60
7542ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany39
7543ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany62
7544ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany55
7545ApheresisAllogeneicAcute Myeloid LeukemiaHematology2012Standard TherapyGermany17
7546ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2012Standard TherapyGermany48
7547ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2012Standard TherapyGermany46
7548ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2012Standard TherapyGermany68
7549ApheresisAllogeneicAcute Myeloid Leukemia (High Risk)Hematology2012Standard TherapyGermany57
7550ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany47
7551ApheresisAllogeneicB-Cell Acute Lymphoblastic LeukemiaHematology2012Standard TherapyGermany43
7552ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2012Standard TherapyGermany70
7553ApheresisAutologousCentral Nervous System Non-Hodgkin LymphomaHematology2012Standard TherapyGermany54
7554ApheresisAutologousCerebral Diffuse Large B-Cell Lymphoma-RelapseHematology2012Standard TherapyGermany55
7555ApheresisAutologousDiffuse Large B-Cell Non-Hodgkin-LymphomaHematology2012Standard TherapyGermany54
7556ApheresisAutologousExtragonadal Germ Cell TumorHematology2012Standard TherapyGermany59
7557ApheresisAutologousFollicular LymphomaHematology2012Standard TherapyGermany54
7558ApheresisAutologousFollicular LymphomaHematology2012Standard TherapyGermany57
7559ApheresisAutologousFollicular Lymphoma-RelapseHematology2012Standard TherapyGermany59
7560ApheresisAutologousLymphoblastic B-Cell Non-Hodgkin-LymphomaHematology2012Standard TherapyGermany52
7561ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany61
7562ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany52
7563ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany57
7564ApheresisAutologousMantle Cell LymphomaHematology2012Standard TherapyGermany55
7565ApheresisAutologousMedulloblastomaHematology2012Standard TherapyGermany42
7566ApheresisAutologousMorbus Hodgkin-RelapseHematology2012Standard TherapyGermany27
7567ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany51
7568ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany60
7569ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany52
7570ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany71
7571ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany61
7572ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany53
7573ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany55
7574ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany70
7575ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany46
7576ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany64
7577ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany56
7578ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany68
7579ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany48
7580ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany59
7581ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany62
7582ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany72
7583ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany50
7584ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany60
7585ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany65
7586ApheresisAutologousMultiple MyelomaHematology2012Standard TherapyGermany67
7587ApheresisAllogeneicMyelodysplastic SyndromeHematology2012Standard TherapyGermany49
7588ApheresisAllogeneicMyelodysplastic SyndromeHematology2012Standard TherapyGermany69
7589ApheresisAutologousNon-Hodgkin LymphomaHematology2012Standard TherapyGermany62
7590ApheresisAutologousNon-Hodgkin LymphomaHematology2012Standard TherapyGermany57
7591ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany62
7592ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany57
7593ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany44
7594ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2012Standard TherapyGermany43
7595ApheresisAllogeneicOsteomyelofibrosisHematology2012Standard TherapyGermany61
7596ApheresisAutologousPlasmablastic LymphomaHematology2012Standard TherapyGermany54
7597ApheresisAutologousPlasmacytomaHematology2012Standard TherapyGermany69
7598ApheresisAutologousTesticular Cancer RelapseHematology2012Standard TherapyGermany36
7599Cord TissueAllogeneic - UnrelatedAcute Graft Versus Host DiseaseHematology2011Experimental TherapyPoland17,2
7600Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2011Standard TherapyPoland5
7601Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2011Standard TherapyUK8
7602Cord BloodAllogeneic - RelatedAcute Myeloid LeukemiaHematology2011Standard TherapyHungary2
7603Cord BloodAutologousBrain DamageNeurology2011Experimental TherapyGermany3
7604Cord BloodAutologousBrain DamageNeurology2011Experimental TherapyGermany7
7605Cord BloodAutologousCerebral PalsyNeurology2011Experimental TherapyPortugal6
7606Cord BloodAllogeneic - RelatedChronic Granulomatous DiseaseHematology2011Standard TherapyPoland7,5
7607Cord BloodAllogeneic - RelatedFanconi AnemiaHematology2011Standard TherapyPoland12
7608Cord BloodAllogeneic - RelatedHistiocytosisHematology2011Standard TherapyPoland2,5
7609Cord BloodAllogeneicScid (Severe Combined Immunodeficiency)Hematology2011Standard TherapyGermany1
7610Cord BloodAllogeneic - RelatedThalassemia MajorHematology2011Standard TherapyTurkey15
7611Cord BloodAllogeneic - RelatedThalassemia MajorHematology2011Standard TherapyTurkey15
7612Cord BloodAutologousTyp-1-DiabetesEndocrinology2011Experimental TherapyGermany2
7613Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany65
7614Bone Marrow FamilyAllogeneicMultiple MyelomaHematology2011Standard TherapyGermany50
7615Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany64
7616Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany45
7617Bone MarrowAutologousCoronary Artery DiseaseHematology2011Standard TherapyGermany68
7618Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany70
7619Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany55
7620Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany64
7621Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany71
7622Bone MarrowAutologousIschemic CardiomyopathyHematology2011Standard TherapyGermany62
7623Bone MarrowAutologousIschemic MyopathyHematology2011Standard TherapyGermany62
7624Bone MarrowAutologousIschemic MyopathyHematology2011Standard TherapyGermany69
7625Bone MarrowAutologousIschemic MyopathyHematology2011Standard TherapyGermany40
7626Bone MarrowAutologousPeripheral Artery DiseaseHematology2011Standard TherapyGermany74
7627Bone MarrowAllogeneicSevere Aplastic AnemiaHematology2011Standard TherapyGermany31
7628ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2011Standard TherapyGermany41
7629ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2011Standard TherapyGermany42
7630ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2011Standard TherapyGermany31
7631ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany64
7632ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany42
7633ApheresisAutologousAcute Myeloid LeukemiaHematology2011Standard TherapyGermany73
7634ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany54
7635ApheresisAutologousAcute Myeloid LeukemiaHematology2011Standard TherapyGermany70
7636ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany65
7637ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany69
7638ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany25
7639ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany48
7640ApheresisAllogeneicAcute Myeloid LeukemiaHematology2011Standard TherapyGermany59
7641ApheresisAllogeneicAcute Myeloid Leukemia - RelapseHematology2011Standard TherapyGermany53
7642ApheresisAutologousAnaplastic Lymphoma Kinase Positive Anaplastic Large-Cell LymphomaHematology2011Standard TherapyGermany60
7643ApheresisAutologousAngioimmunoblastic T-Cell LymphomaHematology2011Standard TherapyGermany63
7644ApheresisAllogeneicAplastic AnemiaHematology2011Standard TherapyGermany62
7645ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany41
7646ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany61
7647ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany51
7648ApheresisAutologousCentral Nervous System Non-Hodgkin LymphomaHematology2011Standard TherapyGermany41
7649ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2011Standard TherapyGermany62
7650ApheresisAutologousFollicular Lymphoma-RelapseHematology2011Standard TherapyGermany68
7651ApheresisAutologousGerm Cell TumorHematology2011Standard TherapyGermany28
7652ApheresisAutologousLymphoblastic LymphomaHematology2011Standard TherapyGermany49
7653ApheresisAutologousMantle Cell LymphomaHematology2011Standard TherapyGermany62
7654ApheresisAutologousMantle Cell LymphomaHematology2011Standard TherapyGermany51
7655ApheresisAutologousMantle Cell LymphomaHematology2011Standard TherapyGermany67
7656ApheresisAutologousMorbus HodgkinHematology2011Standard TherapyGermany70
7657ApheresisAutologousMorbus HodgkinHematology2011Standard TherapyGermany24
7658ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany58
7659ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany70
7660ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany59
7661ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany44
7662ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany52
7663ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany70
7664ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany55
7665ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany69
7666ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany58
7667ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany58
7668ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany60
7669ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany56
7670ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany66
7671ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany57
7672ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany47
7673ApheresisAllogeneicMultiple MyelomaHematology2011Standard TherapyGermany66
7674ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany60
7675ApheresisAllogeneicMultiple MyelomaHematology2011Standard TherapyGermany61
7676ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany69
7677ApheresisAutologousMultiple MyelomaHematology2011Standard TherapyGermany54
7678ApheresisAllogeneicMyelodysplastic SyndromeHematology2011Standard TherapyGermany68
7679ApheresisAllogeneicMyelofibrosisHematology2011Standard TherapyGermany40
7680ApheresisAutologousNon-Hodgkin LymphomaHematology2011Standard TherapyGermany47
7681ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2011Standard TherapyGermany61
7682ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2011Standard TherapyGermany43
7683ApheresisAutologousPlasmacytomaHematology2011Standard TherapyGermany68
7684ApheresisAutologousPlasmacytomaHematology2011Standard TherapyGermany51
7685ApheresisAutologousPrimary Central Nervous System LymphomaHematology2011Standard TherapyGermany43
7686ApheresisAllogeneicPrimary MyelofibrosisHematology2011Standard TherapyGermany36
7687ApheresisAllogeneicRefractory Acute Myeloid LeukemiaHematology2011Standard TherapyGermany27
7688ApheresisAutologousRichter's TransformationHematology2011Standard TherapyGermany71
7689ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany50
7690ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2011Standard TherapyGermany48
7691ApheresisAllogeneicT-Cell Non-Hodgkin Lymphoma RelapseHematology2011Standard TherapyGermany56
7692ApheresisAutologousTesticular Cancer RelapseHematology2011Standard TherapyGermany43
7693Cord BloodAutologousBrain DamageNeurology2010Experimental TherapyGermany5
7694Cord BloodAutologousBrain DamageNeurology2010Experimental TherapyGermany4
7695Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyPortugal1
7696Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyPortugal1
7697Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyPortugal6
7698Cord BloodAutologousCerebral PalsyNeurology2010Experimental TherapyUK3
7699Cord BloodAllogeneic - RelatedPre-B Acute Lymphoblastic Leukemia Hematology2010Standard TherapyHungary1,5
7700Cord BloodAutologousTyp-1-DiabetesEndocrinology2010Experimental TherapyGermany3
7701Cord BloodAutologousTyp-1-DiabetesEndocrinology2010Experimental TherapyGermany2
7702Bone MarrowAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany57
7703Bone MarrowAutologousChronic Ischemic CardiomyopathyHematology2010Standard TherapyGermany71
7704Bone MarrowAutologousCoronary Artery DiseaseHematology2010Standard TherapyGermany75
7705Bone MarrowAutologousCoronary Artery Disease; CardiomyopathyHematology2010Standard TherapyGermany52
7706Bone MarrowAutologousDilated CardiomyopathyHematology2010Standard TherapyGermany67
7707Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany70
7708Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany49
7709Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany48
7710Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany50
7711Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany54
7712Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany73
7713Bone MarrowAutologousIschemic CardiomyopathyHematology2010Standard TherapyGermany47
7714Bone MarrowAutologousMyocardial InfarctionHematology2010Standard TherapyGermany51
7715Bone MarrowAutologousMyocardial InfarctionHematology2010Standard TherapyGermany54
7716Bone MarrowAutologousMyocardial InfarctionHematology2010Standard TherapyGermany51
7717Bone MarrowAutologousPeripheral Artery DiseaseHematology2010Standard TherapyGermany56
7718Bone MarrowAutologousPeripheral Artery Disease With UlcerHematology2010Standard TherapyGermany79
7719ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2010Standard TherapyGermany26
7720ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2010Standard TherapyGermany64
7721ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany47
7722ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany44
7723ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany48
7724ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany59
7725ApheresisAllogeneicAcute Myeloid LeukemiaHematology2010Standard TherapyGermany50
7726ApheresisAllogeneicAcute Myeloid Leukemia; Myelodysplastic SyndromeHematology2010Standard TherapyGermany66
7727ApheresisAllogeneicAtypical Myelodysplastic SyndromeHematology2010Standard TherapyGermany25
7728ApheresisAllogeneicB-Cell Chronic Lymphoblastic LeukemiaHematology2010Standard TherapyGermany56
7729ApheresisAutologousB-Cell Non-Hodgkin LymphomaHematology2010Standard TherapyGermany54
7730ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2010Standard TherapyGermany52
7731ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2010Standard TherapyGermany45
7732ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2010Standard TherapyGermany57
7733ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2010Standard TherapyGermany43
7734ApheresisAutologousDiffuse Large B-Cell Non-Hodgkin-LymphomaHematology2010Standard TherapyGermany57
7735ApheresisAutologousExtramedullary PlasmacytomaHematology2010Standard TherapyGermany48
7736ApheresisAllogeneicMantle Cell LymphomaHematology2010Standard TherapyGermany61
7737ApheresisAutologousMantle Cell LymphomaHematology2010Standard TherapyGermany72
7738ApheresisAllogeneicMantle Cell LymphomaHematology2010Standard TherapyGermany53
7739ApheresisAutologousMorbus HodgkinHematology2010Standard TherapyGermany29
7740ApheresisAutologousMorbus Hodgkin-RelapseHematology2010Standard TherapyGermany21
7741ApheresisAutologousMorbus Hodgkin-RelapseHematology2010Standard TherapyGermany23
7742ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany43
7743ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany57
7744ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany62
7745ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany45
7746ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany47
7747ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany52
7748ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany52
7749ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany67
7750ApheresisAllogeneicMultiple MyelomaHematology2010Standard TherapyGermany55
7751ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany57
7752ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany51
7753ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany53
7754ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany69
7755ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany58
7756ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany70
7757ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany64
7758ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany69
7759ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany68
7760ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany63
7761ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany61
7762ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany56
7763ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany68
7764ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany52
7765ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany60
7766ApheresisAutologousMultiple MyelomaHematology2010Standard TherapyGermany64
7767ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany70
7768ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany57
7769ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany60
7770ApheresisAllogeneicMyelodysplastic SyndromeHematology2010Standard TherapyGermany33
7771ApheresisAllogeneicMyelodysplastic Syndrome; Acute Myelogenous LeukemiaHematology2010Standard TherapyGermany54
7772ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2010Standard TherapyGermany48
7773ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2010Standard TherapyGermany44
7774ApheresisAutologousPrimary Central Nervous System LymphomaHematology2010Standard TherapyGermany66
7775ApheresisAllogeneicPrimary MyelofibrosisHematology2010Standard TherapyGermany60
7776ApheresisAllogeneicPrimary MyelofibrosisHematology2010Standard TherapyGermany59
7777ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2010Standard TherapyGermany48
7778ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2010Standard TherapyGermany61
7779ApheresisAllogeneicT-Cell Non-Hodgkin LymphomaHematology2010Standard TherapyGermany41
7780ApheresisAllogeneicT-Cell Non-Hodgkin Lymphoma RelapseHematology2010Standard TherapyGermany43
7781ApheresisAutologousT-Cell-LymphomaHematology2010Standard TherapyGermany49
7782ApheresisAutologousTesticular CarcinomaHematology2010Standard TherapyGermany39
7783Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2009Standard TherapyGermany10
7784Cord BloodAllogeneic - RelatedBeta ThalassemiaHematology2009Standard TherapyGermany10
7785Cord BloodAutologousBrain DamageNeurology2009Experimental TherapyGermany2
7786Cord BloodAutologousBrain DamageNeurology2009Experimental TherapyGermany4 months
7787Cord BloodAutologousCerebral PalsyNeurology2009Experimental TherapyPortugal2
7788Cord BloodAutologousCerebral PalsyNeurology2009Experimental TherapyPortugal2
7789Cord BloodAutologousCerebral PalsyNeurology2009Experimental TherapyUK3
7790Cord BloodAllogeneic - RelatedMyelodysplastic SyndromeHematology2009Standard TherapyPoland5
7791Cord BloodAllogeneic - RelatedThalassemia MajorHematology2009Standard TherapyTurkey12
7792Cord BloodAutologousTyp-1-DiabetesEndocrinology2009Experimental TherapyGermany3
7793Cord BloodAutologousTyp-1-DiabetesEndocrinology2009Experimental TherapyGermany3
7794Cord BloodAutologousTyp-1-DiabetesEndocrinology2009Experimental TherapyGermany3
7795Bone MarrowAutologousCardiomyopathyHematology2009Standard TherapyGermany67
7796Bone MarrowAutologousCardiomyopathyHematology2009Standard TherapyGermany50
7797Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany49
7798Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany64
7799Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany55
7800Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany56
7801Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany46
7802Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany46
7803Bone MarrowAutologousIschemic CardiomyopathyHematology2009Standard TherapyGermany63
7804Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany57
7805Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany47
7806Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany57
7807Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany61
7808Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany44
7809Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany32
7810Bone MarrowAutologousMyocardial InfarctionHematology2009Standard TherapyGermany57
7811Bone MarrowAutologousNon St-Elevated Myocardial InfarctionHematology2009Standard TherapyGermany56
7812ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2009Standard TherapyGermany24
7813ApheresisAllogeneicAcute Lymphoblastic LeukemiaHematology2009Standard TherapyGermany43
7814ApheresisAutologousAcute Lymphoblastic Leukemia; Lymphoma - RelapseHematology2009Standard TherapyGermany47
7815ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany42
7816ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany49
7817ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany56
7818ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany57
7819ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany56
7820ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany61
7821ApheresisAllogeneicAcute Myeloid LeukemiaHematology2009Standard TherapyGermany57
7822ApheresisAllogeneicB-Cell Non-Hodgkin LymphomaHematology2009Standard TherapyGermany60
7823ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2009Standard TherapyGermany43
7824ApheresisAutologousB-Cell Non-Hodgkin Lymphoma - RelapseHematology2009Standard TherapyGermany61
7825ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2009Standard TherapyGermany47
7826ApheresisAllogeneicChronic Myelogenous LeukemiaHematology2009Standard TherapyGermany49
7827ApheresisAutologousHodgkin RelapseHematology2009Standard TherapyGermany46
7828ApheresisAutologousMantle Cell LymphomaHematology2009Standard TherapyGermany69
7829ApheresisAutologousMantle Cell Non-Hodgkin-LymphomaHematology2009Standard TherapyGermany56
7830ApheresisAutologousMucosa Associated Lymphoid Tissue/ Diffuse Large Cell LymphomaHematology2009Standard TherapyGermany55
7831ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany68
7832ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany55
7833ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany51
7834ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany58
7835ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany63
7836ApheresisAutologousMultiple MyelomaHematology2009Standard TherapyGermany63
7837ApheresisAllogeneicMultiple Myeloma; Myelodysplastic SyndromeHematology2009Standard TherapyGermany44
7838ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany70
7839ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany57
7840ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany67
7841ApheresisAutologousNon-Hodgkin LymphomaHematology2009Standard TherapyGermany68
7842ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2009Standard TherapyGermany46
7843ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2009Standard TherapyGermany74
7844ApheresisAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2009Standard TherapyGermany39
7845ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany63
7846ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany50
7847ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany60
7848ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany49
7849ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany68
7850ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany57
7851ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany53
7852ApheresisAutologousPlasmacytomaHematology2009Standard TherapyGermany64
7853ApheresisAllogeneicSevere Aplastic AnemiaHematology2009Standard TherapyGermany55
7854ApheresisAllogeneicSevere Aplastic Anemia And Paroxysmal Nocturnal HemoglobinuriaHematology2009Standard TherapyGermany47
7855Cord BloodAllogeneic - RelatedAcute Lymphoblastic LeukemiaHematology2008Standard TherapyPoland5
7856Cord BloodAutologousBrain DamageNeurology2008Experimental TherapyGermany1
7857Cord BloodAutologousCerebral IschemiaNeurology2008Experimental TherapyPoland1,5
7858Cord BloodAllogeneic - RelatedThalassemia MajorHematology2008Standard TherapyTurkey7
7859Bone Marrow FamilyAllogeneicAcute Lymphoblastic LeukemiaHematology2008Standard TherapyGermany17
7860Bone Marrow FamilyAllogeneicChronic Myelogenous LeukemiaHematology2008Standard TherapyGermany53
7861Bone MarrowAutologousCardiomyopathyHematology2008Standard TherapyGermany46
7862Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany60
7863Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany44
7864Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany67
7865Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany58
7866Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany56
7867Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany72
7868Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany69
7869Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany53
7870Bone MarrowAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany70
7871Bone MarrowAutologousPeripheral Artery DiseaseHematology2008Standard TherapyGermany76
7872ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany56
7873ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany58
7874ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany70
7875ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany56
7876ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany65
7877ApheresisAllogeneicAcute Myeloid LeukemiaHematology2008Standard TherapyGermany38
7878ApheresisAllogeneicB-Cell Non-Hodgkin Lymphoma - RelapseHematology2008Standard TherapyGermany49
7879ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2008Standard TherapyGermany51
7880ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2008Standard TherapyGermany49
7881ApheresisAutologousDiffuse Large B-Cell Non-Hodgkin-LymphomaHematology2008Standard TherapyGermany44
7882ApheresisAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany73
7883ApheresisAutologousIschemic CardiomyopathyHematology2008Standard TherapyGermany46
7884ApheresisAutologousMantle Cell LymphomaHematology2008Standard TherapyGermany64
7885ApheresisAutologousMorbus HodgkinHematology2008Standard TherapyGermany25
7886ApheresisAllogeneicMultiple MyelomaHematology2008Standard TherapyGermany52
7887ApheresisAllogeneicMultiple MyelomaHematology2008Standard TherapyGermany45
7888ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany61
7889ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany58
7890ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany67
7891ApheresisAutologousMultiple MyelomaHematology2008Standard TherapyGermany57
7892ApheresisAllogeneicMyelodysplastic SyndromeHematology2008Standard TherapyGermany58
7893ApheresisAutologousMyosarcomaHematology2008Standard TherapyGermany56
7894ApheresisAutologousNon-Hodgkin LymphomaHematology2008Standard TherapyGermany55
7895ApheresisAutologousNon-Hodgkin-Lymphoma-RelapseHematology2008Standard TherapyGermany65
7896ApheresisAllogeneicOsteomyelofibrosisHematology2008Standard TherapyGermany62
7897ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany68
7898ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany52
7899ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany53
7900ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany67
7901ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany69
7902ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany56
7903ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany59
7904ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany52
7905ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany60
7906ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany67
7907ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany68
7908ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany57
7909ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany62
7910ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany63
7911ApheresisAutologousPlasmacytomaHematology2008Standard TherapyGermany66
7912ApheresisAllogeneicRefractory Acute Myeloid LeukemiaHematology2008Standard TherapyGermany71
7913ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2008Standard TherapyGermany53
7914ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2008Standard TherapyGermany55
7915ApheresisAllogeneicSecondary Acute Myeloid LeukemiaHematology2008Standard TherapyGermany65
7916ApheresisAllogeneicSevere Aplastic AnemiaHematology2008Standard TherapyGermany29
7917ApheresisAllogeneicT-Cell Lymphoblastic LeukemiaHematology2008Standard TherapyGermany38
7918ApheresisAutologousT-Cell Non-Hodgkin LymphomaHematology2008Standard TherapyGermany28
7919ApheresisAutologousT-Cell Non-Hodgkin Lymphoma RelapseHematology2008Standard TherapyGermany21
7920Cord BloodAllogeneic - RelatedNeuroblastomaHematology2007Standard TherapyPoland8
7921Cord BloodAllogeneic - RelatedScid (Severe Combined Immunodeficiency)Hematology2007Standard TherapyPortugal1
7922Cord BloodAllogeneic - RelatedThalassemiaHematology2007Standard TherapyUK7
7923Bone Marrow FamilyAllogeneicAcute Myeloid LeukemiaHematology2007Standard TherapyGermany68
7924Bone MarrowAllogeneicParoxysmal Nocturnal Hemoglobinuria (Pnh)Hematology2007Standard TherapyGermany38
7925ApheresisAllogeneicAplastic AnemiaHematology2007Standard TherapyGermany49
7926ApheresisAllogeneicChronic Lymphocytic LeukemiaHematology2007Standard TherapyGermany57
7927ApheresisAutologousMyocardial InfarctionHematology2007Standard TherapyGermany61
7928ApheresisAutologousNon-Hodgkin LymphomaHematology2007Standard TherapyGermany57
7929Cord BloodAllogeneic - RelatedAplastic AnemiaHematology2005Standard TherapyGermany5
7930Cord BloodAutologousBrain DamageNeurology2005Experimental TherapyGermany1
7931Cord BloodAllogeneic - RelatedLeukemiaHematology2005Standard TherapyUKno data
7932Cord BloodAllogeneic - RelatedThalassemiaHematology2005Standard TherapyUK4
7933Cord BloodAutologousAcute Lymphoblastic LeukemiaHematology2004Standard TherapyGermany3